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Tyler S. Halpin-Healy 
 
 CRISPR-Cas defense systems are employed by their hosts to prevent parasitization by 
mobile genetic elements. The discovery of nuclease-deficient CRISPR-Cas systems contained 
within transposon ends suggested a repurposing of the contained defense system. One such Type 
I-F3 CRISPR-Cas system was found inside Tn6677, a Tn7-like transposon within the genome of 
a Vibrio cholerae strain. Tn6677 requires coordination between the contained CRISPR-Cas system 
and the transposition proteins for effective transposition. Isolation of this system, and reduction to 
its minimal components, enabled RNA-guided integration of donor DNA in Escherichia coli. 
Base-pairing interactions between the user-specified CRISPR RNA and the target sequence 
precede the integration of donor DNA approximately 49-bp downstream of the end of the target 
sequence. This system is specific regardless of the supplied RNA guide, and successfully integrates 
donors of different lengths. The donor DNA is indicated by flanking cognate transposon end 
sequences. While clearly functional, the mechanism by which the transposition proteins and the 
CRISPR-Cas proteins interact remained unclear. To this end we purified the multi-protein RNA-
guided DNA binding complex (Cascade) from the transposon-encoded minimal I-F3 CRISPR-Cas 
system in complex with the transposition protein TniQ. De novo modeling revealed the unexpected 
dimerization of TniQ, and its location within the complex, bound to the Cas6-end of the 
transposon-encoded Type I-F3 Cascade. Additional models obtained from DNA-bound structures 
of the complex demonstrate initial steps in target binding alongside novel conformations of 
 
 
Cascade subunits. This work reveals the mechanism by which the Tn6677 components guide 
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Chapter 1: Transposon biology and general 
mechanisms of transposition 
1.1: A primer on transposons 
Transposons, or Transposable Elements (TEs), are obligate genomic parasites defined by 
their ability to move from one position to another1. When Dr. Barbara McClintock discovered the 
Ac/Ds system in Maize in 1950, she revealed a category of mobile DNA elements that we now 
have come to realize are not only ubiquitous throughout many organisms but are also exceedingly 
overrepresented compared to other DNA elements2,3,4. These mobile DNA elements are so 
common that most laypeople have encountered them, with jewel maize used as a decoration, the 
British peppered moth that is used as an example of evolution in nearly every secondary-school 
biology textbook, or the RAG proteins that drive antibody generation in our own immune 
system2,5,6. Correlative with transposon mobility is the resulting genomic rearrangement, driving 
both genomic and organismal evolution7.  
TEs vary widely in their features and their mechanisms of transposition. A consequence of 
this variation is that only the most general definition can describe TEs: that a TE is a discrete DNA 
sequence capable of moving or copying itself from one position in a DNA strand to another 
position in a DNA strand8. The TE may encode all necessary factors for its mobilization (an 
autonomous TE), or may rely on other factors not encoded within the discrete DNA segment (a 
nonautonomous TE)9. In moving or copying, the TE may go through intermediate stages as DNA 
(DNA transposons) or RNA (retrotransposons)10. The possibility of massive genomic damage or 
rearrangement is increased with the inclusion of TEs in a genome, stemming from insertion of a 
TE into an open reading frame, an abundance of homologous regions proximal to each other, 
2 
abnormal transposition chemistry yielding novel genomic rearrangements, or a transposition 
mechanism that brings along adjacent (or intervening) DNA sequences11. However, TE integration 
is not intrinsically catastrophic and can even be beneficial depending on the genetic context; 
examples include the introduction of regulatory regions suppressing or enhancing novel reading 
frames, polyadenylation (pA) signals placed upstream of exons, the addition of splice donors or 
acceptors resulting in additional exons, or even the in-frame addition of a partial sequence of a 
gene, ultimately yielding a fusion protein4,10–12. Additionally, TEs are often found harboring 
passenger genes that may benefit the host, ensuring it is more beneficial for the host to keep the 
TE and its progeny by offsetting the metabolic burden of maintaining them13. TE-induced massive 
genomic reorganizations will inevitably drive evolution, solely as a consequence of the diversity 
being generated11.  
Despite TEs being capable of both beneficial and deleterious genomic rearrangement, the 
latter are catastrophic enough to warrant the existence of defense mechanisms to prevent 
transposition10,14,15. Downregulation of transposition often occurs through epigenetic silencing 
mechanisms such as N6-methyladenine in E. coli and 5-methylcytosine in eukaryotes, or through 
RNA interference (RNAi) pathways using PIWI-domain containing Argonaute-family proteins 
that quarantine the transposon by degrading transposon gene RNA transcripts10,15,16. However, due 
to the mutualism between prokaryotic TEs and their hosts, these TEs will often regulate their own 
activity12. This autoregulation can occur through various means, whether by an antisense RNA 
(asRNA), or ensuring specificity of the target site-determining pathway (e.g. conjugative plasmids 




1.2: General mechanisms of transposition 
Despite the diversity of transposition mechanisms, when sufficiently abstracted, common 
elements can be found. The first shared element is the same feature responsible for the discreteness 
of the TE, the ends of the transposon. The ends are the terminal sequences of the DNA sequence 
that establish the boundaries of a TE. Repetitive features within the ends, and what type of 
transposon they flank, determine what the ends are named: some are Inverted Terminal Repeats 
(ITRs), others are Long Terminal Repeats (LTRs), others are simply ends1. Whatever their name, 
the ends of the TE serve to distinguish the TE from the host’s genome. A lack of TE ends all but 
ensures that the protein effectors responsible for mobilizing the TE would be unable to bind to the 
TE1. The second element, regardless of the mechanism of transposition, is an effector protein to 
mobilize the sequence between the ends20. This may be a reverse transcriptase that can identify the 
transcribed TE, or it may be a transposase (also referred to as an integrase) specific to the TE that 
encodes it21,22. Additionally, the TE requires a targeting module, an effector that recognizes 
preferred target sites of the TE, whether via sequence or topological specificity23,24. The TE will 
also require a target site. Lastly, the TE requires an effector, the transposase/integrase, to integrate 
the mobilized TE into the target site specified by the targeting effector1.  
Transposons are first segregated into Class I and Class II transposons8. Class I transposons, 
also called retrotransposons, are TEs that transpose through an RNA-intermediate and as such, 
tend to encode a reverse transcriptase8. Class II transposons, or DNA transposons, are named as 
such, as they are mobilized by their cognate transposase from one DNA locus to a target site 
without proceeding through any RNA intermediates25. DNA transposons may be further 
categorized based on the catalytic domains (e.g. DDE, HUH) present in their transposase, and 
whether their transposition reaction involves ssDNA or dsDNA8. Despite there being a myriad of 
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specific transposition mechanisms for DNA TEs, most pertinent to this thesis are the cut-and-paste 
(sometimes called simple transposition) pathway and the replicative pathway.  
An exemplar of canonical cut-and-paste transposition, Tn5, and its mechanism of 
transposition is generalizable to other cut-and-paste Class II TEs. To initiate productive 
transposition, (1) Tn5’s transposase, TnpA, recognizes the TE ends and binds them26; (2) the Tn5-
end-bound TnpA monomers dimerize to form a loop called the synaptic complex or 
transpososome27; (3) TnpA cleaves at the boundaries of the Tn5 ends, excising the TE27; (4) the 
synaptic complex of the TE and Tn5 TnpA dimer is joined to the target DNA by the Tn5 TnpA 
dimer20; (5) the TnpA dimer integrates the synaptic complex at the target site by catalyzing a 
transesterification reaction with the free 3’-OH’s of the synaptic complex; (6) the integrated TE is 
immediately flanked by short single-stranded DNA (ssDNA) sequences; (7) host gap repair 
mechanisms fill in the ssDNA stretches creating a canonical Target Site Duplication (TSD)8. The 
length of the TSD is determined by the distance between the sites of the strand transfer attack and 
can differ between different TEs4. As the name of the general mechanism suggests, this process 
results in the complete removal of the TE from its initial locus and its insertion at a new one. An 




Figure 1: Mechanism of DNA cut-and-paste transposition by a DDE transposase 
The DDE transposase recognizes the ends of the TE and binds them. Following binding, the 
transposase excises the TE. The bound transposase catalyzes the transesterification reaction and 
drives the free 3’-OH’s attack of the target strand. The gaps formed as a byproduct of the 
integration reaction persist until host factors repair the ssDNA gap. Repair generates the hallmark 
target site duplications. Figure adapted from Craig, N. L. et al. Mobile DNA III8. 
 
 
Unlike cut-and-paste transposition, no step in replicative transposition ever yields a fully 
excised transposon1. The replicative transposition pathway, exemplified here by the Tn3 TE and 




Figure 2: Mechanism of Replicative Transposition with a DDE transposase 
When the TE and target site are proximal, the transposase binds and nicks the 3’-ends of the TE. 
The bound transposase catalyzes the free 3’-OHs attack of the target site. The 5’-ends of the TE 
are still bound to within the starting locus, resulting in a composite DNA molecule joined at a 
Shapiro Intermediate. Replication initiated in part by the topology of the Shapiro Intermediate 
produces a cointegrate. The cointegrate links the donor DNA and target DNA through the TE. 
Lack of a resolvase will cause the reaction to halt here. Introduction of a resolvase will effectively 
return the two dsDNA molecules to their beginning state, but with the TE replicated into the 
target DNA. Figure adapted from Craig, N. L. et al. Mobile DNA III8. 
 
 
proceeds as follows: (1) the Tn3 transposase TnpA forms a complex with both the TE and the 
target DNA; (2) Tn3 TnpA nicks the 3’ ends of the TE; (3) similarly to the cut-and-paste pathway, 
the nicked strands provide free 3’-OH’s resulting in invasion of the target DNA with an offset that 
will yield a TSD of the same length as the offset; (4) the invasion 3’-nicked dsDNA transposon 




TE:target DNA to replication forks; (5) replication is initiated by the host replisome at the free 3’ 
ends of the target DNA, synthesizing the complementary strands of the TE, forming a cointegrate 
containing the entire donor molecule flanked by two repeats of the transposon sequence; (6) if this 
TE contains a resolvase (TnpR in the case of Tn3), the cointegrate may then undergo 
recombination to be separated into two double stranded (dsDNA) molecules28. The first molecule 
is an exact replica of the initial locus with the TE, and the second is the target locus interrupted 
with the replicated Tn3. Without the resolvase or other modes of assisted recombination, the 
cointegrate molecule will persist29. 
Both Tn3 and Tn5 utilize DDE transposases for their integration steps; named as such for 
their catalytic domain resembling an RNase H-like fold and the conservation of the eponymous 
amino acids1,28. This fold brings the DDE residues into proximity with each other, forming the 
active site of the transposase. This active site cleaves DNA phosphodiester bonds and forces the 
strand transfer of the invading TE DNA strand using the free 3’-OH on each strand as the 
nucleophile in the subsequent transesterification reaction1,8. 
 
1.3: Tn7 transposon biology in its endogenous context  
The transposon Tn7 was first discovered in E. coli in 1976. Identified originally through 
its passenger genes that carry antibiotic resistance30,31, it was later found in medical samples, 
hinting at its widespread distribution8. With the explosive growth of sequence repositories, Tn7 
and Tn7-like transposons have been found across many environments in widely diverged 
prokaryotes32. Tn7 is the founding member of the Tn7-like transposon family that contains TEs 
with obvious Tn7-like characteristics, mainly the protein components encoded by tnsA, tnsB, tnsC, 
tnsD, and in the case of the seminal member, tnsE8. Broadly, Tn7 transposition proceeds as 
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follows: First, TnsB recognizes the ends of the TE and together with TnsA, forms the heteromeric 
transposase responsible for the unique transposition reaction mechanism of Tn733,34. Second, the 
TnsA/TnsB heteromeric transposase brings the ends of the Tn7 TE together to form the Paired-
End Complex (PEC)35. The PEC is structurally and functionally analogous to Tn5’s synaptic 
complex given in the initial example of cut-and-paste transposition. Third, TnsC mediates the 
interaction between the PEC and the targeting proteins TnsD and TnsE (but never 
simultaneously)36. The heteromeric transposase TnsA/TnsB only excises the PEC when in 
complex with TnsC and either TnsD or TnsE at their specified target sites37. Tn7, like other DDE-
family transposons, integrates the TE through a transesterification reaction and as such will yield 
a 5-bp TSD due to the 5-bp offset of the nucleophilic attacks from the TnsB integrases when 
attacking opposite strands of the target DNA38. Should this reaction proceed down the TnsE 
pathway, the PEC+TnsA/B/C is recruited to TnsE, a site-selecting protein that identifies and binds 
the 3’-recessed ends in the lagging-strand during DNA replication. The PEC+TnsA/B/C/E 
complex then integrates at the TnsE-bound free 3’ DNA end24. This pathway facilitates horizontal 
gene transfer of Tn7 by allowing Tn7 to transpose onto conjugal plasmids13. Alternatively, should 
the transposition reaction proceed via TnsD instead of TnsE, the PEC+TnsA/B/C/D complex is 
recruited to 3’-end of the highly conserved glucosamine 6-phosphate synthase (glmS) gene through 
the sequence-specific binding of TnsD. The TnsD pathway results in Tn7 integrating the TE just 
downstream of the coding region of glmS and allows Tn7 to be transmitted vertically22,39.  
A curious feature of Tn7 transposition is target site immunity. Wild type Tn7 will transpose 
with severely reduced efficiency into a target site that has already been used for transposition and 
contains an integrated Tn7 TE nearby40. This phenomenon can persist through closely related 
homologous Tn7 systems but may be bypassed if the integrated TE and the transposing homolog 
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are diverged enough41. Furthermore, target site immunity is not likely due to DNA-molecule 
specific effects, as the presence of Tn7 ends on one of two spatially proximal, but separate plasmids 
intercalated with each other will reduce transposition into both42. Target immunity is hypothesized 
to be essential to preventing rampant genomic instability from sequential transposition into the 
same locus, as the target sequence recognized by TnsD is not disrupted by the first transposition 
event8. It is likely required due to 1) the high efficiency of Tn7 transposition, and 2) that a high 
concentration of homologous regions at a single locus will almost invariably result in 
recombination that may create deleterious chromosomal rearrangements8.  
 
1.4: Components and mechanistic details of E. coli Tn7 transposition 
Tn7 ends 
Denoted as Left and Right, the ends of E. coli Tn7 serve to distinguish the TE from the 
surrounding sequence. The Left end is 150 bp long and contains 3 TnsB binding sites, each 22 bp 
long. The Right end is shorter at 90 bp, but contains four TnsB binding sites, and is the end closest 
to tnsA (see Figure 3)33,43,32. When transposing through the TnsD pathway, the Tn7 transposon will 
always integrate with the Right end proximal to glmS end37.  
 
 
Figure 3: Distribution of TnsB binding sites in Tn7 ends 
The bounds of the Tn7 are determined by the Left and Right end sequences. The Right end is 
always closer to tnsA. The Right end contains four 22-bp TnsB binding sites within its 90-bp 
10 
length. The Left end contains only three, spread across its 150-bp length. Figure adapted from 




TnsA is the endonuclease responsible for cleaving the 5’-ends of the TE, at +3 bp just 
upstream of the Tn7 ends44. TnsA may be specific to Tn7 and its homologs, as it shows little 
sequence homology to other proteins outside of the Tn7 family. A crystal structure of TnsA 
revealed structural similarity between the N-terminal region of TnsA and the active site of the 
endonuclease FokI45. The C-terminal domain (CTD) of TnsA displays structural similarity to the 
linker histone H5 and is responsible for interfacing not only with the Tn7 ends, but also TnsB and 
TnsC34,44. CTD fragments of TnsC (TnsC495-555) bind to TnsA and stimulate nonspecific DNA 
binding. Furthermore, the TnsC495-555 fragment stimulates cleavage of DNA bound by a TnsAB 
heterotransposase44. TnsA stimulates formation of the PEC when bound to TnsB on Tn7 ends46. 
Perhaps unsurprisingly, loss-of-function mutations (E63A, D114A, K132A) place the catalytic site 
of TnsA, thus the endonuclease domain, within the first half of the TnsA sequence34,45. 
Interestingly, a Tn7 TE with a TnsA active site loss-of-function mutant (TnsAD114A) will 
completely lose 5’ cleavage, forcing the TE through replicative transposition in lieu of its normal 




Figure 4: Length and key features of E. coli Tn7 core components 
Relevant features mentioned in the text are diagrammed here for E. coli Tn7 proteins. Indicated 
amino acids comprise a classifying feature of the protein, e.g. the D273, D361, E396 that make up 




As a DDE retroviral integrase, TnsB is the archetypal transposition protein in Tn78. The 
DDE motif (D273, D361, E396) is contained within TnsB residues 266 to 40647. As with other 
DDE integrases, disrupting the motif’s interaction with metal ions, whether by mutation or 
chelation, removes TnsB’s ability to catalyze integration34. TnsB binds to repeated 22-bp 
sequences within the Left and Right ends of Tn733. Following end binding, TnsB will recruit and 
complex with TnsA on the ends of Tn7, ultimately leading to the formation of the PEC46. When 
bound on the ends of the PEC, TnsB is poised to cleave the 3’-ends of the TE and catalyze the 
strand-transfer reaction to the target site, presumably upon signaling from TnsC. Truncating TnsB 
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by removing the last 40aa in TnsB’s CTD, creating TnsB1-662, will abolish all integration. The 
removed 40 aa are implicated in TnsC interaction, as while there is no productive integration with 
the full TnsAB1-662C+D complex, there is also no productive integration with the TnsAB1-662CA225V 
complex35. Additional support for TnsC interaction with TnsB through TnsB’s CTD is that specific 
mutations within the CTD (P686S, V6899M, and P690L) produce a TnsB that fails to establish 
target immunity. Given that the model of target immunity (shown in Figure 5) is dependent on 
TnsB-TnsC interactions, TnsB’s CTD is implicated in contacting TnsC36. See Figure 4 for noted 
features of E. coli TnsB.  
 
 
Figure 5: TnsB-mediated target immunity 
Target immunity prevents the transposition of Tn7 into a site that already contains an integrated 
Tn7 nearby. TnsB binding at the ends of the integrated element results in an increased local 
concentration of TnsB. TnsB interaction with TnsC prevents productive complex formation of 
TnsC with either TnsD or TnsE if they are adjacent to the high concentration of TnsB. Figure 




TnsC is a AAA+ ATPase that functions primarily as a mediator between the TnsA/TnsB 
heteromeric transposase and the target site selectors, TnsD and TnsE 8. In vitro reactions have 
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shown that ATP is essential for Tn7-transposition and that it cannot occur in the presence of 
ADP37,48. However, when the same reactions are carried out using a non-hydrolyzable ATP analog, 
in the absence of TnsD & TnsE, random integration will occur37. Use of the TnsCA225V ATPase 
active site mutant in transposition reactions will allow a TnsA/B/CA225V complex to integrate the 
TE in a sequence-independent fashion. Strangely, the same mutation does not abolish TnsC’s 
ability to bind to TnsD and TnsE and can still transpose through those targeting pathways40,47,49. 
Concomitant with the ease at which targeting pathways can be circumvented is the theory that the 
site selectivity of TnsD and TnsE must confer a survival advantage on Tn7. The CTD of TnsC 
(residues 504-555 of 555) interact with TnsA34,44. To date, there is no published work indicating 
what portion of TnsC interacts with TnsB.  
Analysis of target immunity indicates a relationship between TnsB and TnsC. Currently, 
target immunity is thought to emerge from the increased local concentration of TnsB around Tn7 
ends, granting primacy to TnsC-TnsB interactions over DNA-bound TnsD/TnsE interactions with 
TnsC. As ATP is required not only for productive transposition, but for TnsC binding to DNA, it 
is likely that TnsB forces TnsC to hydrolyze any bound ATP, preventing transposition40,42,50. This 
model is further supported by the findings that target immunity can be bypassed with the use of 
non-hydrolyzable ATP analogs or the use of the TnsC mutant TnsCS401YΔ402, which ablates the 
requirement for ATP and will allow productive transposition in the presence of ATP or ADP. 
While the TnsCS401YΔ402 mutant bypasses target immunity, it also foregoes any site selectivity, 
integrating regardless of DNA sequence through TnsC-DNA interactions40,42. Furthermore, 
mutations in TnsC that abolish TnsB interaction (and vice-versa) create additional target immunity 
bypass Tn7 variants49. Most oddly, the TnsCS401YΔ402 mutation does not appear to affect ATP 
hydrolysis activity and is thought to instead force a permanent conformational change in TnsC that 
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would otherwise occur upon TnsD/TnsE binding and subsequent ATP hydrolysis40. While TnsC 
recruitment to TnsD-attTn7 (attTn7 is the DNA sequence within glmS recognized by TnsD) is 
dependent upon the topological changes of the local DNA enforced by TnsD, it appears that 
simultaneous expression of TnsC and TnsD will increase recruitment of TnsD to attTn722. Lastly, 
while in the TnsC-TnsD-attTn7 complex, TnsC binds the minor groove of the DNA in between 
attTn7 and the Tn7 insertion site22,39. Footprinting assays suggest that it is TnsC that is responsible 
for the 25-bp separation of attTn7 and the downstream insertion site43. See Figure 4 for noted 
features of E. coli TnsC. 
 
TnsD 
TnsD is one of two target-site selecting proteins in the Tn7 transposon. TnsD recognizes 
the DNA sequence at attTn7 and coordinates integration 25-bp downstream of the recognized site, 
just outside of the coding region of glmS. A zinc finger domain of CCCH can be found at positions 
C124, C127, C152, and H155. While mutations in these residues ablate recognition of the attTn7 
sequence, they do not prevent DNA binding, suggesting TnsD harbors additional DNA-binding 
motifs22. TnsD binding to attTn7 requires the essential host factors ACP (acyl carrier protein) and 
L29 (large ribosomal subunit 29)51. Binding of TnsD to attTn7 results in a distortion in the DNA 
that is required for TnsC recruitment22. Beyond the target site distortion, TnsD and TnsC interact 
through their N-terminal domains, as deletion of either abrogates attTn7:TnsD:TnsC complex 






TnsE stimulates Tn7 transposition into lagging-strand DNA during replication, specifically 
recognizing the 3’-recessed ends of DNA in the lagging strand. Mutations in the C-terminus of 
TnsE will generate hyperactive 3’-recessed end DNA-binding mutants, implicating the C-terminus 
of TnsE in DNA binding. However, initial targeting to replicating DNA likely occurs through a 
conserved sliding clamp interacting sequence from residues 121-131 that moderates the interaction 
of TnsE with DnaN. Electrophoretic Mobility Shift Assays (EMSAs) of TnsE incubated with DNA 
containing a 3’ recessed end yield both shifted and supershifted species, indicating a potential for 
TnsE multimerization24,52. See Figure 4 for noted features of E. coli TnsE. 
 
TnsD-mediated transposition 
As mentioned before, Tn7 may transpose through two different pathways. One is the TnsD 
driven pathway, in which the target-site binding protein TnsD binds to the attTn7 TnsD attachment 
site at the end of the coding region of the highly conserved glmS gene (see Figure 6 and Figure 
7)38. The binding of TnsD to this sequence is stimulated by the host factors ACP and L2951. 
Binding of TnsD to attTn7 distorts the DNA topology at the distal end of glmS 22. This distortion, 
in concert with the N-terminus of TnsD, recruits and binds TnsC through TnsC’s N-terminal 
domain39. Simultaneously, the integrase TnsB has bound the TnsB binding sites located in the 
Right- and Left-ends of the Tn7 TE33. TnsB binding to the TE ends recruits the endonuclease TnsA 
to assemble the heteromeric transposase TnsA/TnsB on the ends of the TE. TnsA binding to TnsB 
effects a topological change of the TE that results in the formation of the toroidal shape of the 
PEC46. With the PEC in proximity of the target-bound TnsD and TnsC, the C-terminal domain of 
TnsC binds to the C-terminal domain of TnsA, while undergoing a conformational change that 
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allows the catalytic core of the TnsBs bound to each end of the PEC to access the downstream 
integration site with a 5-bp offset. TnsA cleaves the 5’-strands of the TE and TnsB performs a 5-
bp staggered strand-transfer reaction with the 3’-ends of the TE post 3’-end cleavage44. At this 
point the TE has been completely excised from the donor DNA and has left two free DNA ends 
behind. The now integrated Tn7 is flanked by two 5-bp ssDNA segments connecting it to the rest 
of the flanking dsDNA sequence. These ssDNA segments are a consequence of the 
transesterification reaction chemistry performed by TnsB. They will be filled in by a host 
polymerase forming the TSDs1,8. Perhaps as a consequence of the asymmetric distribution of TnsB 
binding sites within the ends of the TE, the transposon has integrated with the Right end proximal 
to the TnsD binding site37. With the ends of the Tn7 TE now adjacent to the attTn7, the local 
concentration of TnsB is sufficiently high enough to discourage productive TnsC interaction with 
DNA or TnsD, resulting in the observed target immunity40,42,50. 
 
 
Figure 6: Tn7 transposition at attTn7 
An ideogram of the full complex of the Tn7 transpososome at the moment before integration just 
downstream of attTn7. The PEC is formed by the transposing Tn7 element, multiple copies of 
TnsB, and multiple copies of TnsA bound to TnsD through the coordinating transposition 
protein, TnsC. Exact protein structures and interacting residues are currently unknown. Figure 




Figure 7: Detail of TnsD – glmS interaction at attTn7 
TnsD contains a DNA-binding Domain of exquisite specificity. Binding to the nigh-terminal 25 
bases of glmS, TnsD directs integration immediately downstream of the attTn7 attachment site. 
The integration site is indicated, with the 5 bases that will create the TSD between the noted -2 




Other than the target site and the target-site binding protein, much of the pathway of TnsE-
mediated transposition is similar to the TnsD-mediated pathway. The substrate for TnsE binding 
is a 3’-recessed end of DNA (most often found in the lagging strand during DNA replication) and 
the sliding clamp processivity factor DnaN, likely through TnsE’s own N-terminal domain (Figure 
8). Interestingly, TnsE preferentially targets conjugal plasmids, and may target replicating 
bacterial chromosomes, and even the filamentous phage M1324,52. The TnsE-mediated pathway of 
Tn7 transposition is sensitive to target immunity, likely due to the fact that only the target site 





Figure 8: Tn7 transposition into a lagging strand during DNA replication 
An ideogram of the full complex of the Tn7 transpososome at the moment before integration into 
a growing lagging strand. TnsE is recruited to the replicating DNA through its interaction with 
DnaN and the recessed 3’ DNA ends. As in the TnsD pathway, TnsC coordinates integration with 
the PEC+TnsA/B. Exact protein structures and interacting residues are currently unknown. Figure 
adapted from Peters, J. E. Mol. Microbiol. 112, 1635–1644 (2019)38. 
 
 
1.5: Genetic engineering with transposable elements 
Due to their precise integration chemistry, transposons present exciting targets for tool 
development. The ability to insert a genetic payload with minimal scarring and requiring few to 
no host factors will always be useful, whether for use in a research lab or in a clinical setting. The 
existence of transposons with extreme sequence specificity requirements has emboldened 
scientists to attempt altering transposon insertion site sequence specificity, with the holy grail 
resembling an easily programmable system akin to the CRISPR-Cas systems used to generate 
knockouts54,23,55,56,57. Currently, the most widely used transposons for genetic engineering have 
strict, but common, target site sequence requirements, such as Sleeping Beauty’s -TA- site 
specificity23. Despite the frequency of potential integration sites, transposon-based gene insertion 
is being used in clinical trials, notably for ex vivo integration of Chimeric Antigen Receptors in T-
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cells for immunotherapeutic approaches to malignancies58. There are more well-established 
methods for genetic payload insertion, such as lentiviral methods. However, transposons have 
some key advantages, notably they are less immunogenic and easier to produce than lentivirus-





Chapter 2: CRISPR-Cas Biology 
2.1: CRISPR-Cas systems in their native context 
Phages and mobile genetic elements (MGEs) have besieged prokaryotes since their first 
encounter. Phages alone are estimated to lyse 30% of all bacteria daily60. This unending battle has 
forced an arms race with all members evolving new mechanisms of defense and counter defense. 
It is perhaps one of the oldest theories of biology, that pressure yields diversification. While 
certainly not speaking about phages and prokaryotes, Charles Darwin once (presciently) wrote 
“One may say there is a force like a hundred thousand wedges trying to force every kind of adapted 
structure into the gaps in the economy of nature, or rather forming gaps by thrusting out weaker 
ones”61. The diversity this arms race has yielded is a treasure trove of biological mechanisms that 
the scientific community has only begun to appreciate the scope of. While a sample of these 
systems are less obviously applicable and thus have been studied only for their own sake62, others 
such as restriction enzymes from restriction modification systems, have been utilized by scientists 
daily for decades63. One such system has been thrust to the fore only recently but is poised to make 
an enormous contribution to the biological sciences and tangential fields: the CRISPR-Cas 
systems64. 
Clustered Regularly Interspaced Palindromic Repeats (CRISPR) and their CRISPR-
associated (Cas) genes describe a family of adaptive immune systems in prokaryotes and archaea. 
There are myriad distinct mechanisms by which CRISPR-Cas systems effect their response to 
invading nucleic acids, but common to all are the eponymous CRISPR RNAs (crRNAs) derived 
from a genomic feature named the CRISPR array. Regardless of which Cas-protein or Cas-protein 
complex binds its cognate crRNA, the crRNA is responsible for specifying at least the initial target 
of the CRISPR-Cas complex65. Compared with rationally engineering protein structure to alter 
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protein binding specificity, the relative ease with which crRNAs may be altered has given modern 
scientists unprecedented levels of control over their model organisms. 
Broadly, CRISPR-Cas systems mount their defense against invasive nucleic acid species 
in three stages, as shown in Figure 9.  
 
 
Figure 9: Stages of CRISPR-Cas defense 
Host defense by a CRISPR-Cas system ensues as follows: 1, an invading phage (or other invasive 
nucleic acid) is processed by adaptation machinery and has a protospacer removed and 
incorporated into the bacterium’s CRISPR array. 2, production of Cas effector proteins and pre-
crRNA, maturation of the pre-crRNA into discrete crRNAs. 3, assembly of the interference 
module and protospacer binding based on crRNA spacer sequence, target cleavage follows 
shortly after. Figure adapted from Klompe, S. E. & Sternberg, S. H. Cris. J. 1, 141–158 (2018)66. 
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In the first stage, spacer acquisition, short sequences of an invading nucleic acid are processed by 
distinct Cas proteins and incorporated into the host’s CRISPR array. In the second stage, 
expression and processing, the Cas gene expression may be upregulated and the CRISPR array is 
transcribed, creating the pre-crRNA. Processing of the pre-crRNA into mature crRNAs then allows 
complexing of the expressed Cas proteins with a single mature crRNA per complex. In the third 
stage, interference, Cas-crRNA Ribonucleoprotein (RNP) complexes interrogate their target 
nucleic acids; guided by their crRNA, the complexes bind a complementary sequence, and 
degrade, or signal for the degradation of, the bound nucleic acid66. Target search occurs in three 
dimensions and with the RNP complex interrogating the bound DNA for Protospacer Adjacent 
Motifs (PAMs)67. PAMs serve as a self-other identifier to prevent binding and cleavage of the 
spacer within the CRISPR array from whence the crRNA came68. Should the RNP encounter a 
PAM, the crRNA spacer will begin binding the protospacer (site with complementarity to the 
spacer) through canonical nucleic acid base pairing. Mismatches between the crRNA spacer and 
the target DNA are poorly tolerated in the PAM-proximal region of the crRNA, termed the seed 
sequence67,69. The end of the seed sequence is set at the nucleotide beyond which mismatches will 
not entirely ablate spacer-protospacer binding70. Complete binding of the RNP to the protospacer 
toggles a conformational change resulting in cleavage of the bound target, or recruitment of a 
nuclease, and subsequent cleavage or degradation of the RNP-bound DNA67,71,72. 
 
2.2: Two CRISPR-Cas classes and mechanistic differences 
As a product of an ongoing arms race, CRISPR-Cas systems are staggeringly diverse in 
both their form and function65,73. To accommodate this ever-expanding diversity, CRISPR-Cas 
systems are classified primarily by their evolutionary relationships; focusing on Cas gene operonic 
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composition, the architecture of CRISPR-Cas loci, sequence similarity, the phylogeny of more 
conserved Cas genes, and more recently, by mutual association with non-Cas genes74,65. The 
greatest distinction is between the Class 1 and Class 2 systems. Class 1 systems utilize multiple 
Cas proteins in complex as the interference module. Class 2 systems use a single effector protein 
for interference66. Although the Class 2 Type II Cas9 containing systems are most broadly 
recognized, it is the Class 1 Type I-F systems, and the Cas12-containing Class 2 Type V systems 
are most relevant to this thesis9,65,66,75.  
The most diverse of the Class I systems, Class I Type I systems, are typified by their use 
of a multiprotein complex built around a mature crRNA responsible for target site binding and R-
loop formation76. Based on the previously mentioned classification parameters, Type I systems are 
further segregated into Type I-A through I-G, with the I-F subclass divided into I-F1, I-F2, and I-
F365. With the exception of Type I-D and Type I-F3 systems, all Type I systems use the nuclease 
Cas3, or a homolog, for target degradation65,77. Most Type I systems utilize Cas6 to mature the 
pre-crRNA by cleaving stem-loop structures formed within the repeats of the pre-crRNA78,79. The 
cleavage site within the repeats leaves a portion of each repeat flanking the spacer region; these 
partial repeats are referred to as the 5’- and 3’-handles of the crRNA80. The Cas6 of some Type I 
systems remains bound to the stem-loop of the 3’-handle post-maturation79,81,78. At the other end 
of the crRNA, Cas5 binds the 5’-handle, and is positioned adjacent to Cas8, the large subunit 
responsible for PAM recognition82,83. Across the spacer, 6 copies of Cas7 form a helical spine. 
Some Type I systems utilize the small subunit, Cas11, to stabilize the crRNA-DNA interaction. 
This assembled RNP complex is referred to as Cascade, or the CRISPR Associated Complex for 
Antiviral Defense84–86. Cascade can only bind the target DNA and possesses no inherent nuclease 
activity87. A notable feature of Type I systems is the Cas7-crRNA interaction that “flips” every 
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sixth base in the crRNA away from potential protospacer binding88. Consequently, Cascade 
binding is tolerant of mismatches between the spacer region of the crRNA and the protospacer 
DNA at every 6th position89.  
In 2015, Makarova et al defined a putative Type V CRISPR-Cas system containing the 
interference module Cpf1 (later reclassified as Cas12a), a CRISPR array, along with the adaptation 
module expressed from Cas1, Cas2, and Cas474. Initial work on Cas12a established that it is an 
RNA-guided dsDNA endonuclease with a RuvC domain, a Nuc domain, and a ribonuclease 
domain71. Cas12a catalyzes the maturation of its own pre-crRNA to crRNA via said ribonuclease 
domain90. Unsurprisingly, Cas12a recognition and processing of the pre-crRNA requires full 
length repeats that maintain their stem-loop structure. However, so long as mutations in the repeat 
do not alter the secondary structure, Cas12a is still able to process the repeat90. Early work on 
Cas12a homologs established a 5’-TTN-3’ or 5’-TTTN-3’ PAM immediately upstream of the 
protospacer71. Cas12a tolerates truncated crRNAs as well as single mismatches, even when 
directly adjacent to the PAM90,91. Upon binding of a complementary protospacer, crRNA guided 
Cas12a initially cleaves the displaced strand in the RuvC domain, then further unwinds the target 
dsDNA and cleaves the crRNA-bound DNA strand an additional 5-7bp PAM-distal92. Although 
the cuts are staggered, they are in close enough proximity that a double strand break will follow 
successful cleavage of both the non-target and target strands of DNA71. By 2020, the Type V clade 
had drastically expanded with novel variants, displaying a diversity of CRISPR-Cas systems with 
varying requirements for trans-activating CRISPR-RNAs (tracrRNA, a structural RNA with 
partial complementarity to the crRNA, contributes to crRNA maturation), different genomic 
organization, and differing amounts of Cas genes. As a result of these differences, Type V systems 
are currently the most diverged of the Class 2 systems65,69. Some subgroups completely lack 
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adaptation modules or contain a nuclease-deficient Cas12 homolog65,93. Currently, there are four 
other major types of CRISPR-Cas systems, but they fall beyond the scope of this thesis.65 
 
2.3: Class I Type I-F mechanism of target degradation 
Class I Type I-F systems differ from the rest of the Type I family, as they lack the small 
subunit Cas11 and contain a fusion Cas2/Cas3 helicase/nuclease65,72. The Cas2/Cas3 fusion is 
responsible for both spacer acquisition and degradation of DNA at the Cascade-bound target site94. 
Early work refers to the Type I-F Cascade as Csy complex, or CRISPR subtype Yersinia pestis95. 
Prior to recruitment by Cascade, the Cas2/Cas3 protein homodimerizes and complexes with four 
molecules of the Cas1 integrase, forming a Cas2/Cas32Cas14 multimer. The bound Cas1 inhibits 
Cas2/Cas3 activity until recruited by target-bound Cascade94. While they all lack Cas 11, Cascade 
composition differs between the three subtypes of I-F systems. The Cascade of Type I-F1 systems 
most closely resemble the aforementioned Type I Cascade, just lacking Cas11. The Type I-F2 
systems lack Cas11 and Cas8, with PAM recognition now executed by Cas5. The Type I-F3 
systems are the most reduced, lacking Cas11, and with a Cas8-Cas5 fusion protein responsible for 
both PAM-recognition and binding of the 5’-handle of the crRNA.  
Regardless of subtype, Type I-F Cascades form a characteristic seahorse morphology 




Figure 10: Atomic model of a Type I-F Cascade (Csy complex) 
A 3.2 Å cryo EM model of a Type I-F Cascade from P. aeruginosa bound to an 80-bp dsDNA target. 
Identity and location of subunits are indicated in the figure. Figure adapted from Rollins, M. C. 
F. et al. Mol. Cell 74, 132-142.e5 (2019)72.  
 
 
A curious feature of Type I-F Cascade complexes is that the number of Cas7 subunits can be 
regulated by the length of the crRNA, the addition or removal of sets of six bases within the spacer 
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region of the crRNA will allow a commensurate gain or loss of additional Cas7 subunits96,97. 
Complete binding of the Cascade complex to a fully complementary target site triggers a 
conformational change of the DNA bound complex: The gross morphology differs little between 
the DNA-bound and unbound Cascade, but the bound complex has undergone three notable 
conformational changes. First, with Cas8 and Cas7.6, Cascade has “clamped” the dsDNA at the 
PAM. Second, Cas5 has rotated away from the Cas6 end of the complex, elongating the Cas7 
spine, and thus the entire complex. Third, a helical bundle in Cas8 rotates 180° so that it now 
contacts Cas 7.2 and Cas7.3. The rotation of Cas8 is dependent on R-loop formation and is the 
trigger to recruit and dissociate the Cas2/Cas32Cas14 multimer; freeing Cas2/Cas3 from inhibition 
by Cas1 (Figure 11)72. Liberated from Cas1, Cas2/Cas3 degrades both the bound and displaced 




Figure 11: Conformational change of I-F Cascade as it binds a dsDNA target 
Representation of the conformational change I-F Cascade undergoes when bound to a dsDNA 
target with complete R-loop formation. Left, unbound complex. Middle, bound to a partially 
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duplexed dsDNA. Right, dsDNA bound complex with full R-loop formation, poised for 
Cas2/Cas3 recruitment. Figure adapted Rollins, M. C. F. et al. Mol. Cell 74, 132-142.e5 (2019)72. 
 
 
2.4: Heterologous genetic engineering with Type I-F or Type V CRISPR-Cas 
systems 
As with most CRISPR-Cas systems, there is extensive interest in the development of Type 
I and Type V systems as tools in heterologous systems, most notably, mammalian cells. Three 
reports from 2019 establish the use of Type I-E systems in mammalian cells. Dolan et al describe 
long range deletions of up to 20kb of genomic DNA in human embryonic stem cells98. Cameron 
et al fused a non-sequence-specific FokI nuclease domain to Cas8 and assembled paired FokI-
Cascade complexes for precise cleavage between the two protospacers99. Lastly, Pickar-Oliver et 
al fused transcriptional activators to Cascade components and noted specific upregulation of 
transcripts from genes immediately downstream of the crRNA target100. This strategy, initially 
developed with a catalytically inactive Cas9 (dCas9) fused to transcriptional activators is named 
CRISPR activation, or CRISPRa101. Yang et al followed Pickar-Oliver, but instead of a I-E system, 
repurposed a I-F system by fusing transcriptional activators to Cas7, resulting in 6 copies of the 
transcriptional activator, VPR,  per Cascade to effect CRISPRa where targeted102. To date, no I-F 
system has been used for DNA cleavage in mammalian cells. 
In the very first paper demonstrating Cas12 (then Cpf1) function, Zetsche et al screened 
Cas12 orthologs for activity in human cells, with two candidates showing clear editing90. A later 
report from the same lab mutated Cas12b orthologs to increase the efficiency of their dsDNA 
cleavage at temperatures lower than their optimal reaction temperatures103. More recently, 
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Kleinstiver et al subjected a Cas12a to rampant, albeit rational, mutation to yield a novel Cas12a 
nuclease with reduced off-target effects and increased multiplex gene editing efficacy91.  
 
2.5: Transposon-encoded CRISPR-Cas systems 
Within prokaryotic genomes, CRISPR-Cas systems and other defense genes tend to cluster 
in defense islands, either on or near MGEs104. As Transposable Elements carry defense genes, and 
are themselves MGEs, these defense islands provide plausible intersections of CRISPR-Cas 
systems and TEs. Although CRISPR-Cas systems have broad-ranging mechanisms, common to 
all is their programmability and specificity, suggesting this shared characteristic provides a fitness 
advantage. Given that: 1, the proximity of CRISPR-Cas systems and TEs within the highly mutable 
defense islands; 2, that CRISPR-Cas systems display extreme target specificity; and 3, that some 
TEs autoregulate their transposition through severe site-specificity of integration, it seemed 
plausible that CRISPR-Cas systems and TEs may have previously co-opted functional modules 
from one another104. To this end, the identification of persistent partial CRISPR-Cas systems 
suggested they may be put to another use. The identification of such a partial system, a minimal I-
F system (now called I-F3), lacking Cas1, the Cas2/Cas3 fusion, and containing a fusion of Cas8 
and Cas5 initiated an in silico screen of minimal I-F3 systems and their surrounding loci74. 
Construction of phylogenies based on I-F3 Cas7 homologs and the local gene neighborhood 
yielded a monophyletic branch with the minimal I-F3 system and homologs of the Tn7 
transposition proteins TnsA, and TnsD or its homolog, TniQ32. Similar dendrograms created with 
either a TnsA seed or a TniQ/TnsD seed both produced clades with the minimal I-F3 systems 
(Figure 12)32. These phylogenetic analyses demonstrate an unusually common co-occurrence of a 
minimal Type I-F3 system with Tn7 elements. Subsequent analysis of these clades showed no 
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intact minimal I-F3 systems beyond the +/-10kb sampled from the Tn7 elements, indicating that 
the minimal I-F3 systems may only be functional when proximal to Tn7 elements32. Sequences 
that contained intact minimal I-F3 systems near Tn7 elements were further analyzed to determine 
whether the I-F3 system was contained between the Left and Right ends of the Tn7 elements32. 
Analysis of the spacers within the minimal I-F3 CRISPR array mapped mostly to plasmids and 
phages associated with the host genera32. But, in two cases, the spacers mapped to a sequence 
directly upstream of the Right end of the Tn7-like transposon, suggesting these spacers may have 
been used to direct transposition32. Taken in concert, these data pointed towards a model of I-F3 
CRISPR-Cas-mediated transposition of Tn7-like transposons. 
 
 
Figure 12: Dendrograms constructed from I-F Cas7, TnsA, and TnsD/TniQ protein families 
The gene indicated below each dendrogram was used as the seed of a PSI BLAST. After obtaining 
a number of orthologs, the sequences were mapped back onto their respective genomes and a 
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window of 20 kb was centered on the seed, genes within that window were annotated, and used 
to construct the above phylogenetic trees. Left, sampling of 2,905 minimal I F Cas7 proteins from 
a PSI BLAST and their neighboring genes produced the large orange triangular group labeled 
tnsA/tniQ/tnsD, indicating minimal I F systems are often proximal to Tn7 family genes. The same 
process was repeated with TnsA (middle, 7,203 variants) and Tnsd/TniQ (right, 7,963 variants). 
Figure adapted from Peters, J. E et al, Proc. Natl. Acad. Sci. 114, E7358–E7366 (2017)32. 
 
 
Shortly after the previous findings regarding the rate of co-occurrence of minimal I-F3 
systems and Tn7 elements were released, a paper doing the same for Type V-K systems 
followed105. The Class 2 Type V-K system appeared to contain Cas12 homologs with an 
inactivated RuvC domain. Similar to the aforementioned minimal Type I-F3 system, this V-K 
family was predicted to be unable to carry out any nuclease function and would therefore lack any 
defense capability106,107.  
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Chapter 3: Transposon-Encoded CRISPR-Cas 
Systems Direct RNA-Guided DNA Integration 
 
 
This chapter has been adapted from: 
Klompe, S.E., Vo, P.L.H., Halpin-Healy, T.S. & Sternberg, S. H. Transposon-encoded CRISPR–
Cas systems direct RNA-guided DNA integration. Nature 571, 219–225 (2019). 
 
Appendix A contains the paper as published. 
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3.1: Abstract 
Conventional CRISPR–Cas systems maintain genomic integrity by leveraging guide RNAs 
for the nuclease-dependent degradation of mobile genetic elements, including plasmids and 
viruses. Here we describe a notable inversion of this paradigm, in which bacterial Tn7-like 
transposons have co-opted nuclease-deficient CRISPR–Cas systems to catalyze RNA-guided 
integration of mobile genetic elements into the genome. Programmable transposition of Vibrio 
cholerae Tn6677 in Escherichia coli requires CRISPR and transposon-associated molecular 
machineries, including a co-complex between the DNA-targeting complex Cascade and the 
transposition protein TniQ. Integration of donor DNA occurs in one of two possible orientations 
at a fixed distance downstream of target DNA sequences, and can accommodate variable length 
genetic payloads. Deep-sequencing experiments reveal highly specific, genome-wide DNA 
insertion across dozens of unique target sites. This discovery of a fully programmable, RNA-
guided integrase lays the foundation for genomic manipulations that obviate the requirements for 
double-strand breaks and homology-directed repair. 
 
3.2: Introduction 
Horizontal gene transfer, a process that allows genetic information to be transmitted 
between phylogenetically unrelated species, is a major driver of genome evolution across the three 
domains of life7,108,109. Mobile genetic elements that facilitate horizontal gene transfer are 
especially pervasive in bacteria and archaea, in which viruses, plasmids and transposons constitute 
the vast prokaryotic mobilome110. In response to the ceaseless assault of genetic parasites, bacteria 
have evolved numerous innate and adaptive defense strategies for protection, including RNA-
guided immune systems encoded by clustered regularly interspaced short palindromic repeats 
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(CRISPR) and CRISPR-associated (Cas) genes64,111,112. Remarkably, the evolution of CRISPR–
Cas is intimately linked to the large reservoir of genes provided by mobile genetic elements, with 
core enzymatic machineries involved in both new spacer acquisition (Cas1) and RNA-guided 
DNA targeting (Cas9 and Cas12) derived from transposable elements113–118. These examples 
support a ‘guns-for-hire’ model, in which the rampant shuffling of genes between offensive and 
defensive roles results from the perennial arms race between bacteria and mobile genetic elements. 
We set out to uncover examples of functional associations between defense systems and 
mobile genetic elements. In this regard, we were inspired by a recent report that described a class 
of bacterial Tn7-like transposons encoding evolutionarily linked CRISPR–Cas systems and 
proposed a functional relationship between RNA-guided DNA targeting and transposition32. The 
well-studied E. coli Tn7 transposon is unique in that it mobilizes via two mutually exclusive 
pathways—one that involves non-sequence-specific integration into the lagging-strand template 
during replication, and a second that involves site-specific integration downstream of a conserved 
genomic sequence119. Notably, those Tn7-like transposons that specifically associate with 
CRISPR–Cas systems lack a key gene involved in DNA targeting, and the CRISPR–Cas systems 
that they encode lack a key gene involved in DNA degradation. We therefore hypothesized that 
transposon-encoded CRISPR–Cas systems have been repurposed for a role other than adaptive 
immunity, in which RNA-guided DNA targeting is leveraged for a novel mode of transposon 
mobilization. 
Here we demonstrate that a CRISPR–Cas effector complex from V. cholerae directs an 
accompanying transposase to integrate DNA downstream of a genomic target site complementary 
to a guide RNA, representing the discovery of a programmable integrase. Beyond revealing an 
elegant mechanism by which mobile genetic elements have hijacked RNA-guided DNA targeting 
35 
for their evolutionary success, our work highlights an opportunity for facile, site-specific DNA 
insertion without requiring homologous recombination. 
 
3.3: Cascade directs site-specific DNA integration 
We set out to develop assays for monitoring transposition from a plasmid-encoded donor 
into the genome, first using E. coli Tn7, a well-studied cut-and-paste DNA transposon120 (Figure 
18a). The Tn7 transposon contains characteristic left- and right-end sequences and encodes five 
tns genes, tnsA–tnsE119, which collectively encode a heteromeric transposase: TnsA and TnsB are 
catalytic enzymes that excise the transposon donor via coordinated double-strand breaks; TnsB, a 
member of the retroviral integrase superfamily, catalyzes DNA integration; TnsD and TnsE 
constitute mutually exclusive targeting factors that specify DNA insertion sites; and TnsC is an 
ATPase that communicates between TnsAB and TnsD or TnsE. Previous studies have shown that 
E. coli TnsD (EcoTnsD) mediates site-specific Tn7 transposition into a conserved Tn7 attachment 
site (attTn7) downstream of the glmS gene in E. coli121,122, whereas EcoTnsE mediates random 
transposition into the lagging-strand template during replication24. We recapitulated TnsD-
mediated transposition by transforming E. coli BL21(DE3) cells with pEcoTnsABCD and 
pEcoDonor, and detecting genomic transposon insertion events by PCR and Sanger sequencing 
(Figure 18). 
To test the hypothesis that CRISPR-associated targeting complexes direct transposons to 
genomic sites complementary to a guide RNA (Figure 18a), we selected a representative 
transposon from V. cholerae strain HE-45, Tn6677, which encodes a variant type I-F CRISPR–
Cas system123,124 (Figure 18f, 28-34). This transposon is bounded by left- and right-end sequences, 
distinguishable by their TnsB-binding sites, and includes a terminal operon that comprises the 
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tnsA, tnsB and tnsC genes. Notably, the tniQ gene, a homolog of E. coli tnsD, is encoded within 
the cas rather than the tns operon, whereas tnsE is absent entirely. Like other such transposon-
encoded CRISPR–Cas systems32, the cas1 and cas2 genes responsible for spacer acquisition are 
conspicuously absent, as is the cas3 gene responsible for target DNA degradation. The putative 
DNA-targeting complex Cascade (also known as Csy complex64) is encoded by three genes: cas6, 
cas7 and a natural cas8–cas5 fusion124 (hereafter referred to simply as cas8). The native CRISPR 
array, comprising four repeat and three spacer sequences, encodes mature CRISPR RNAs 
(crRNAs) that we also refer to as guide RNAs. 
We transformed E. coli with plasmids that encode components of the V. cholerae 
transposon, including a mini-transposon donor (pDonor), the tnsA-tnsB-tnsC operon (pTnsABC), 
and the tniQ-cas8-cas7-cas6 operon alongside a synthetic CRISPR array (pQCascade) (Figure 
13b). The CRISPR array was designed to produce a non-targeting crRNA or crRNA-1, which 
targets a genomic site downstream of glmS flanked by a 5′-CC-3′ protospacer adjacent motif 
(PAM)125. Notably, we observed PCR products from cellular lysate between a genome-specific 
primer and either of two transposon-specific primers in experiments containing pTnsABC, pDonor 
and pQCascade expressing crRNA-1, but not with a non-targeting crRNA or any empty vector 
controls (Figure 13c, d). 
Because parallel reactions with oppositely oriented transposon primers revealed integration 
events within the same biological sample, we hypothesized that, unlike E. coli Tn7, RNA-guided 
transposition might occur in either orientation. We tested this by performing additional PCRs, by 
adding a downstream genomic primer, and by targeting an additional site with crRNA-2 found in 
the same genomic locus but on the opposite strand. For both crRNA-1 and crRNA-2, transposition 
products in both orientations were present, although with distinct orientation preferences based on 
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relative band intensities (Figure 13e). Given the presence of discrete bands, it appeared that 
integration was occurring at a set distance from the target site, and Sanger and next-generation 
sequencing (NGS) analyzes revealed that more than 95% of integration events for crRNA-1 
occurred 49 base pairs (bp) from the 3′ edge of the target site. The observed pattern with crRNA-
2 was more complex, with integration clearly favoring distances of 48 and 50 bp over 49 bp. Both 
sequencing approaches also revealed the expected 5-bp target-site duplication that is a hallmark 
feature of Tn7 transposition products119 (Figure 13f, g). 
The V. cholerae Tn6677 transposon is not naturally present downstream of glmS, and we 
saw no evidence of site-specific transposition within this locus when we omitted the crRNA 
(Figure 13d). Nevertheless, we wanted to ensure that integration specificity was solely guided by 
the crRNA sequence, and not by any intrinsic preference for the glmS locus. We therefore cloned 
and tested crRNA-3 and crRNA-4, which target opposite strands within the lacZ coding sequence. 
We again observed bidirectional integration 48–50 bp downstream of both target sites, and were 
able to isolate clonally integrated, lacZ-knockout strains after performing blue–white colony 
screening on X-gal-containing LB-agar plates (Figure 13h, i and Figure 19). Collectively, these 
experiments demonstrate transposon integration downstream of genomic target sites 





Figure 13: RNA-guided DNA integration with a V. cholerae transposon 
a, Hypothetical scenario for Tn6677 transposition into plasmid or genomic target sites 
complementary to a crRNA. b, Plasmid schematics for transposition experiments in which a mini-
transposon on pDonor is mobilized in trans. The CRISPR array comprises two repeats (grey 
diamonds) and a single spacer (maroon rectangle). c, Genomic locus targeted by crRNA-1 and 
crRNA-2, two potential transposition products, and the PCR primer pairs to selectively amplify 
them. The PAMs and target sites are in yellow and maroon, respectively. d, PCR analysis of 
transposition with a non-targeting crRNA (crRNA-NT) and crRNA-1, resolved by agarose gel 
electrophoresis. e, PCR analysis of transposition with crRNA-NT, crRNA-1 and crRNA-2 using 
four distinct primer pairs, resolved by agarose gel electrophoresis. f, Sanger sequencing 
chromatograms for upstream and downstream junctions of genomically integrated transposons 
from experiments with crRNA-1 and crRNA-2. Overlapping peaks for crRNA-2 suggest the 
presence of multiple integration sites. The distance between the 3′ end of the target site and the 
first base of the transposon sequence is designated ‘d’. TSD, target-site duplication. g, NGS 
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analysis of the distance between the Cascade target site and transposon integration site, 
determined for crRNA-1 and crRNA-2 with four primer pairs. h, Genomic locus targeted by 
crRNA-3 and crRNA-4. i, PCR analysis of transposition with crRNA-NT, crRNA-3 and crRNA-4, 




3.4: Protein requirements of RNA-guided DNA integration 
To confirm the involvement of transposon- and CRISPR-associated proteins in catalyzing 
RNA-guided DNA integration, we cloned and tested a series of plasmids in which each individual 
tns and cas gene was deleted, or in which the active site of each individual enzyme was mutated. 
Removal of any protein component abrogated transposition activity, as did mutations in the active 
site of the TnsB transposase, which catalyzes DNA integration126, the TnsC ATPase, which 
regulates target site selection49vv, and the Cas6 RNase, which catalyzes pre-crRNA processing81 
(Figure 14a). A TnsA mutant that is catalytically impaired still facilitated RNA-guided DNA 
integration. On the basis of previous studies of E. coli Tn7, this variant system is expected to 
mobilize via replicative transposition as opposed to cut-and-paste transposition29. 
In E. coli, site-specific transposition requires attTn7 binding by EcoTnsD, followed by 
interactions with the EcoTnsC regulator protein to directly recruit the EcoTnsA-TnsB-donor 
DNA36. Given the essential nature of tniQ (a tnsD homolog) in RNA-guided transposition, and its 
location within the cas8-cas7-cas6 operon, we envisioned that the Cascade complex might directly 
bind TniQ and thereby deliver it to genomic target sites. We tested this hypothesis by 
recombinantly expressing CRISPR RNA and the V. cholerae tniQ-cas8-cas7-cas6 operon 
containing an N-terminal His10 tag on the TniQ subunit (Figure 20.a). TniQ co-purified with Cas8, 
Cas7 and Cas6, as shown by SDS–PAGE and mass spectrometry analysis, and the relative band 
intensities for each Cas protein were similar to TniQ-free Cascade and consistent with the 1:6:1 
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Cas8:Cas7:Cas6 stoichiometry expected for a I-F variant Cascade complex80 (Figure 14b and 
Figure 20b). The complex migrated through a gel filtration column with an apparent molecular 
mass of roughly 440 kDa, in good agreement with its approximate expected mass, and both 
Cascade and TniQ–Cascade co-purified with a 60-nucleotide RNA species, which we confirmed 
was a mature crRNA by deep sequencing (Figure 14c, d and Figure 2.c, d). To validate the 
interaction between Cascade and TniQ further, we incubated separately purified samples in vitro 
and demonstrated complex formation by size-exclusion chromatography (Figure 20e). Together, 
these results reveal the existence of a novel TniQ–Cascade co-complex, highlighting a direct 
functional link between a CRISPR RNA-guided effector complex and a transposition protein. 
To determine whether specific TniQ–Cascade interactions are required, or whether TniQ 
could direct transposition adjacent to generic R-loop structures or via artificial recruitment to 
DNA, we used Streptococcus pyogenes Cas9 (SpyCas9)69 and Pseudomonas aeruginosa Cascade 
(PaeCascade)80 as orthogonal RNA-guided DNA-targeting systems. After generating protein–
RNA expression plasmids and programming both effector complexes with crRNAs that target the 
same lacZ sites as our earlier transposition experiments, we first validated DNA targeting by 
demonstrating efficient cell killing in the presence of an active Cas9 nuclease or the PaeCascade-
dependent Cas2-3 nuclease (Figure 21a, b). When we transformed strains containing pTnsABCQ 
and pDonor with a plasmid encoding either catalytically deactivated Cas9-sgRNA (dCas9-sgRNA) 
or PaeCascade and performed PCR analysis of the resulting cell lysate, we found no evidence of 
site-specific transposition (Figure 14e), indicating that a genomic R-loop is insufficient for site-
specific integration. We also failed to detect transposition when TniQ was directly fused to either 
terminus of dCas9, or to the Cas8 or Cas6 subunit of PaeCascade (Figure 14e), at least for the 
linker sequences tested. Notably, however, a similar fusion of TniQ to the Cas6 subunit of V. 
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cholerae Cascade, but not to the Cas8 subunit, restored RNA-guided transposition activity (Figure 
14e and Figure 21c). 
Together with our biochemical results, we conclude that TniQ forms essential interactions 
with Cascade, possibly via the Cas6 subunit, which could account for our finding that RNA-guided 
DNA insertion occurs downstream of the PAM-distal end of the target site where Cas6 is 
bound84,127v (Figure 14f). Because TniQ is required for transposition, we propose that it serves as 
an important connection between the CRISPR- and transposon-associated machineries during 
DNA targeting and integration, although further biochemical and structural studies will be required 




Figure 14: TniQ forms a complex with Cascade and is necessary for RNA-guided DNA 
integration. 
a, PCR analysis of transposition with crRNA-4 and a panel of gene deletions or point mutations, 
resolved by agarose gel electrophoresis. b, SDS–PAGE analysis of purified TniQ, Cascade and a 
TniQ–Cascade (Q–Cascade) co-complex. Asterisk denotes an HtpG contaminant. c, Denaturing 
urea–PAGE analysis of co-purifying nucleic acids. nt, nucleotides. d, Top, RNA sequencing 
analysis of RNA co-purifying with Cascade. Bottom, reads mapping to the CRISPR array reveal 
the mature crRNA sequence. e, PCR analysis of transposition experiments testing whether 
generic R-loop formation or artificial TniQ tethering can direct targeted integration. The V. 
cholerae transposon and TnsA-TnsB-TnsC were combined with DNA-targeting components that 
comprise V. cholerae (Vch) Cascade, P. aeruginosa (Pae) Cascade, or S. pyogenes dCas9-RNA 
(dCas9). TniQ was expressed either on its own from pTnsABCQ or as a fusion to the targeting 
complex (pCas-Q) at the Cas6 C terminus (6), Cas8 N terminus (8), or dCas9 N or C terminus. f, 
Schematic of the R-loop formed upon target DNA binding by Cascade, with the approximate 
position of each protein subunit denoted. The putative TniQ-binding site and the distance to the 
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primary integration site are indicated. NT, non-target strand; T, target strand. For a and e, 
amplification of rssA serves as a loading control. 
 
 
3.5: Donor requirements of RNA-guided DNA integration 
To determine the minimal donor requirements for RNA-guided DNA integration, as well 
as the effects of truncating the transposon ends and altering the cargo size, we first developed a 
quantitative PCR (qPCR) method for scoring transposition efficiency that could accurately and 
sensitively measure genomic integration events in both orientations (Figure 22). Analysis of cell 
lysates from transposition experiments using lacZ-targeting crRNA-3 and crRNA-4 yielded 
overall integration efficiencies of 62% and 42% without selection, respectively. The preference 
for integrating the ‘right’ versus the ‘left’ transposon end proximal to the genomic site targeted by 
Cascade was 39-to-1 for crRNA-3 and 1-to-1 for crRNA-4, suggesting the existence of additional 
sequence determinants that regulate integration orientation (Figure 15a, b). 
With a quantitative assay in place, we were curious to investigate the effect of transposon 
size on RNA-guided integration efficiency and determine possible size constraints. When we 
progressively shortened or lengthened the DNA cargo in between the donor ends, beginning with 
our original mini-transposon donor plasmid (977 bp), we found that integration efficiency with our 
three-plasmid expression system was maximal with a 775-bp transposon and decayed with both 
the shorter and longer cargos tested (Figure 15c). Interestingly, naturally occurring Tn7-like 
transposons that encode CRISPR–Cas systems range from 20 to more than 100 kb in size32, 
although their capacity for active mobility is unknown. 
We next separately truncated both ends of the transposon. We found that around 105 bp of 
the left end and 47 bp of the right end were absolutely crucial for efficient RNA-guided DNA 
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integration, corresponding to three and two intact putative TnsB-binding sites, respectively (Figure 
23). Shorter transposons containing right-end truncations were integrated more efficiently, 
accompanied by a notable change in the orientation bias. 
These experiments reveal crucial parameters for the development of programmable DNA 
integration technology. Future efforts will be required to explore how transposition is affected by 
vector design, to what extent transposon end mutations are tolerated, and whether rational 





Figure 15: Influence of cargo size, PAM sequence, and crRNA mismatches on RNA-guided 
DNA integration. 
a, Schematic of alternative integration orientations and the primer pairs to selectively detect them 
by qPCR. b, qPCR-based quantification of transposition efficiency in both orientations with 
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crRNA-NT, crRNA-3 and crRNA-4. T-LR and T-RL denote transposition products in which the 
transposon left end and right end are proximal to the target site, respectively. c, Total integration 
efficiency with crRNA-4 as a function of transposon size. The arrow denotes the wild-type (WT) 
pDonor used in most assays throughout this study. d, crRNAs were tiled along the lacZ gene in 
1-bp increments relative to crRNA-4 (4.0) (top), and the resulting integration efficiencies were 
determined by qPCR (bottom). Data are normalized to crRNA-4.0, and the 2-nucleotide PAM for 
each crRNA is shown. e, Heat map showing the integration site distribution (x axis) for each of 
the tiled crRNAs (y axis) in d, determined by NGS. The 49-bp distance for each crRNA is denoted 
by a black box. f, crRNAs were mutated in 4-nucleotide blocks to introduce crRNA-target DNA 
mismatches (black, top), and the resulting integration efficiencies were determined by qPCR 
(bottom). Data are normalized to crRNA-4. g, The crRNA-4 spacer length was shortened or 
lengthened by 12 nucleotides (top), and the resulting integration efficiencies were determined by 
qPCR (bottom). Data are normalized to crRNA-4 (WT). The inset shows a comparison of 
integration site distributions for crRNA-4 and crRNA-4.+12, determined by NGS. Data in b–d, f 
and g are shown as mean ± s.d. for n = 3 biologically independent samples. 
 
 
3.6: Guide RNA and target DNA requirements 
The Tn6677-encoded CRISPR–Cas system is most closely related to the I-F subtype, in 
which DNA target recognition by Cascade requires a consensus 5′-CC-3′ PAM125, a high degree 
of sequence complementarity within a PAM-proximal seed sequence80, and additional base-
pairing across the entire 32-bp protospacer128. To determine sequence determinants of RNA-
guided DNA integration, we first tested 12 dinucleotide PAMs by sliding the guide sequence in 1-
bp increments along the lacZ gene relative to crRNA-4 (Figure 15d). In total, 8 distinct 
dinucleotide PAMs supported transposition at levels that were more than 25% of the 5′-CC-3′ 
PAM, and transposition occurred at over 1% total efficiency across the entire set of PAMs tested 
(Figure 15d). Additional deep sequencing revealed that the distance between the Cascade target 
site and primary transposon insertion site remained fixed at approximately 47–51 bp across the 
panel of crRNAs tested, although interesting patterns emerged, suggesting an additional layer of 
insertion site preference that requires further investigation (Figure 15e and Figure 24a). 
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Nevertheless, these experiments highlight how PAM recognition plasticity can be harnessed to 
direct a high degree of insertion flexibility and specificity at base-pair resolution. 
To probe the sensitivity of transposition to RNA–DNA mismatches, we tested consecutive 
blocks of 4-nucleotide mismatches along the guide portion of crRNA-4 (Figure 15f). As expected 
from previous studies with Cascade homologs129–131, mismatches within the 8-nucleotide seed 
sequence severely reduced transposition, probably owing to the inability to form a stable R-loop. 
Unexpectedly, however, our results highlighted a second region of mismatches at positions 25–28 
that abrogated DNA integration, despite previous studies demonstrating that the stability of DNA 
binding is largely insensitive to mismatches in this region129–131. For the terminal mismatch block, 
which retained 17% integration activity, the distribution of observed insertion sites was markedly 
skewed to shorter distances from the target site relative to crRNA-4 (Figure 24b), which we 
hypothesize is the result of R-loop conformational heterogeneity. 
Our emerging model for RNA-guided DNA integration involves Cascade-mediated 
recruitment of TniQ to target DNA. In the absence of any structural data, we realized that we could 
investigate whether TniQ may be positioned near the PAM-distal end of the R-loop by testing 
engineered crRNAs that contain spacers of variable lengths. Previous work with E. coli Cascade 
has demonstrated that crRNAs with extended spacers form complexes that contain additional Cas7 
subunits132, which would increase the distance between the PAM-bound Cas8 and the Cas6 at the 
other end of the R-loop. We therefore cloned and tested modified crRNAs containing spacers that 
were either shortened or lengthened in 6-nucleotide increments from the 3′ end. crRNAs with 
truncated spacers showed little or no activity, whereas extended spacers facilitated targeted 
integration, albeit at reduced levels with increasing length (Figure 24c, d). The +12-nucleotide 
crRNA directed transposition to two distinct regions: one approximately 49 bp from the 3′ end of 
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the wild-type 32-nucleotide spacer, and an additional region shifted 11–13 bp away, in agreement 
with the expected increase in the length of the R-loop measured from the PAM (Figure 15g). 
Although more experiments are required to deduce the underlying mechanisms that explain this 
bimodal distribution, as well as the insertion site distribution observed for other extended crRNAs, 
these data, together with the mismatch panel, provide further evidence that TniQ is tethered to the 
PAM-distal end of the R-loop structure. 
 
3.7: Programmability and genome-wide specificity 
We lastly sought to examine both the programmability and the genome-wide specificity of 
our RNA-guided DNA integration system. First, we cloned and tested a series of crRNAs targeting 
additional genomic sites flanked by 5′-CC-3′ PAMs within the lac operon. Using the same primer 
pair for each resulting cellular lysate, we showed by PCR analysis that transposition was 
predictably repositioned with each distinct crRNA (Figure 16a). Our experiments thus far 
specifically interrogated genomic loci containing the anticipated integration products, and it 
therefore remained possible that non-specific integration was simultaneously occurring elsewhere, 
either at off-target genomic sites bound by Cascade, or independently of Cascade targeting. We 
thus adopted a transposon insertion sequencing (Tn-seq) pipeline previously developed for mariner 
transposons133,134, in which all integration sites genome-wide are revealed by NGS (Figure 16b, 
Figure 25a, b and Methods). We first applied Tn-seq to a plasmid-encoded mariner transposon and 
found that our pipeline successfully recapitulated the genome-wide integration landscape 
previously observed with the Himar1c9 transposase133,135 (Figure 16c, d and Figure 25c, d). 
When we performed the same analysis for the RNA-guided V. cholerae transposon 
programmed with crRNA-4, we observed exquisite selectivity for lacZ-specific DNA integration 
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(Figure 16c). The observed integration site, which accounted for 99.0% of all Tn-seq reads that 
passed our filtering criteria (Methods), precisely matched the site observed by previous PCR 
amplicon NGS analysis (Figure 16e), and we did not observe reproducible off-target integration 
events elsewhere in the genome across three biological replicates (Figure 25e, f). Our Tn-seq data 
furthermore yielded diagnostic read pile-ups that highlighted the 5-bp target-site duplication and 
corroborated our previous measurements of transposon insertion orientation bias (Figure 16f). Tn-
seq libraries from E. coli strains expressing pQCascade programmed with the non-targeting 
crRNA, or from strains lacking Cascade altogether (but still containing pDonor and pTnsABCQ), 
yielded far fewer genome-mapping reads, and no integration sites were consistently observed 
across several biological replicates (Figure 16c, Figure 136g, h). 
In addition to performing Tn-seq with the crRNAs targeting glmS and lacZ genomic loci 
(Figure 26a), we cloned and tested an additional 16 crRNAs targeting the E. coli genome at 8 
arbitrary locations spaced equidistantly around the circular chromosome. Beyond requiring that 
target sites were unique, were flanked by a 5′-CC-3′ PAM, and would direct DNA insertion to 
intergenic regions, we applied no further design rules or empirical selection criteria. Remarkably, 
when we analyzed the resulting Tn-seq data, we found that 16 out of 16 crRNAs directed highly 
precise RNA-guided DNA integration 46–55 bp downstream of the Cascade target, with around 
95% of all filtered Tn-seq reads mapping to the on-target insertion site (Figure 16g and Figure 26b, 
c). These experiments highlight the high degree of intrinsic programmability and genome-wide 




Figure 16: Genome-wide analysis of programmable RNA-guided DNA integration. 
a, Genomic locus targeted by crRNAs 4–8 (top), and PCR analysis of transposition resolved by 
agarose gel electrophoresis (bottom). Amplification of rssA serves as a loading control. Tn-seq 
workflow for deep sequencing of genome-wide transposition events. c, Mapped Tn-seq reads 
from transposition experiments with the mariner transposon, and with the V. cholerae transposon 
programmed with either crRNA-NT or crRNA-4. The crRNA-4 target site is denoted by a maroon 
triangle. d, Sequence logo of all mariner Tn-seq reads, highlighting the TA dinucleotide target-
site preference. e, Comparison of integration site distributions for crRNA-4 determined by PCR 
amplicon sequencing and Tn-seq, for the T-RL product; the distance between the Cascade target 
site and transposon integration site is plotted. f, Zoomed-in view of Tn-seq read coverage at the 
primary integration site for experiments with crRNA-4, highlighting the 5-bp target-site 
duplication (TSD); the distance from the Cascade target site is plotted. g, Genome-wide 
distribution of genome-mapping Tn-seq reads from transposition experiments with crRNAs 9–




Transposases and integrases are generally thought to mobilize their specific genetic 
payloads either by integrating randomly, with a low degree of sequence specificity, or by targeting 
specialized genomic loci through inflexible, sequence-specific homing mechanisms8. We have 
discovered a fully programmable integrase, in which the DNA insertion activity of a heteromeric 
transposase from V. cholerae is directed by an RNA-guided complex known as Cascade, the DNA-
targeting specificity of which can be easily tuned. Beyond defining fundamental parameters that 
govern this activity, our work also reveals a complex between Cascade and TniQ that 
mechanistically connects the transposon- and CRISPR-associated machineries. On the basis of our 
results, and of previous studies of Tn7 transposition119, we propose a model for the RNA-guided 
mobilization of Tn7-like transposons encoding CRISPR–Cas systems (Figure 17). Because 
integration does not disrupt the Cascade-binding site, an important question for future investigation 
is whether the V. cholerae transposon exhibits a similar mode of target immunity as E. coli Tn742, 
in which repeated transposition into the same genomic locus is prevented. 
Almost all type I-F CRISPR–Cas systems within the Vibrionaceae family are associated 
with mobile genetic elements, and those found within Tn7-like transposons frequently co-occur 
with restriction-modification and type three secretion systems32,123. It is therefore tempting to 
speculate that RNA-guided DNA integration may facilitate sharing of innate immune systems and 
virulence mechanisms via horizontal gene transfer, particularly within marine environments136. 
Interestingly, we and others137,138 recently observed a unique clade of type V CRISPR–Cas systems 
that also reside within bacterial transposons, which bear many of the same features as V. cholerae 
Tn6677: the presence of the tniQ gene, the lack of predicted DNA cleavage activity by the RNA-
guided effector complex117, and cargo genes that frequently include other innate immune systems 
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(Figure 27). Although future experiments will be necessary to determine whether these systems 
also possess RNA-guided DNA integration activity, the bioinformatic evidence points to a more 
pervasive functional coupling between CRISPR–Cas systems and transposable elements than 
previously appreciated. 
Many biotechnology products require genomic integration of large genetic payloads, 
including gene therapies139, engineered crops140 and biopharmaceuticals141, and the advent of 
CRISPR-based genome editing has increased the need for effective knock-in methods. Yet current 
genome engineering solutions are limited by a lack of specificity, as with viral transduction142, 
randomly integrating transposases143 and non-homologous end joining144 approaches, or by a lack 
of efficiency and cell-type versatility, as with homology-directed repair145,146. The ability to INsert 
Transposable Elements by Guide RNA-Assisted TargEting (INTEGRATE) offers an opportunity 
for site-specific DNA integration that would obviate the need for double-strand breaks in the target 
DNA, homology arms in the donor DNA, and host DNA repair factors. By virtue of its facile 
programmability, this technology could furthermore be leveraged for multiplexing and large-scale 
screening using guide RNA libraries. Together with other recent studies107,147–149, our work 
highlights the far-reaching possibilities for genetic manipulation that continue to emerge from the 




Figure 17: Proposed model for RNA-guided DNA integration by Tn7-like transposons 
encoding CRISPR-Cas systems. 
The V. cholerae Tn6677 transposon encodes a programmable RNA-guided DNA-binding complex 
called Cascade, which we have shown forms a co-complex with TniQ. We propose that TniQ–
Cascade complexes survey the cell for matching DNA target sites, which may be found on the 
host chromosome or mobile genetic elements. After target binding and R-loop formation, TniQ 
presumably recruits the non-sequence-specific DNA-binding protein TnsC, based on previous 
studies of E. coli Tn7 (reviewed in ref.106). The transposon itself is bound at the left and right ends 
by TnsA and TnsB, forming a so-called paired-end complex that is recruited to the target DNA 
by TnsC. Excision of the transposon from its donor site allows for targeted integration at a fixed 




3.9: Materials and Methods  
Data Reporting 
No statistical methods were used to predetermine sample size. The experiments were not 




All plasmids used in this study are described in an appended Supplementary Table, and a 
subset is available from Addgene. In brief, genes encoding V. cholerae strain HE-45 TnsA-TnsB-
TnsC and TniQ-Cas8-Cas7-Cas6 (Figures 28-34) were synthesized by GenScript and cloned into 
pCOLADuet-1 and pCDFDuet-1, respectively, yielding pTnsABC and pQCascadeΔCRISPR. A 
pQCascade entry vector (pQCascade_entry) was generated by inserting tandem BsaI restriction 
sites flanked by two CRISPR repeats downstream of the first T7 promoter, and specific spacers 
(Supplementary Table 3) were subsequently cloned by oligoduplex ligation, yielding pQCascade. 
To generate pDonor, a gene fragment (GenScript) encoding both transposon ends was cloned into 
pUC19, and a chloramphenicol-resistance gene was subsequently inserted within the mini-
transposon. Further derivatives of these plasmids were cloned using a combination of methods, 
including Gibson assembly, restriction digestion-ligation, ligation of hybridized oligonucleotides, 
and around-the-horn PCR. Plasmids were cloned and propagated in NEB Turbo cells (NEB), 
purified using Miniprep Kits (Qiagen), and verified by Sanger sequencing (GENEWIZ). 
For transposition experiments involving the E. coli Tn7 transposon, pEcoDonor was 
generated similarly to pDonor, and pEcoTnsABCD was subcloned from pCW4 (a gift from N. 
Craig, Addgene plasmid 8484). For transposition and cell killing experiments involving the I-F 
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system from P. aeruginosa, genes encoding Cas8-Cas5-Cas7-Cas6 (also known as Csy1-Csy2-
Csy3-Csy4) were subcloned from pBW64 (a gift from B. Wiedenheft), and the gene encoding the 
natural Cas2-3 fusion protein was subcloned from pCas1_Cas2/3 (a gift from B. Wiedenheft, 
Addgene plasmid 89240). For transposition and cell killing experiments involving the II-A system 
from S. pyogenes, the gene encoding Cas9 was subcloned from a vector in-house. For control Tn-
seq experiments using the mariner transposon and Himar1C9 transposase, the relevant portions 
were subcloned from pSAM_Ec (a gift from M. Mulvey, Addgene plasmid 102939). 
Expression plasmids for protein purification were subcloned from pQCascade into p2CT-
10 (a gift from the QB3 MacroLab, Addgene plasmid 55209), and the crRNA expression construct 
was cloned into pACYCDuet-1. 
Multiple sequence alignments (Figures 28-34) were performed using Clustal Omega with 
default parameters and visualized with ESPript 3.0150. Analysis of spacers from C2c5 CRISPR 
arrays (Figure 27) was performed using CRISPRTarget. 
 
Transposition Experiments 
All transposition experiments were performed in E. coli BL21(DE3) cells (NEB). For 
experiments including pDonor, pTnsABC and pQCascade (or variants thereof), chemically 
competent cells were first co-transformed with pDonor and pTnsABC, pDonor and pQCascade, or 
pTnsABC and pQCascade, and transformants were isolated by selective plating on double 
antibiotic LB-agar plates. Liquid cultures were then inoculated from single colonies, and the 
resulting strains were made chemically competent using standard methods, aliquoted and snap 
frozen. The third plasmid was introduced in a new transformation reaction by heat shock, and after 
recovering cells in fresh LB medium at 37 °C for 1 h, cells were plated on triple antibiotic LB-agar 
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plates containing 100 µg ml−1 carbenicillin, 50 µg ml−1 kanamycin, and 50 µg ml−1 
spectinomycin. After overnight growth at 37 °C for 16 h, hundreds of colonies were scraped from 
the plates, and a portion was resuspended in fresh LB medium before being re-plated on triple 
antibiotic LB-agar plates as before, this time supplemented with 0.1 mM IPTG to induce protein 
expression. Solid media culturing was chosen over liquid culturing in order to avoid growth 
competition and population bottlenecks. Cells were incubated an additional 24 h at 37 °C and 
typically grew as densely spaced colonies, before being scraped, resuspended in LB medium, and 
prepared for subsequent analysis. Control experiments lacking one or more molecular components 
were performed using empty vectors and the exact same protocol as above. Experiments 
investigating the effect of induction level on transposition efficiency contained variable IPTG 
concentrations in the media (Figure 22d). To isolate clonal, lacZ-integrated strains via blue-white 
colony screening, cells were re-plated on triple antibiotic LB-agar plates supplemented with 1 mM 
IPTG and 100 µg ml−1 X-gal (GoldBio), and grown overnight at 37 °C before colony PCR 
analysis. 
 
PCR and Sanger Sequencing Analysis of Transposition Products 
Optical density measurements at 600 nm were taken of scraped colonies that had been 
resuspended in LB medium, and approximately 3.2 × 108 cells (the equivalent of 200 µl of OD600 
= 2.0) were transferred to a 96-well plate. Cells were pelleted by centrifugation at 4,000g for 5 min 
and resuspended in 80 µl of H2O, before being lysed by incubating at 95 °C for 10 min in a thermal 
cycler. The cell debris was pelleted by centrifugation at 4,000g for 5 min, and 10 µl of lysate 
supernatant was removed and serially diluted with 90 µl of H2O to generate 10- and 100-fold 
lysate dilutions for qPCR and PCR analysis, respectively. 
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PCR products were generated with Q5 Hot Start High-Fidelity DNA Polymerase (NEB) 
using 5 µl of 100-fold diluted lysate per 12.5 µl reaction volume serving as template. Reactions 
contained 200 µM dNTPs and 0.5 µM primers, and were generally subjected to 30 thermal cycles 
with an annealing temperature of 66 °C. Primer pairs contained one genome-specific primer and 
one transposon-specific primer, and were varied such that all possible integration orientations 
could be detected both upstream and downstream of the target site (see Supplementary Tables for 
selected oligonucleotides used in this study). Colony PCRs (Figure 19b) were performed by 
inoculating overnight cultures with individual colonies and performing PCR analysis as described 
above. PCR amplicons were resolved by 1–2% agarose gel electrophoresis and visualized by 
staining with SYBR Safe (Thermo Scientific). Negative control samples were always analyzed in 
parallel with experimental samples to identify mispriming products, some of which presumably 
result from the analysis being performed on crude cell lysates that still contain the high-copy 
pDonor. PCRs were initially performed with different DNA polymerases, variable cycling 
conditions, and different sample preparation methods. We note that higher concentrations of the 
crude lysate appeared to inhibit successful amplification of the integrated transposition product. 
To map integration sites by Sanger sequencing, bands were excised after separation by gel 
electrophoresis, DNA was isolated by Gel Extraction Kit (Qiagen), and samples were submitted 
to and analyzed by GENEWIZ. 
 
Integration Site Distribution Analysis by NGS of PCR Amplicons 
PCR-1 products were generated as described above, except that primers contained 
universal Illumina adaptors as 5′ overhangs (Supplementary Tables) and the cycle number was 
reduced to 20. These products were then diluted 20-fold into a fresh polymerase chain reaction 
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(PCR-2) containing indexed p5/p7 primers and subjected to 10 additional thermal cycles using an 
annealing temperature of 65 °C. After verifying amplification by analytical gel electrophoresis, 
barcoded reactions were pooled and resolved by 2% agarose gel electrophoresis, DNA was isolated 
by Gel Extraction Kit (Qiagen), and NGS libraries were quantified by qPCR using the NEBNext 
Library Quant Kit (NEB). Illumina sequencing was performed using a NextSeq mid output kit 
with 150-cycle single-end reads and automated demultiplexing and adaptor trimming (Illumina). 
Individual bases with Phred quality scores under 20 (corresponding to a base miscalling rate of 
>1%) were changed to ‘N,’ and only reads with at least half the called bases above Q20 were 
retained for subsequent analysis. 
To determine the integration site distribution for a given sample, the following steps were 
performed using custom Python scripts. First, reads were filtered based on the requirement that 
they contain 20 bp of perfectly matching transposon end sequence. Fifteen base pairs of sequence 
immediately flanking the transposon were then extracted and aligned to a 1-kb window of the E. 
coli BL21(DE3) genome (GenBank accession CP001509) surrounding the crRNA-matching 
genomic target site. The distance between the nearest transposon–genome junction and the PAM-
distal edge of the 32-bp target site was determined. Histograms were plotted after compiling these 
distances across all the reads within a given library (Supplementary Tables for NGS statistics). 
 
Cell Killing Experiments 
For experiments with Cas9, 40 µl chemically competent BL21(DE3) cells were 
transformed with 100 ng Cas9-sgRNA expression plasmid encoding either sgRNA-3 or sgRNA-
4, which target equivalent lacZ sites as V. cholerae crRNA-3 or crRNA-4 but on opposite strands, 
or a truncated/non-functional sgRNA derived from the BsaI-containing entry vector 
59 
(Supplementary Tables). After a one-hour recovery at 37 °C, variable dilutions of cells were plated 
on LB-agar plates containing 100 µg ml−1 carbenicillin and 0.1 mM IPTG and grown an additional 
16 h at 37 °C. The number of resulting colonies was quantified across three biological replicates, 
and the data were plotted as colony-forming units per microgram of plasmid DNA. Additional 
control experiments used an expression plasmid encoding Cas9 nuclease-inactivating D10A and 
H840A mutations (dCas9). 
For experiments with Cascade and Cas2-3 from P. aeruginosa, BL21(DE3) cells were first 
transformed with a Cas2-3 expression vector, and the resulting strains were made chemically 
competent. Forty microlitres of these cells were then transformed with 100 ng PaeCascade 
expression plasmid encoding either crRNA-Pae3 or crRNA-Pae4, which target equivalent lacZ 
sites as V. cholerae crRNA-3 or crRNA-4, or a truncated/non-functional crRNA derived from the 
BsaI-containing entry vector (Supplementary Tables). After a one-hour recovery at 37 °C, variable 
dilutions of cells were plated on LB-agar plates containing 100 µg ml−1 carbenicillin and 50 µg 
ml−1 kanamycin and grown an additional 16 h at 37 °C. The number of resulting colonies was 
quantified across three biological replicates, and the data were plotted as colony-forming units per 
microgram of plasmid DNA. We found that even low concentrations of IPTG led to crRNA-
independent toxicity in these experiments, whereas crRNA-dependent cell killing was readily 
observed in the absence of induction, presumably from leaky expression by T7 RNAP. We 
therefore omitted IPTG from experiments using PaeCascade and Cas2-3. 
 
qPCR analysis of transposition efficiency 
For both crRNA-3 and crRNA-4, pairs of transposon- and genome-specific primers were 
designed to amplify an approximately 140–240-bp fragment resulting from RNA-guided DNA 
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integration at the expected lacZ locus in either orientation. A separate pair of genome-specific 
primers was designed to amplify an E. coli reference gene (rssA) for normalization purposes 
(Supplementary Tables). qPCR reactions (10 µl) contained 5 µl of SsoAdvanced Universal SYBR 
Green Supermix (BioRad), 1 µl H2O, 2 µl of 2.5 µM primers, and 2 µl of tenfold diluted lysate 
prepared from scraped colonies, as described for the PCR analysis above. Reactions were prepared 
in 384-well clear/white PCR plates (BioRad), and measurements were performed on a CFX384 
Real-Time PCR Detection System (BioRad) using the following thermal cycling parameters: 
polymerase activation and DNA denaturation (98 °C for 2.5 min), 40 cycles of amplification 
(98 °C for 10 s, 62 °C for 20 s), and terminal melt-curve analysis (65–95 °C in 0.5 °C per 5 s 
increments). 
We first prepared lysates from a control BL21(DE3) strain containing pDonor and both 
empty expression vectors (pCOLADuet-1 and pCDFDuet-1), and from strains that underwent 
clonal integration into the lacZ locus downstream of both crRNA-3 and crRNA-4 target sites in 
both orientations. By testing our primer pairs with each of these samples diluted across five orders 
of magnitude, and then determining the resulting Cq values and PCR efficiencies, we verified that 
our experimental and reference amplicons were amplified with similar efficiencies, and that our 
primer pairs selectively amplified the intended transposition product (Figure 22a, b). We next 
simulated variable transposition efficiencies across five orders of magnitude (ranging from 0.002 
to 100%) by mixing control lysates and clonally-integrated lysates in various ratios, and showed 
that we could accurately and reproducibly detect transposition products at both target sites, in 
either orientation, at levels >0.01% (Figure 22.b). Finally, we simulated variable integration 
orientation biases by mixing clonally-integrated lysates together in varying ratios together with 
control lysates, and showed that these could also be accurately measured (Figure 22c). 
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In our final qPCR analysis protocol, each biological sample is analyzed in three parallel 
reactions: one reaction contains a primer pair for the E. coli reference gene, a second reaction 
contains a primer pair for one of the two possible integration orientations, and a third reaction 
contains a primer pair for the other possible integration orientation. Transposition efficiency for 
each orientation is then calculated as 2ΔCq, in which ΔCq is the Cq difference between the 
experimental reaction and the control reaction. Total transposition efficiency for a given 
experiment is calculated as the sum of transposition efficiencies for both orientations. All 
measurements presented in the text and figures were determined from three independent biological 
replicates. 
We note that experiments with pDonor variants were performed by delivering pDonor in 
the final transformation step, whereas most other experiments were performed by delivering 
pQCascade in the final transformation step. Integration efficiencies between samples from these 
two experiments appeared to differ slightly as a result (compare Figure 15b with Figure 15c). 
Additionally, because we did not want to bias our qPCR analysis of the donor end truncation 
samples by successively shortening the PCR amplicon, different primer pairs were used for these 
samples. Within the left and right end truncation panel (Figure 23b, c), the transposon end that was 
not being perturbed was selectively amplified during qPCR analysis. 
 
Recombinant protein expression and purification 
The protein components for Cascade, TniQ and TniQ–Cascade were expressed from a 
pET-derivative vector containing an N-terminal His10-MBP-TEVsite fusion on Cas8, TniQ and 
TniQ, respectively (see Figure 20a). The crRNAs for Cascade and TniQ–Cascade were expressed 
separately from a pACYC-derivative vector (Supplementary Tables). E. coli BL21(DE3) cells 
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containing one or both plasmids were grown in 2xYT medium with the appropriate antibiotic(s) at 
37 °C to OD600 = 0.5–0.7, at which point IPTG was added to a final concentration of 0.5 mM and 
growth was allowed to continue at 16 °C for an additional 12–16 h. Cells were harvested by 
centrifugation at 4,000g for 20 min at 4 °C. 
Cascade and TniQ–Cascade were purified as follows. Cell pellets were resuspended in 
Cascade lysis buffer (50 mM Tris-Cl, pH 7.5, 100 mM NaCl, 0.5 mM PMSF, EDTA-free Protease 
Inhibitor Cocktail tablets (Roche), 1 mM dithiothreitol (DTT), 5% glycerol) and lysed by 
sonication with a sonic dismembrator (Fisher) set to 40% amplitude and 12 min total process time 
(cycles of 10 s on and 20 s off, for a total of 4 min on and 8 min off). Lysates were clarified by 
centrifugation at 15,000g for 30 min at 4 °C. Initial purification was performed by immobilized 
metal-ion affinity chromatography with NiNTA Agarose (Qiagen) using NiNTA wash buffer (50 
mM Tris-Cl, pH 7.5, 100 mM NaCl, 10 mM imidazole, 1 mM DTT, 5% glycerol) and NiNTA 
elution buffer (50 mM Tris-Cl pH 7.5, 100 mM NaCl, 300 mM imidazole, 1 mM DTT, 5% 
glycerol). The His10-MBP fusion was removed by incubation with TEV protease overnight at 4 °C 
in NiNTA elution buffer, and complexes were further purified by anion exchange chromatography 
on an AKTApure system (GE Healthcare) using a 5 ml HiTrap Q HP Column (GE Healthcare) 
with a linear gradient from 100% buffer A (20 mM Tris-Cl, pH 7.5, 100 mM NaCl, 1 mM DTT, 
5% glycerol) to 100% buffer B (20 mM Tris-Cl, pH 7.5, 1 M NaCl, 1 mM DTT, 5% glycerol) over 
20 column volumes. Pooled fractions were identified by SDS–PAGE analysis and concentrated, 
and the sample was further refined by size exclusion chromatography over one or two tandem 
Superose 6 Increase 10/300 columns (GE Healthcare) equilibrated with Cascade storage buffer (20 
mM Tris-Cl, pH 7.5, 200 mM NaCl, 1 mM DTT, 5% glycerol). Fractions were pooled, 
concentrated, snap frozen in liquid nitrogen, and stored at −80 °C. 
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TniQ was purified similarly, except the lysis, NiNTA wash, and NiNTA elution buffers 
contained 500 mM NaCl instead of 100 mM NaCl. Separation by ion exchange chromatography 
was performed on a 5 ml HiTrap SP HP Column (GE Healthcare) using the same buffer A and 
buffer B as above, and the final size-exclusion chromatography step was performed on a HiLoad 
Superdex 75 16/600 column (GE Healthcare) in Cascade storage buffer. The TniQ protein used in 
TniQ–Cascade binding experiments (Figure 20e) contained an N-terminal StrepII tag 
(Supplementary Tables). 
 
Mass spectrometry analysis 
Total protein (0.5–5 µg) was separated on 4–20% gradient SDS–PAGE and stained with 
Imperial Protein Stain (Thermo Scientific). In-gel digestion was performed essentially as 
described, with minor modifications. Protein gel slices were excised, washed with 1:1 
acetonitrile:100 mM ammonium bicarbonate (v/v) for 30 min, dehydrated with 100% acetonitrile 
for 10 min, and dried in a speed-vac for 10 min without heat. Gel slices were reduced with 5 mM 
DTT for 30 min at 56 °C and then alkylated with 11 mM iodoacetamide for 30 min at room 
temperature in the dark. Gel slices were washed with 100 mM ammonium bicarbonate and 100% 
acetonitrile for 10 min each, and excess acetonitrile was removed by drying in a speed-vac for 10 
min without heat. Gel slices were then rehydrated in a solution of 25 ng μl−1 trypsin in 50 mM 
ammonium bicarbonate for 30 min on ice, and trypsin digestions were performed overnight at 
37 °C. Digested peptides were collected and further extracted from gel slices in mass spectrometry 
(MS) extraction buffer (1:2 5% formic acid:acetonitrile (v/v)) with high-speed shaking. 
Supernatants were dried down in a speed-vac, and peptides were dissolved in a solution containing 
3% acetonitrile and 0.1% formic acid. 
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Desalted peptides were injected onto an EASY-Spray PepMap RSLC C18 50 cm × 75 μm 
column (Thermo Scientific), which was coupled to the Orbitrap Fusion Tribrid mass spectrometer 
(Thermo Scientific). Peptides were eluted with a nonlinear 100-min gradient of 5–30% mass 
spectrometry buffer B (MS buffer A: 0.1% (v/v) formic acid in water; MS buffer B: 0.1% (v/v) 
formic acid in acetonitrile) at a flow rate of 250 nl min−1. Survey scans of peptide precursors were 
performed from 400 to 1,575 m/z at 120K full width at half-maximum resolution (at 200 m/z) with 
a 2 × 105 ion count target and a maximum injection time of 50 ms. The instrument was set to run 
in top speed mode with 3-s cycles for the survey and the tandem mass spectrometry (MS/MS) 
scans. After a survey scan, tandem mass spectrometry was performed on the most abundant 
precursors exhibiting a charge state from 2 to 6 of greater than 5 × 103 intensity by isolating them 
in the quadrupole at 1.6 Th. CID fragmentation was applied with 35% collision energy, and 
resulting fragments were detected using the rapid scan rate in the ion trap. The AGC target for 
MS/MS was set to 1 × 104 and the maximum injection time limited to 35 ms. The dynamic 
exclusion was set to 45 s with a 10 ppm mass tolerance around the precursor and its isotopes. 
Monoisotopic precursor selection was enabled. 
Raw mass spectrometric data were processed and searched using the Sequest HT search 
engine within the Proteome Discoverer 2.2 software (Thermo Scientific) with custom sequences 
and the reference E. coli BL21(DE3) strain database downloaded from Uniprot. The default search 
settings used for protein identification were as follows: two mis-cleavages for full trypsin, with 
fixed carbamidomethyl modification of cysteine and oxidation of methionine; deamidation of 
asparagine and glutamine and acetylation on protein N termini were used as variable 
modifications. Identified peptides were filtered for a maximum 1% false discovery rate using the 
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Percolator algorithm, and the PD2.2 output combined folder was uploaded in Scaffold (Proteome 
Software) for data visualization. Spectral counting was used for analysis to compare the samples. 
 
crRNA analysis and RNA sequencing 
To analyze the nucleic acid component co-purifying with Cascade and TniQ–Cascade, 
nucleic acids were isolated by phenol-chloroform extraction, resolved by 10% denaturing urea–
PAGE, and visualized by staining with SYBR Gold (Thermo Scientific). Analytical RNase and 
DNase digestions were performed in 10 µl reactions with approximately 4 pmol nucleic acid and 
either 10 µg RNase A (Thermo Scientific) or 2 U DNase I (NEB), and were analyzed by 10% 
denaturing urea–PAGE and SYBR Gold staining. 
RNA sequencing was performed generally as previously described151. In brief, RNA was 
isolated from Cascade and TniQ–Cascade complexes by phenol-chloroform extraction, ethanol 
precipitated, and 5′-phosphorylated/3′-dephosphorylated using T4 polynucleotide kinase (NEB), 
followed by clean-up using the ssDNA/RNA Clean & Concentrator Kit (Zymo Research). A 
ssDNA universal Illumina adaptor containing 5′-adenylation and 3′-dideoxycytidine modifications 
(Supplementary Tables) was ligated to the 3′ end with T4 RNA Ligase 1 (NEB), followed by 
hybridization of a ssDNA reverse transcriptase primer and ligation of ssRNA universal Illumina 
adaptor to the 5′ end with T4 RNA Ligase 1 (NEB). cDNA was synthesized using Maxima H 
Minus Reverse Transcriptase (Thermo Scientific), followed by PCR amplification using indexed 
p5/p7 primers. Illumina sequencing was performed using a NextSeq mid output kit with 150-cycle 
single-end reads and automated demultiplexing and adaptor trimming (Illumina). Individual bases 
with Phred quality scores under 20 (corresponding to a base miscalling rate of >1%) were changed 
to ‘N,’ and only reads with at least half the called bases above Q20 were retained for subsequent 
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analysis. Reads were aligned to the crRNA expression plasmid used for recombinant Cascade and 
TniQ–Cascade expression and purification. 
 
TniQ-Cascade binding experiments 
Binding reactions (120 µl) contained 1 µM Cascade and 5 µM StrepII-tagged TniQ, and 
were prepared in Cascade storage buffer and incubated at room temperature for 30 min, before 
being loaded into a 100 µl sample loop on an AKTApure system (GE Healthcare). Reactions were 
resolved by size exclusion chromatography over a Superose 6 Increase 10/300 column (GE 
Healthcare) in Cascade storage buffer, and proteins in each peak fraction were acetone precipitated 
and analyzed by SDS–PAGE. Control reactions lacked either Cascade or TniQ. 
 
Tn-seq experiments 
Transposition experiments were performed as described above, except pDonor contained 
two point mutations in the transposon right end that introduced an MmeI restriction site 
(Supplementary Tables and Figure 25a, b). Colonies from triple antibiotic LB-agar plates 
containing IPTG (typically numbering in the range of 102–103) were resuspended in 4 ml fresh LB 
medium, and 0.5 ml (corresponding to around 2 × 109 cells) was used for genomic DNA (gDNA) 
extraction with the Wizard Genomic DNA Purification Kit (Promega). This procedure typically 
yielded 50 µl of 0.5–1.5 µg µl−1 gDNA, which is a mixture of the E. coli circular chromosome 
(4.6 Mb, copy number of 1), pDonor (3.6 kb, copy number 100+), pTnsABC (6.9 kb, copy number 
~20–40), and pQCascade (8.4 kb, copy number ~20–40). 
NGS libraries were prepared in parallel on 96-well plates, as follows. First, 1 µg of gDNA 
was digested with 4 U of MmeI (NEB) for 12 h at 37 °C in a 50 µl reaction containing 50 µM S-
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adenosyl methionine and 1× CutSmart Buffer, before heat inactivation at 65 °C for 20 min. MmeI 
cleaves the transposon 17–19 nucleotides outside of the terminal repeat, leaving 2-nucleotide 3′-
overhangs. Reactions were cleaned up using 1.8× Mag-Bind TotalPure NGS magnetic beads 
(Omega) according to the manufacturer’s instructions, and elutions were performed using 30 µl of 
10 mM Tris-Cl, pH 7.0. MmeI-digested gDNA was ligated to a double-stranded i5 universal 
adaptor containing a 3′-terminal NN overhang (Supplementary Tables) in a 20 µl ligation reaction 
containing 16.86 µl of MmeI-digested gDNA, 280 nM adaptor, 400 U T4 DNA ligase (NEB), and 
1× T4 DNA ligase buffer. Reactions were incubated at room temperature for 30 min before being 
cleaned up with magnetic beads as before. To reduce the degree of pDonor contamination within 
our NGS libraries, since pDonor also contains the full-length transposon with an MmeI site, we 
took advantage of the presence of a unique HindIII restriction site just outside the transposon right 
end within pDonor. The entirety of the adaptor-ligated gDNA sample was thus digested with 20 
Units of HindIII (NEB) in a 34.4 µl reaction for 1 h at 37 °C, before a heat inactivation step at 
65 °C for 20 min. Magnetic bead-based DNA clean-up was performed as before. 
Adaptor-ligated transposons were enriched in a PCR-1 step using a universal i5 adaptor 
primer and a transposon-specific primer containing a universal i7 adaptor as 5′ overhang. 
Reactions were 25 µl in volume and contained 16.75 µl of HindIII-digested gDNA, 200 µM 
dNTPs, 0.5 µM primers, 1× Q5 reaction buffer, and 0.5 U Q5 Hot Start High-Fidelity DNA 
Polymerase (NEB). Amplification was allowed to proceed for 25 cycles, with an annealing 
temperature of 66 °C. Reaction products were then diluted 20-fold into a second 20 µl polymerase 
chain reaction (PCR-2) containing indexed p5/p7 primers, and this was subjected to 10 additional 
thermal cycles using an annealing temperature of 65 °C. After verifying amplification for select 
libraries by analytical gel electrophoresis, barcoded reactions were pooled and resolved by 2% 
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agarose gel electrophoresis, DNA was isolated by Gel Extraction Kit (Qiagen), and NGS libraries 
were quantified by qPCR using the NEBNext Library Quant Kit (NEB). Illumina sequencing was 
performed using a NextSeq mid output kit with 150-cycle single-end reads and automated 
demultiplexing and adaptor trimming (Illumina). Individual bases with Phred quality scores under 
20 (corresponding to a base miscalling rate of >1%) were changed to ‘N,’ and only reads with at 
least half the called bases above Q20 were retained for subsequent analysis. 
Tn-seq libraries with the mariner transposon were prepared as for the V. cholerae 
transposon, but with the following changes. Transformation reactions contained BL21(DE3) cells 
and a single pDonor plasmid, which encodes a KanR-containing mariner transposon with MmeI 
restriction sites on both ends, and a separate expression cassette for the Himar1C9 transposase 
controlled by a lac promoter. Transformed cells were recovered at 37 °C for 1 h before being plated 
on bioassay dishes containing 100 µg ml−1 carbenicillin, yielding on the order of 5 × 104 colonies. 
Cells were resuspended in 20 ml fresh LB medium after a single 16-h overnight growth, and the 
equivalent of 2 × 109 cells were used for genomic DNA (gDNA) extraction. NGS libraries were 
prepared as described above, except the restriction enzyme digestion reactions to deplete pDonor 
contained 20 U of BamHI and KpnI instead of HindIII. 
 
Tn-seq data visualization and analysis 
The software application Geneious Prime was used to further filter reads based on three 
criteria: that read lengths correspond to the expected products resulting from MmeI cleavage and 
adaptor ligation to genomically integrated transposons (112–113 bp for the V. cholerae transposon 
and 87–88 bp for mariner); that each read contain the expected transposon end sequence (allowing 
for one mismatch); and that the transposon-flanking sequence (trimmed to 17 bp for the V. cholerae 
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transposon and 14 bp for mariner) map perfectly to the reference genome. Mapping to the E. coli 
BL21(DE3) genome (GenBank accession CP001509) was done using the function ‘Map to 
reference’ and the following settings: Mapper: Geneious; Fine tuning: None (fast / read mapping); 
Word length: 17; Maximum mismatches: 0%; Maximum Ambiguity: 1. The ‘Map multiple best 
matches’ setting was set to either ‘none,’ effectively excluding any reads except those that map 
uniquely to a single site (which we will refer to as ‘uniquely mapping reads’), or to ‘all,’ which 
allows reads to map to one or multiple sites on the E. coli genome (which we will refer to as 
‘processed mapping reads’). Both sets of reads were exported as fastq files and used for 
downstream analysis using custom Python scripts. We note that many reads removed in this 
process perfectly mapped to the donor plasmid (Supplementary Table 4), revealing that HindIII or 
BamHI/KpnI cleavage was insufficient to completely remove contaminating pDonor-derived 
sequences. Coverage data for ‘processed mapping reads’ were exported to generate Figure 16f. 
To visualize the genome-wide integration site distribution for a given sample, ‘uniquely 
mapping reads’ were mapped to the same E. coli reference genome with custom Python scripts. 
We define the integration site for each read as the genomic coordinate (with respect to the reference 
genome) corresponding to the 3′ edge of the mapped read. For visualization purposes, integration 
events within 5-kb bins were computed and plotted as genome-wide histograms in Figure 16c, g 
and Figure 3.101.14.a, b. Plots were generated using the Matplotlib graphical library. The sequence 
logo in Figure 16.d was generated using WebLogo 3. 
Plots comparing integration sites among biological replicates (Figure 25d-h) were 
generated by binning the genome-wide histograms based on gene annotations (mariner) using 
GenBank accession CP001509, or into 100-bp bins (V. cholerae transposon). For the V. cholerae 
transposon, the bins were shifted so that the 3′ end of the Cascade target site for each sample would 
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correspond to the start of its corresponding 100-bp bin. Linear regression and bivariate analysis 
for the mariner plot (Figure 25d) was performed using the SciPy statistical package. 
To analyze the primary integration site for each sample, custom Python scripts were used 
to map ‘processed mapping reads’ to a 600-bp genomic window surrounding the corresponding 
genomic target site. For reads mapping to the opposite strand as the target (that is, for the T-LR 
orientation, in which integration places the ‘left’ transposon end closest to the Cascade-binding 
site), the integration site was shifted 5 bp from the 3′ edge of the target site in order to account for 
the 5-bp target-site duplication. We define the primary integration site within this 600-bp window 
by the largest number of mapped reads, while we arbitrarily designate 100 bp centered at the 
primary integration site as the ‘on-target’ window. The percentage of on-target integration for each 
sample is calculated as the number of reads resulting from transposition within the 100-bp window, 
divided by the total number of reads mapping to the genome. We also determined the ratio of 
integration in one orientation versus the other; this parameter only utilizes on-target reads, and is 
calculated as the number of reads resulting from integration of the transposon ‘right’ end closest 
to the Cascade-binding site (T-RL), divided by the number reads resulting from integration of the 
transposon left end closest to the Cascade target site (T-LR). The distribution of integration around 
the primary site was plotted for both orientations for each sample, and was used to generate Figure 
16e and Figure 26c. We note that these analyzes are susceptible to potential biases from differential 
efficiencies in the ligation of 3′-terminal NN overhang adaptors, which are not taken into account 





Statistics and reproducibility 
Analytical PCRs resolved by agarose gel electrophoresis gave similar results in three 
independent replicates (Figures 13d, e, i, 14a, and 16a) or were analyzed by gel electrophoresis 
once (Figure 14e and Figures 18d, 19b, d, and f) but verified with qPCR for three independent 
replicates (Figure 14e). Sanger sequencing and next-generation sequencing of PCR amplicons was 
performed once (Figures 13f, g, 15e, 16e and Figures 18e, 19a, e, and ref. 132). SDS–PAGE 
experiments were performed for two or more different preparations of the same protein complexes 
and yielded similar results (Figure 14b and Figure 20b). Protein binding reactions were performed 
and analyzed by SDS–PAGE once (Figure 20e). Nucleic acid extraction from purified protein 
preparations and urea–PAGE analysis of samples with and without RNase or DNase treatment was 
performed twice, with similar results (Figure 14c and Figure 3.101.8.d). RNA sequencing was 





Figure 18: Transposition of the E. coli Tn7 transposon and genetic architecture of the Tn6677 
transposon from V. cholerae  
a, Genomic organization of the native E. coli Tn7 transposon adjacent to its known attachment site 
(attTn7) within the glmS gene. b, Expression plasmid and donor plasmid for Tn7 transposition 
experiments. c, Genomic locus containing the conserved TnsD-binding site (attTn7), including 
the expected and alternative orientation Tn7 transposition products and PCR primer pairs to 
selectively amplify them. d, PCR analysis of Tn7 transposition, resolved by agarose gel 
electrophoresis. Amplification of rssA serves as a loading control. e, Sanger sequencing 
chromatograms of both upstream and downstream junctions of genomically integrated Tn7. f, 
Genomic organization of the native V. cholerae strain HE-45 Tn6677 transposon. Genes that are 
conserved between Tn6677 and the E. coli Tn7 transposon, and between Tn6677 and a canonical 
type I-F CRISPR–Cas system from P. aeruginosa28, are highlighted. The cas1 and cas2-3 genes, 
which mediate spacer acquisition and DNA degradation during the adaptation and interference 
stages of adaptive immunity, respectively, are missing from CRISPR–Cas systems encoded by 
Tn7-like transposons. Similarly, the tnsE gene, which facilitates non-sequence-specific 
transposition, is absent. The V. cholerae HE-45 genome contains another Tn7-like transposon 
(located within GenBank accession ALED01000025.1), which lacks an encoded CRISPR–Cas 




Figure 19: Analysis of E. coli cultures and strain isolates containing lacZ-integrated 
transposons 
a, Top, genomic locus targeted by crRNA-3 and crRNA-4, including both potential transposition 
products and the PCR primer pairs to selectively amplify them. Bottom, NGS analysis of the 
distance between the Cascade target site and transposon insertion site for crRNA-3 (left) and 
crRNA-4 (right), determined with two alternative primer pairs. b, Top, schematic of the lacZ locus 
with or without integrated transposon after transposition experiments with crRNA-4. T-LR and 
T-RL denote transposition products in which the transposon left end and right end are proximal 
to the target site, respectively. Primer pairs g and h (external–internal) selectively amplify the 
integrated locus, whereas primer pair i (external–external) amplifies both unintegrated and 
integrated loci. Bottom, PCR analysis of 10 colonies after 24-h growth on +IPTG plates (left) 
indicates that all colonies contain integration events in both orientations (primer pairs g and h), 
but with efficiencies sufficiently low that the unintegrated product predominates after 
amplification with primer pair i. After resuspending cells, allowing for an additional 18 h of clonal 
growth on −IPTG plates, and performing the same PCR analysis on 10 colonies (right), 3 out of 10 
colonies now exhibit clonal integration in the T-LR orientation (compare primer pairs h and i). 
The remaining colonies show low-level integration in both orientations, which presumably 
occurred during the additional 18-h growth owing to leaky expression. These analyses indicate 
that colonies are genetically heterogeneous after growth on +IPTG plates, and that RNA-guided 
DNA integration only occurs in a proportion of cells within growing colonies. I, integrated 
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product; U, unintegrated product. Asterisk denotes mispriming product also present in the 
negative (unintegrated) control. c, Photograph of LB-agar plate used for blue–white colony 
screening. Cells from IPTG-containing plates were replated on X-gal-containing plates, and white 
colonies expected to contain lacZ-inactivating transposon insertions were selected for further 
characterization. d, PCR analysis of E. coli strains identified by blue–white colony screening that 
contain clonally integrated transposons, as in b. e, Schematic of Sanger sequencing coverage 
across the lacZ locus for strains shown in d. f, PCR analysis of transposition experiment with 
crRNA-4 after serially diluting lysate from a clonally integrated strain with lysate from a control 
strain to simulate variable integration efficiencies, as in b. These experiments demonstrate that 
transposition products can be reliably detected by PCR with an external–internal primer pair at 
efficiencies above 0.5%, but that PCR bias leads to preferential amplification of the unintegrated 
product using the external-external primer pair at any efficiency substantially below 100%. 
 
 
Figure 20: Analysis of V. cholerae Cascade and TniQ-Cascade complexes. 
a, Expression vectors for recombinant protein or ribonucleoprotein complex purification. b, Left, 
SDS–PAGE analysis of purified TniQ, Cascade and TniQ–Cascade complexes, highlighting 
protein bands excised for in-gel trypsin digestion and mass spectrometry analysis. Right, table 
listing E. coli and recombinant proteins identified from these data, and spectral counts of their 
associated peptides. Note that Cascade and TniQ–Cascade samples used for this analysis are 
distinct from the samples presented in Fig. 2. c, Size-exclusion chromatogram of the TniQ–
Cascade co-complex on a Superose 6 10/300 column (left), and a calibration curve generated using 
protein standards (right). The measured retention time of TniQ–Cascade (maroon) is consistent 
with a complex having a molecular mass of approximately 440 kDa. d, RNase A and DNase I 
sensitivity of nucleic acids that co-purified with Cascade and TniQ–Cascade, resolved by 
denaturing urea–PAGE. e, TniQ, Cascade and a Cascade + TniQ binding reaction were resolved 
by size-exclusion chromatography (left), and indicated fractions were analysed by SDS–PAGE 




Figure 21: Control experiments demonstrating efficient DNA targeting with Cas9 and P. 
aeruginosa Cascade. 
a, Plasmid expression system for S. pyogenes (Spy) Cas9-sgRNA (type II-A, left) and P. aeruginosa 
Cascade (PaeCascade) and Cas2-3 (type I-F, right). The Cas2-3 expression plasmid was omitted 
from experiments described in Figure 14.e, b, Cell killing experiments using S. pyogenes Cas9-
sgRNA (left) or PaeCascade and Cas2-3 (right), monitored by determining colony-forming units 
(CFU) after plasmid transformation. Complexes were programmed with guide RNAs that target 
the same genomic lacZ sites as with V. cholerae crRNA-3 and crRNA-4, such that efficient DNA 
targeting and degradation results in lethality and thus a drop in transformation efficiency. c, 
qPCR-based quantification of transposition efficiency from experiments using the V. cholerae 
transposon donor and TnsA-TnsB-TnsC, together with DNA targeting components comprising 
V. cholerae Cascade (Vch), P. aeruginosa Cascade (Pae) or S. pyogenes dCas9–RNA (dCas9). TniQ 
was expressed either on its own from pTnsABCQ or as a fusion to the targeting complex (pCas-
Q) at the Cas6 C terminus (6), Cas8 N terminus (8), or dCas9 N or C terminus. The same sample 
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Figure 22: qPCR-based quantification of RNA-guided DNA integration efficiencies 
a, Potential lacZ transposition products in either orientation for both crRNA-3 and crRNA-4, and 
qPCR primer pairs to selectively amplify them. b, Comparison of simulated integration 
efficiencies for T-LR and T-RL orientations, generated by mixing clonally integrated and 
unintegrated lysates in known ratios, versus experimentally determined integration efficiencies 
measured by qPCR. c, Comparison of simulated mixtures of bidirectional integration efficiencies 
for crRNA-4, generated by mixing clonally integrated and unintegrated lysates in known ratios, 
versus experimentally determined integration efficiencies measured by qPCR. d, RNA-guided 
DNA integration efficiency as a function of IPTG concentration for crRNA-3 and crRNA-4, 





Figure 23: Influence of transposon end sequences on RNA-guided DNA integration 
a, Sequence (top) and schematic (bottom) of V. cholerae Tn6677 left- and right-end sequences. The 
putative TnsB-binding sites (blue) were determined based on sequence similarity to the 
TnsBbinding sites previously described in 28. The 8-bp terminal ends are shown in yellow, and 
the empirically determined minimum end sequences required for transposition are denoted by 
red dashed boxes. b, Integration efficiency with crRNA-4 as a function of transposon end length, 
as determined by qPCR. c, The relative fraction of both integration orientations as a function of 
transposon end length, determined by qPCR. ND, not determined. Data in b and c are shown as 
mean ± s.d. for n = 3 biologically independent samples. 
78 
 
Figure 24: Analysis of RNA-guided DNA integration for PAM-tiled crRNAs and extended 
spacer length crRNAs 
a, Integration site distribution for all crRNAs described in Figure 18.d & Figure 18.e having a 
normalized transposition efficiency more than 20%, determined by NGS. b, Integration site 
distribution for a crRNA containing mismatches at positions 29–32, compared with the 
distribution with crRNA-4, determined by NGS. c, The crRNA-4 spacer length was shortened or 
lengthened by 6-nucleotide increments, and the resulting integration efficiencies were 
determined by qPCR. Data are normalized to crRNA-4 and are shown as mean ± s.d. for n = 3 
biologically independent samples. d, Integration site distribution for extended length crRNAs 




Figure 25: Development and analysis of Tn-seq. 
a, Schematic of the V. cholerae transposon end sequences. The 8-bp terminal sequence of the 
transposon is boxed and highlighted in light yellow. Mutations generated to introduce MmeI 
recognition sites are shown in red letters, and the resulting recognition site is highlighted in red. 
Cleavage by MmeI occurs 17–19 bp away from the transposon end, generating a 2-bp overhang. 
b, Comparison of integration efficiencies for the wild-type and MmeI-containing transposon 
donors, determined by qPCR. Labels on the x axis denote which plasmid was transformed last; 
we reproducibly observed higher integration efficiencies when pQCascade was transformed last 
(crRNA-4) than when pDonor was transformed last. The transposon containing an MmeI site in 
the transposon ‘right’ end (R∗-L pDonor) was used for all Tn-seq experiments. Data are mean ± 
s.d. for n = 3 biologically independent samples. c, Plasmid expression system for Himar1C9 and 
the mariner transposon. d, Scatter plot showing correlation between two biological replicates of 
Tn-seq experiments with the mariner transposon. Reads were binned by E. coli gene annotations, 
and a linear regression fit and Pearson linear correlation coefficient (r) are shown. e, Schematic of 
100-bp binning approach used for Tn-seq analysis of transposition experiments with the V. 
cholerae transposon, in which bin 1 is defined as the first 100 bp immediately downstream (PAM-
distal) of the Cascade target site. f, Scatter plots showing correlation between biological replicates 
of Tn-seq experiments with the V. cholerae transposon programmed with crRNA-4. All highly 
sampled reads fall within bin 1, but we also observed low-level but reproducible, long-range 
integration into 100-bp bins just upstream and downstream of the primary integration site (bins 
1, 2 and 3). g, Scatter plot showing correlation between biological replicates of Tn-seq experiments 
with the V. cholerae transposon programmed with a non-targeting crRNA (crRNA-NT). h, Scatter 
plot showing correlation between biological replicates of Tn-seq experiments with the V. cholerae 
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transposon expressing TnsA-TnsB-TnsC-TniQ but not Cascade. For f–h, bins are only plotted 







Figure 26: Tn-seq data for additional crRNAs tested. 
a, b, Genome-wide distribution of genome-mapping Tn-seq reads from transposition experiments 
with the V. cholerae transposon programmed with crRNAs 1–8 (a) and crRNAs 17–24 (b). The 
location of each target site is denoted by a maroon triangle. Dagger symbol indicates that the lacZ 
target site for crRNA-3 is duplicated within the λ DE3 prophage, as is the transposon integration 
site; Tn-seq reads for this dataset were mapped to both genomic loci for visualization purposes 
only, although we are unable to determine from which locus they derive. c, Analysis of 
integration site distributions for crRNAs 1–24 determined from the Tn-seq data; the distance 
between the Cascade target site and transposon insertion site is shown. Data for both integration 
orientations are superimposed, with filled blue bars representing the T-RL orientation and the 
dark outlines representing the T-LR orientation. Values in the top-right corner of each graph give 
the on-target specificity (%), calculated as the percentage of reads resulting from integration 
within 100 bp of the primary integration site, as compared with the total number of reads aligning 
to the genome; and the orientation bias (X:Y), calculated as the ratio of reads for the T-RL 
orientation to reads for the T-LR orientation. Most crRNAs favor integration in the T-RL 
orientation 49–50 bp downstream of the Cascade target site. crRNA-21 is greyed out because the 
expected primary integration site is present in a repetitive stretch of DNA that does not allow us 
to map the reads confidently. Asterisks denote samples for which more than 1% of the genome-




Figure 27: Bacterial transposons also contain type V-U5 CRISPR-Cas systems encoding C2c5. 
Representative genomic loci from various bacterial species containing identifiable transposon left 
and right ends (blue boxes, L and R), genes with homology to tnsB-tnsC-tniQ (shades of yellow), 
CRISPR arrays (maroon), and the CRISPR-associated gene c2c5 (blue). The example from 
Hassallia byssoidea (top) highlights the target-site duplication and terminal repeats, as well as 
genes found within the cargo portion of the transposon. As with the type I CRISPR–Cas system-
containing Tn7-like transposons, type V CRISPR–Cas system-containing transposons appear to 
preferentially contain genes associated with innate immune system functions, such as restriction-
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modification systems. c2c5 genes are frequently flanked by the predicted transcriptional 
regulator, merR (light blue), and the C2c5-containing transposons appear to usually fall just 
upstream of tRNA genes (green), a phenomenon that has also been observed for other prokaryotic 
integrative elements152,153. Analysis of 50 spacers from the 8 CRISPR arrays shown with 
CRISPRTarget154 revealed 6 spacers with imperfectly matching targets (average of 6 mismatches), 
none of which mapped to bacteriophages, plasmids, or to the same bacterial genome containing 






3.11: Supplementary Figures 
 
Figure 28: Multiple sequence alignment of TnsA. 
Conserved catalytic residues are indicated with red triangles. Vch, Vibrio cholerae; Ecl, Enterobacter 
cloacae; Asa, Aeromonas Salmonicida; Pmi, Proteus Mirabilis; Eco, Escherichia coli. 
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Figure 29: Multiple sequence alignment of TnsB. 
Conserved catalytic residues of the DDE motif are indicated with red triangles. Vch, Vibrio 





Figure 30: Multiple sequence alignment of TnsC. 
Walker A and Walker B motifs characteristic of AAA+ ATPases are indicated, and active site 
residues involved in ATPase activity are indicated with blue triangles. Some TnsC homologs are 
annotated as TniB. Vch, Vibrio cholerae; Ecl, Enterobacter cloacae; Asa, Aeromonas Salmonicida; Pmi, 
Proteus Mirabilis; Eco, Escherichia coli. 
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Figure 31: Multiple sequence alignment of TniQ/TnsD. 
VchTniQ is aligned to members of the TniQ/TnsD family. Conserved zinc finger motif residues 
are indicated with blue arrows. Vch, Vibrio cholerae; Ecl, Enterobacter cloacae; Asa, Aeromonas 




Figure 32:  Multiple sequence alignment of Cas6. 
VchCas6 is aligned to other I-F Cas6 proteins, which are often annotated as Cas6f or Csy4. 
Conserved catalytic residues are indicated with red arrows. Vch, Vibrio cholerae; Rho, 




Figure 33: Multiple sequence alignment of Cas7. 
VchCas6 is aligned to other I-F Cas7 proteins, which are often annotated as Csy3. Conserved 
catalytic residues are indicated with red arrows. Vch, Vibrio cholerae; Rho, Rhodanobacter sp; Bpl, 




Figure 34: Multiple sequence alignment of Cas8 and Cas5. 
VchCas8, a natural Cas8-Cas5 fusion protein, is aligned to other I-F Cas8 proteins (top, which are 
often annotated as Csy1, and to other I-F Cas5 proteins (bottom_, which are often annotated as 
Csy2. Vch, Vibrio cholerae; Rho, Rhodanobacter sp; Bpl, Burkholderia plantarii; Idi, Idiomarina sp. 
H105; Pae, Pseudomonas aeruginosa. 
  
91 
Chapter 4: Structural Basis of DNA Targeting by a 
Transposon-Encoded CRISPR-Cas System 
 
This chapter has been adapted from:  
Halpin-Healy, T.S., Klompe, S.E., Sternberg, S.H. & Fernandez, I.F. Structural basis of DNA 
targeting by a transposon-encoded CRISPR–Cas system. Nature 577, 271–274 (2020). 
 
Appendix B contains the paper as published. 
 
Contributions:  
All authors conceived and designed the project. T.S.H.-H. purified ribonucleoprotein complexes 
and assisted in cryo-EM data acquisition. I.S.F. collected EM data and solved the structures. I.S.F., 
S.H.S. and the other authors discussed the data and wrote the manuscript. 
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4.1: Abstract 
Bacteria use adaptive immune systems encoded by CRISPR and Cas genes to maintain 
genomic integrity when challenged by pathogens and mobile genetic elements64,111,112.  Type I 
CRISPR–Cas systems typically target foreign DNA for degradation via joint action of the 
ribonucleoprotein complex Cascade and the helicase–nuclease Cas3155,156, but nuclease-deficient 
type I systems lacking Cas3 have been repurposed for RNA- guided transposition by bacterial Tn7-
like transposons32,157.  How CRISPR- and transposon-associated machineries collaborate during 
DNA targeting and insertion remains unknown. Here we describe structures of a TniQ–Cascade 
complex encoded by the Vibrio cholerae Tn6677 transposon using cryo-electron microscopy, 
revealing the mechanistic basis of this functional coupling. The cryo-electron microscopy maps 
enabled de novo modelling and refinement of the transposition protein TniQ, which binds to the 
Cascade complex as a dimer in a head-to-tail configuration, at the interface formed by Cas6 and 
Cas7 near the 3′ end of the CRISPR RNA (crRNA). The natural Cas8–Cas5 fusion protein binds 
the 5′ crRNA handle and contacts the TniQ dimer via a flexible insertion domain. A target DNA-
bound structure reveals critical interactions necessary for protospacer-adjacent motif recognition 
and R-loop formation. This work lays the foundation for a structural understanding of how DNA 
targeting by TniQ–Cascade leads to downstream recruitment of additional transposase proteins, 
and will guide protein engineering efforts to leverage this system for programmable DNA 
insertions in genome-engineering applications. 
 
4.2: Introduction 
We previously demonstrated that a transposon derived from V. cholerae Tn6677 undergoes 
programmable transposition in Escherichia coli directed by a crRNA, and that this activity requires 
93 
four transposon- and three CRISPR-associated genes in addition to a CRISPR array157 (Figure 
35a). Whereas TnsA, TnsB and TnsC exhibit functions that are consistent with their homologs 
from the related and well-studied cut-and-paste DNA transposon E. coli Tn7119, we showed that 
TniQ, a homolog of E. coli TnsD, forms a co-complex with the Cascade ribonucleoprotein 
complex encoded by the type I-F variant CRISPR–Cas system. This finding suggested an 
alternative role for TniQ, compared with the role of E. coli TnsD in identifying target sites during 
Tn7 transposition. We proposed that RNA-guided DNA targeting by Cascade could deliver TniQ 
to DNA in a manner compatible with downstream transpososome formation, and that TniQ might 
interact with Cascade near the 3′ end of the crRNA, consistent with RNA-guided DNA insertion 
occurring around 49 bp down-stream of the protospacer-adjacent motif (PAM)-distal edge of the 
target site. To determine this unambiguously, we purified the V. cholerae TniQ– Cascade complex 
loaded with a native crRNA and determined its structure by cryo-electron microscopy (cryo-EM) 
(Supplementary Table 1) 
 
4.3: Cryo-EM Structure of TniQ-Cascade Complex 
The overall complex adopts a helical architecture with protuberances at both ends (Figure 
35, Figure 39, and 40). The global architecture is similar to previously determined structures of 
Cascade from I-E and I-F systems89,158–160 (Figure 41), with the exception of a large mass of 
additional density attributable to TniQ (Figure 35c). Maximum likelihood classification methods 
implemented in Relion3161 enabled us to identify marked dynamics in the entire complex, which 
appears to ‘breathe’, widening and narrowing the distance between the two protuberances (Figure 
39d). The large subunit encoded by a natural Cas8–Cas5 fusion protein (hereafter referred to 
simply as Cas8) forms one protuberance and recognizes the 5′ end of the crRNA via base- and 
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backbone-specific contacts (Figure 42, 43a–c, 44a), similar to the canonical roles of Cas8 and Cas5 
(Figure 41). Cas8 contains two primary subdomains formed mainly by α-helices and a third 
domain of approximately 100 residues (residues 277 to 385) that is predicted to form three α-
helices but could not be built in our maps owing to its intrinsic flexibility (Figure 35c). However, 
low-pass-filtered maps revealed that this flexible domain connects with the TniQ protuberance at 
the opposite end of the crescent-shaped complex (Figure 40e). Additionally, there seemed to be a 
loose coupling between the Cas8 flexible domain and overall breathing of the complex, as stronger 
density for that domain could be observed in the closed state (Figure 40d). 
Six Cas7 subunits protect much of the crRNA by forming a helical filament along its length 
(Figure 35b, d), similar to other type I Cascade complexes88,89,127,158 (Figure 41). A ‘finger’ motif 
in Cas7 clamps the crRNA at regular intervals, causing every sixth nucleotide (nt) of the 32-nt 
spacer to flip out while leaving the flanking nucleotides available for DNA recognition (Figure 
42f, 44). These bases are pre-ordered in short helical segments, with a conserved phenylalanine 
stacking below the first base of every segment. Cas7.1, the monomer furthest away from Cas8, 
interacts with Cas6 (also known as Csy4), which is the RNase responsible for processing of the 
precursor RNA transcript derived from the CRISPR locus. The Cas6–Cas7.1 interaction is 
mediated by a β-sheet formed by the contribution of a β-strand from Cas6 and the two β-strands 
that form the finger of Cas7.1 (Figure 43f). Cas6 also forms extensive interactions with the 
conserved stem-loop in the repeat-derived 3′ crRNA handle (Figure 35, Figure 43d, e), with an 
arginine-rich α-helix (residues 110 to 128) docked in the major groove, positioning multiple basic 





Figure 35: Overall architecture of the V. cholerae TniQ-Cascade complex 
a, Genetic architecture of the Tn6677 transposon (top), and plasmid constructs used to express 
and purify the TniQ–Cascade complex. Right, selected cryo-EM reference-free two-dimensional 
class averages in multiple orientations. b, Orthogonal views of the cryo-EM map of the TniQ–
Cascade complex, showing Cas8 (purple), six Cas7 monomers (green), Cas6 (salmon), crRNA 
(grey) and TniQ monomers (blue, yellow). The complex adopts a helical architecture with 
protuberances at both ends. c, A flexible domain in Cas8 comprising residues 277–385 (grey) 
could only be visualized in low-pass-filtered maps. The unsharpened map is shown as semi-
transparent, grey map overlaid on the post-processed map segmented and colored as in a. d, 
Refined model for the TniQ–Cascade complex derived from the cryo-EM maps shown in b. 
 
 
The interaction established between Cas6 and Cas7.1 forms a continuous surface on which 
TniQ is docked, forming the other protuberance of the crescent. The intrinsic flexibility of the 
complex resulted in lower local resolutions in this area of the maps, which we overcame using 
local alignments masking the area comprising TniQ, Cas6, Cas7.1 and the crRNA handle (Figure 
45). The enhanced maps enabled de novo modelling and refinement of TniQ, for which no previous 
structure or homology model has been reported, to our knowledge (Figure 36). Notably, TniQ 
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binds to Cascade as a dimer with head-to-tail configuration (Figure 36), a surprising result given 
the expectation that E. coli TnsD functions as a monomer during Tn7 transposition162. 
 
 
Figure 36: TniQ binds Cascade in a dimeric, head-to-tail configuration. 
a, Left, overall view of the TniQ–Cascade cryo-EM unsharpened map (grey) overlaid on the post-
processed map segmented and colored as in Figure 35. Right, cryo-EM map (top) and refined 
model (bottom) of the TniQ dimer. The two monomers interact with each other in a head-to-tail 
configuration and are anchored to Cascade by Cas6 and Cas7.1. b, Secondary structure diagram 
of the TniQ dimer: thirteen α-helices are organized into an N-terminal HTH domain and a C-
terminal TniQ domain. Dimer interactions between H3 and H12 are indicated, as are interaction 
sites with Cas6 and Cas7.1. c, Cryo-EM density for the H3–H12 interaction shows clear side-chain 
features (top), allowing accurate modelling of the interaction (bottom). d, Schematic of the dimer 
interaction, showing the important dimerization interface between the HTH and TniQ domain. 
 
 
4.4: TniQ Binds to Cascade as a dimer  
TniQ is composed of two domains: an N-terminal domain of approximately 100 residues 
formed by three short α-helices and a second, larger domain of approximately 300 residues with a 
signature sequence for the TniQ family. A DALI163 search using the refined TniQ model as a probe 
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yielded marked structural similarity of the N-terminal domain to proteins containing helix–turn–
helix (HTH) domains. This domain is often involved in nucleic acid recognition; however, there 
are examples where it has been re-purposed for protein–protein interactions164. The remaining C-
terminal TniQ domain is formed by ten α-helices of variable length and is predicted to contain two 
tandem zinc finger motifs, although this region was poorly defined in the maps (Figure 36). 
Overall, the double domain composition of TniQ results in an elongated structure, bent at the 
junction of the HTH and the TniQ domain (Figure 36). The HTH domain of one monomer engages 
the TniQ domain of the other monomer via interactions between α-helix 3 (H3) and α-helix 12 
(H12), respectively, in a tight protein–protein interaction (Figure 36c). This reciprocal interaction 
is complemented by multiple interactions established between the TniQ domains from both 
monomers (up to 45 non-covalent interactions as reported by PISA165). 
Tethering of the TniQ dimer to Cascade is accomplished by specific interactions 
established with both Cas6 and Cas7.1 (Figure 37). One monomer of TniQ interacts with Cas6 via 
its C-terminal TniQ domain, whereas the other TniQ monomer contacts Cas7.1 through its N-
terminal HTH domain (Figure 36b, 37). The loop connecting α-helices H7 and H8 of the TniQ 
domain of the first TniQ monomer is inserted in a hydrophobic cavity formed at the interface of 
two α-helices of Cas6 (Figure 37b, d). The TniQ histidine residue 265 is involved in rearranging 
the hydrophobic loop connecting H7 and H8 (Figure 37d), which is inserted in the hydrophobic 
pocket of Cas6 formed by residues L20, Y74, M78, Y83 and F84. The buried surface in the Cas6–
TniQ.1 interaction interface has an area of 420 Å2. The HTH domain of the other TniQ monomer 
interacts with Cas7.1 through a network of interactions established mainly by α-helix H2 and the 
linker connecting H2 and H3, burying a surface area of 595 Å2 (Figure 37c, e). Thus, the HTH 
domain and the TniQ domain exert dual roles to drive TniQ dimerization and dock onto Cascade. 
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The aggregate buried surface area for the TniQ–Cascade interaction is 1,015 Å2, significantly 
smaller than other Cascade–effector interactions such as with the nuclease Cas3, in which 2,433 
Å2 is buried166. This difference is not surprising given the flexibility observed for the TniQ dimer 
in its association with Cascade. 
 
 
Figure 37: Cas6 and Cas7.1 form a binding platform for TniQ 
a, Top, magnified area showing the interaction site of Cascade and the TniQ dimer. Cas6 and 
Cas7.1 are displayed as molecular Van der Waals surfaces, the crRNA is shown as grey spheres 
and the TniQ monomers are shown as ribbons. b, The loop connecting TniQ.1 α-helices H7 and 
H8 (blue) binds within a hydrophobic cavity of Cas6. c, Cas7.1 interacts with the HTH domain of 
the TniQ.2 monomer (yellow), mainly through H2 and the loop connecting H2 and H3. d, e, 




4.5: Structure of the DNA-bound TniQ-Cascade Complex  
To investigate the structural determinants of DNA recognition by the TniQ–Cascade 
complex, we determined the structure of the complex bound to a double-stranded DNA (dsDNA) 
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substrate containing the 32-bp target sequence, 5′-CC-3′ PAM, and 20 bp of flanking dsDNA on 
both ends (Figure 38, 46). Density for 28 nucleotides of the target strand and 8 nucleotides of the 
non-target strand could be confidently assigned in the reconstructed maps (Figure 38c). As with 
previous I-F Cascade structures, Cas8 recognizes the double-stranded PAM within the minor 
groove127 (Figure 47), and an arginine residue (R246) establishes a stacking interaction with a 
guanine nucleotide on the target strand, which acts as a wedge to separate the double-stranded 
PAM from the neighboring unwound DNA where base-pairing with the crRNA begins (Figure 
38c). 
Twenty-two nucleotides of the target strand within the 32-bp target showed clear density, 
but surprisingly, the terminal nine nucleotides were not ordered. The target-strand base pairs with 
the spacer region of the crRNA in short, discontinuous helical segments, as observed previously 
for I-E and I-F DNA-bound Cascade complexes88,127, with every sixth base flipped out of the 
heteroduplex by the insertion of a Cas7 finger (Figure 44b). The observed 22-bp heteroduplex is 
stabilized by the four Cas7 monomers proximal to the PAM (Cas7.6–Cas7.3), but even after local 
masked refinements, no density could be observed for any target strand nucleotides that would 
base-pair with the 3′ end of the crRNA spacer bound by Cas7.2 and Cas7.1. These two Cas7 
monomers are proximal to Cas6 and in the region previously described to exhibit dynamics owing 
to the interaction of the Cas8 flexible domain with the inner face of the TniQ dimer. In addition, 
the disordered nucleotides also correspond to positions 25–28 of the target site where RNA–DNA 
mismatches are detrimental for RNA-guided DNA integration157. Thus, we propose that the partial 
R-loop structure that we observed could represent an intermediate conformation refractory to 
integration, and that further structural rearrangements may be critical for further stabilization of 




Figure 38: DNA-bound structure of the TniQ-Cascade complex. 
a, Schematic of crRNA and the portion of the dsDNA substrate that was experimentally observed 
within the electron density map for DNA-bound TniQ–Cascade. The target strand, non-target 
strand, PAM and seed regions are indicated (left); protein components are shown on the right. b, 
Selected cryo-EM reference-free two-dimensional class averages for DNA-bound TniQ–Cascade; 
density corresponding to dsDNA could be directly observed protruding from the Cas8 
component in the two-dimensional class averages (white arrows). c, Cryo-EM map for DNA-
bound TniQ–Cascade. The crRNA is shown in dark grey and the DNA is shown in red. Right 
bottom, detailed views of the PAM and seed-recognition regions of the map, with refined models 
represented as sticks within the electron density. Cas8 is shown in purple, Cas7 is shown in green, 
the crRNA is in grey and DNA is shown in red. NTS, non-target strand. d, The V. cholerae 
transposon encodes a TniQ–Cascade co-complex that uses the sequence content of the crRNA to 
bind complementary DNA target sites. We propose that the incomplete R-loop observed in our 
structure (middle) represents an intermediate state that may precede a downstream ‘locking’ step 
involving proofreading of the RNA–DNA complementarity. TniQ is positioned at the PAM-distal 
end of the DNA-bound Cascade complex, where it probably interacts with TnsC during 





Here we present cryo-EM structures of a CRISPR–Cas effector complex bound to the 
transposition protein TniQ, with and without target DNA. These structures reveal the unexpected 
presence of TniQ as a dimer that forms bipartite interactions with Cas6 and Cas7.1 within the 
Cascade complex, forming a probable recruitment platform for downstream-acting transposition 
proteins167 (Figure 38d). Our structures further reveal a possible fidelity checkpoint, whereby 
formation of a complete R-loop requires conformational rearrangements that may depend on 
extensive RNA–DNA complementarity and/or downstream factor recruitment; this proofreading 
step could account for the highly specific RNA-guided DNA integration that we previously 
reported for the V. cholerae transposon157. In light of recent work demonstrating exaptation of type 
V-K CRISPR–Cas systems by similar Tn7-like transposons that also encode TniQ73,93, it will be 
informative to determine whether tethering of TniQ to evolutionarily distinct crRNA effector 
complexes— Cascade or Cas12k—is a general theme of RNA-guided transposition. 
 
4.7: Materials and Methods  
Statistics 
No statistical methods were used to predetermine sample size. The experiments were not 




TniQ–Cascade purification Protein components of TniQ–Cascade were expressed from a 
pET-derivative vector containing the native V. cholerae tniQ-cas8-cas7- cas6 operon with an N-
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terminal His10-MBP-TEV site fusion on TniQ. The crRNA was expressed separately from a 
pACYC-derivative vector containing a minimal repeat–spacer–repeat CRISPR array encoding a 
spacer from the endogenous V. cholerae CRISPR array. The TniQ–Cascade complex was 
overexpressed and purified as described previously157, and was stored in Cascade storage buffer 
(20 mM Tris-Cl, pH 7.5, 200 mM NaCl, 1 mM DTT, 5% glycerol). 
 
Sample Preparation for Electron Microscopy 
For negative staining, 3 µl of purified TniQ–Cascade ranging from 100 nM to 2 µM was 
incubated with plasma treated (H2/O2 gas mix, Gatan Solarus) CF400 carbon-coated grids (EMS) 
for 1 min. Excess solution was blotted and 3 µl of 0.75% uranyl formate was added for an 
additional minute. Excess stain was blotted away and grids were air-dried overnight. Grid 
screening for both negative staining and cryo conditions was performed on a Tecnai-F20 
microscope (FEI) operated at 200 KeV and equipped with a Gatan K2-Summit direct detector. 
Microscope operation and data collection were carried out using the Leginon/Appion software. 
Initial negative staining grid screening allowed determination of a suitable concentration range for 
cryo conditions. Several grid geometries were tested in the 1–4 µM concentration range for cryo 
conditions using a Vitrobot Mark-II operated at 4 °C, 100% humidity, blot force 3, drain time 0, 
waiting time 15 s, and blotting times ranging from 3–5 s. The best ice distribution and particle 
density was obtained with 0.6/1 UltrAuFoil grids (Quantifoil). 
 
Electron Microscopy 
A preliminary dataset of 300 images in cryo was collected with the Tecnai-F20 microscope 
using a pixel size of 1.22 Å/pixel with illumination conditions adjusted to 8 e−/pixel/second with 
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a frame window of 200 ms. Preprocessing and image processing were integrally done in Relion3168 
with ctf estimation integrated via a wrapper to Gctf169. An initial model computed using the SGD 
algorithm170 implemented in Relion3 was used as initial reference for a refine three-dimensional 
job that generated a sub-nanometric reconstruction with approximately 10,000 selected particles. 
Clear secondary structure features in the two-dimensional averages and the three-dimensional 
reconstruction could be identified. For the DNA-bound TniQ–Cascade complex containing DNA, 







for 5 min at 95 °C in hybridization buffer (20 mM Tris-Cl, pH 7.5, 100 mM KCl, 5 mM MgCl2) 
to form dsDNA,which was subsequently aliquoted and flash-frozen. Complex formation was 
performed by incubating a 3× molar excess of dsDNA with TniQ–Cascade at 37 °C for 5 min 
before vitrification, which followed the conditions optimized for the apo complex (defined as 
TniQ–Cascade with High-resolution data for the apo complex were collected in a Tecnai-Polara-
F30 microscope operated at 300 KeV equipped with a K3 direct detector (Gatan). A 30-µm C2 
aperture was used with a pixel size of 0.95 Å/pixel and illumination conditions in microprobe 
mode adjusted to a fluence of 16 e−/pixel/second. Four-second images with a frame width of 100 
ms (1.77 e−/Å2/frame) were collected in counting mode. For the DNA-bound complex, high-
resolution data were collected in a Titan Krios microscope (FEI) equipped with an energy filter 
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(20 eV slit width) and a K2 direct detector (Gatan) operated at 300 KeV. A 50-µm C2 aperture 
was used with a pixel size of 1.06 Å/pixel and illumination conditions adjusted in nanoprobe mode 
to a fluence of 8 e−/pixel/second. Eight-second images with a frame width of 200 ms(1.42 
e−/Å2/frame) were collected in counting mode.  
 
Image Processing 
Motion correction was performed for every micrograph applying the algorithm described 
for Motioncor2171 implemented in Relion3 with 5-by-5 patches for the K2 data and 7 by 5 patches 
for the K3 data. Parameters of the contrast transfer function for each motion-corrected micrograph 
were obtained using Gctf169 integrated in Relion3. Initial particle picking of a subset of 200 images 
randomly chosen was performed with the Laplacian tool of the Auto-picking module of Relion3, 
using an estimated size for the complex of 200 Å. Then, 15,000 particles were extracted in a 300-
pixel box size and binned 3 times for an initial two- dimensional classification job. Selected two-
dimensional averages from this job were used as templates for Auto-picking of the full dataset. 
The full dataset of binned particles was subjected to a two-dimensional classification job to 
identify particles able to generate averages with clear secondary structure features. The selected 
subgroup of binned particles after the two-dimensional classification selection was refined against 
a three-dimensional volume obtained by SGD with the F20 data. This consensus volume was 
inspected to localize areas of heterogeneity that were clearly identified at both ends of the crescent 
shape characteristic of this complex. Both ends were then individually masked using soft masks 
of around 20 pixels that were subsequently used in classification jobs without alignments in 
Relion3. The T parameter used for this classification job was 6 and the total number of classes was 
10. This strategy allowed us to identify two main population of particles which correspond to an 
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open and closed state of the complex. Particles from both subgroups were separately re-extracted 
to obtain unbinned data sets for further refinement. New features implemented in Relion3, namely 
Bayesian polishing and ctf parameters refinement, allowed the extension of the resolution to 3.4, 
3.5 and 2.9 Å for the two apo and the DNA-bound complexes, respectively. Post-processing was 
performed with a soft-mask of 5 pixels being the B-factor estimated automatically in Relion3 
following standard practice. A final set of local refinements was performed with the masks used 
for classification. The locally aligned maps exhibit very good quality for the ends of the C-shape. 
These maps were used for de novo modelling and initial model refinement. 
 
Model Building and Refinement 
For the Cas7 and Cas6 monomers, the E. coli homologs (PDB accession code 4TVX) were 
initially docked with Chimera172 and transformed to poly-alanine models. Substantial 
rearrangement of the finger region of Cas7 monomers, as well as other secondary structure 
elements of Cas6, were performed manually in COOT173 before amino acid substitution of the 
poly-alanine model. Well-defined bulky side chains of aromatic residues allowed a confident 
assignment of the register. The crRNA was also well defined in the maps and was traced de novo 
with COOT. For Cas8 and TniQ in particular, no structural similarity was found in the published 
structures that was able to explain our densities. Locally refined maps using soft masks at both 
ends of the crescent-shaped complex rendered well-defined maps below 3.5 Å resolution. These 
maps were used for manual de novo tracing of a poly-alanine model in COOT that was 
subsequently mutated to the V. cholerae sequences. Bulky side chains for aromatic residues 
showed excellent density and were used as landmarks to adjust the register of the sequence. For 
refinement, an initial step of real-space refinement against the cryo-EM maps was performed with 
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the phenix.real_space refinement tool of the Phenix package174, with secondary structure restraints 
activated. A second step of reciprocal space refinement was performed in Refmac5175, with 
secondary restraints calculated with Prosmart176 and LibG177. Weight of the geometry term versus 
the experimental term was adjusted to avoid overfitting of the model into cryo-EM map, as 








Figure 39: Cryo-EM sample optimization and image processing workflow 
a, Representative negatively stained micrograph for 500 nM TniQ–Cascade. b, Left, 
representative cryo-EM image for 2 µM TniQ–Cascade. A small dataset of 200 images was 
collected in a Tecnai-F20 microscope equipped with a Gatan K2 camera. Right, reference-free two-
dimensional class averages for this initial cryo-EM dataset. c, Left, representative image from a 
large dataset collected in a Tecnai Polara microscope equipped with a Gatan K3 detector. Middle, 
detailed two-dimensional class averages were obtained that were used for initial model 
generation using the SGD algorithm170 implemented in Relion3161 (right). d, Image processing 
workflow used to identify the two main classes of the TniQ–Cascade complex in open and closed 
conformations. Local refinements with soft masks were used to improve the quality of the map 
within the terminal protuberances of the complex. These maps were instrumental for de novo 




Figure 40: Fourier shell correlation curves, local resolution, and unsharpened filter maps for 
the TniQ-Cascade complex in closed conformation 
a, Gold-standard Fourier shell correlation (FSC) curve using half maps; the global resolution 
estimation is 3.4 Å by the FSC 0.143 criterion. b, Cross-validation model-versus-map FSC. Blue 
curve, FSC between the shacked model refined against half map 1; red curve, FSC against half 
map 2, not included in the refinement; black curve, FSC between final model against the final 
map. The overlap observed between the blue and red curves guarantees a non-overfitted model. 
c, Unsharpened map colored according to local resolutions, as reported by RESMAP180. d, Final 
model colored according to B-factors calculated by REFMAC175. e, A flexible Cas8 domain 
encompassing residues 277–385 contacts the TniQ dimer at the other side of the crescent shape. 
Applying a Gaussian filter of increasing width to the unsharpened map allows for a better 






Figure 41: Alignment of TniQ-Cascade with structurally similar Cascade complexes. 
The V. cholerae I-F variant TniQ–Cascade complex (left) was superposed with Pseudomonas 
aeruginosa I-F Cascade127 (also known as Csy complex; middle, PDB ID: 6B45) and E. coli I-E 
Cascade158 (right, PDB ID: 4TVX). Shown are alignments of the entire complex (top), the Cas8 and 
Cas5 subunits with the 5′ crRNA handle (second from top), the Cas7 subunit with a fragment of 




Figure 42: Representative cryo-EM densities for all the components of TniQ-Cascade complex 
in closed conformation 
a, Final refined model of TniQ–Cascade, with Cas8 in purple, Cas7 monomers in green, Cas6 in 
salmon, the TniQ monomers in blue and yellow, and the crRNA in grey. b–h, Final refined model 
inserted in the final cryo-EM density for select regions of all the molecular components of the 





Figure 43: Cas8 and Cas6 interaction with the crRNA 
a, Refined model for the TniQ–Cascade shown as ribbons inserted in the semi-transparent Van 
der Waals surface, coloured as in Figure 35. b, c, Magnified view of Cas8, which interacts with 
the 5′ end of the crRNA. The inset shows electron density for the highlighted region, where the 
base of nucleotide C1 is stabilized by stacking interactions with arginine residues R584 and R424. 
d, Cas6 interacts with the 3′ end of the crRNA ‘handle’ (nucleotides 45–60). e, An arginine-rich α-
helix is deeply inserted within the major groove of the terminal stem–loop. This interaction is 
mediated by electrostatic interactions between basic residues of Cas6 and the negatively charged 
phosphate backbone of the crRNA. f, Cas6 (salmon) also interacts with Cas7.1 (green), 





Figure 44: Schematic representation of crRNA and target DNA recognition by TniQ Cascade 
a, TniQ–Cascade residues that interact with the crRNA are indicated. Approximate location for 
all protein components of the complex are also shown, as well as the position of each Cas7 




Figure 45: FSC curves, local resolution, and local refined maps for the TniQ-Cascade complex 
in open conformation 
a, Gold-standard FSC curve using half maps; the global resolution estimation is 3.5 Å by the FSC 
0.143 criterion. b, Cross-validation model-versus-map FSC. Blue curve, FSC between shacked 
model refined against half map 1; red curve, FSC against half map 2, not included in the 
refinement; black curve, FSC between final model against the final map. The overlapping between 
the blue and red curves guarantees a non-overfitted model. c, Unsharpened map colored 
according to local resolutions, as reported by RESMAP180. Right, slice through the map shown on 
the left. d, Local refinements with soft masks improved the maps in flexible regions. Shown is the 
region of the map corresponding to the TniQ dimer. Unsharpened maps colored according to the 
local resolution estimations are shown before (left) and after (right) masked refinements. e, Final 






Figure 46: FSC curves, local resolution, and unsharpened filter maps for the DNA-bound 
TniQ-Cascade complex 
a, Gold-standard FSC curve using half maps; the global resolution estimation is 2.9 Å by the FSC 
0.143 criterion. b, Cross-validation model-versus-map FSC. Blue curve, FSC between the shacked 
model refined against half map 1; red curve, FSC against half map 2, not included in the 
refinement; black curve, FSC between final model against the final map. The overlap observed 
between the blue and red curves guarantees a non-overfitted model. c, Left, unsharpened map 
colored according to local resolutions, as reported by RESMAP180. dsDNA is visible at the top 
right projecting outside of the complex. Right, final model colored according to B-factors 






Figure 47: Alignment of DNA-bound TniQ-Cascade with structurally similar Cascade 
complexes  
The DNA-bound structure of V. cholerae I-F variant TniQ–Cascade complex (left) was superposed 
with DNA-bound structures of P. aeruginosa I-F Cascade127 (also known as Csy complex; middle, 
PDB ID: 6B44) and E. coli I-E Cascade158sc (right, PDB ID: 5H9F). Shown are alignments of the 
entire complex (top), the Cas8 and Cas5 subunits with the 5′ crRNA handle and double-stranded 
PAM DNA (middle top), the Cas7 subunit with a fragment of crRNA (middle bottom), and the 




4.9: Supplementary Table 
Table 1: Supplementary Table 1 
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Chapter 5: Epilogue & Future Directions 
The structural and functional analysis of Tn6677 along with the Type V-K system have 
further expanded the CRISPR toolkit, paving the way for facile programmable insertions of 
specified genetic cargos41,106,181–185. The work presented in this thesis is already being used for 
discovery of related systems, and rational engineering of well-studied CRISPR-guided transposons 
to assess not only their molecular origins, but also how they might be adapted as tools for the 
scientific community. These systems could again prove the benefit of basic research as they appear 
tailor-made to address the difficulties of targeted integration; the same difficulties that have had 
scientists working for more than a decade to engineer a system that nature, and the microbial 
pangenome, has had eons to evolve. A facet of that evolution that others have started to untangle 
is how the transposons encoding CRISPR-Cas systems segregate their CRISPR-Cas machinery 
from host CRISPR-Cas machinery. CRISPR-associated transposons are mobile genetic elements, 
and since MGEs move between hosts, in doing so they may encounter traditional CRISPR-Cas 
immune systems. It is not unlikely that there is “crosstalk” between the CRISPR-Cas immune 
system and the newly- acquired transposon-encoded CRISPR-Cas system.  
While we have demonstrated the stringent specificity of both the protein-protein 
interactions of the Tn6677-derived transposon (see Figure 21) and integration itself, others have 
shown that Type I-F1 CRISPR-Cas immune systems are fully capable of processing and utilizing 
the mature crRNA produced from a transposon-encoded Type I-F3 CRISPR array for targeted 
cleavage, creating the potential for Type I-F3 spacers to result in cleavage of the host genome186. 
To avoid this, and the resulting demise of their host, the Type I-F3 transposon-encoded CRISPR-
Cas systems have adopted at least two strategies to avoid targeting host genomes. First, they have 
incorporated the use of autoinhibitory regulatory elements, such as Xre-family transcriptional 
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regulators. As a result, there is a burst of expression from the transposon-encoded CRISPR-Cas 
locus upon initial host infiltration, and subsequent silencing of the transposon-encoded CRISPR 
locus when the Xre-family transcriptional regulators achieve a high enough concentration, 
presumably after the transposon has integrated into the host genome186. Second, crRNA’s from the 
transposon-encoded CRISPR-Cas system are segregated by the targets of the spacers within said 
CRISPR array. The spacers within the transposon-encoded CRISPR array do not correspond to 
genomic targets within potential hosts, as they are instead complementary to sequences found in 
mobile plasmids, and phage genomes32. Therefore, if concentration-dependent regulation fails, the 
host’s I-F1 CRISPR system will not target the host’s genome, and will instead cleave a different 
mobile genetic element. Interestingly, this mechanism of regulation could potentially be used by 
the transposon to out-compete other MGEs within the same host. However, the CRISPR-
containing transposons must still integrate into host genomes. To accomplish this, Type I-F3 and 
Type V-K systems appear to have a repeat-spacer-repeat sequence with atypical repeats, and 
imperfectly matching spacers, encoded shortly downstream of the transposon-encoded CRISPR 
array. Allowing for imperfect crRNA:DNA pairing, these sequences are complementary to host 
genomic sequences that are the expected distance from the end of the transposon186,188. The 
atypical crRNA not only has altered repeats that are poorly recognized by some Type I-F CRISPR 
immune systems, but also contains mismatches in the spacer region (other than in the tolerated 
N+6 positions) that further ablate target cleavage should this atypical crRNA be used by a I-F1 
immune system186. This strategy is expanded upon in V-K systems where the atypical and 
delocalized crRNAs are also shortened188. Regardless of the system in question, it appears that 
nature has evolved a mechanism similar to what has been engineered with Cas9 to reduce off-
target cleavage189.  By utilizing a crRNA that is suboptimal for target-binding, the energetic 
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threshold is increased enough that binding to the desired genomic target is now less efficient, but 
the mismatches between the spacer and target will near-completely abolish off-target binding, and 
thus cleavage, or in this case, transposition. While spacer-target mismatches are one mechanism 
of control, altered RNA structure with atypical repeats, like those found in the I-F3 systems, 
mitigate off-target insertion likely by again, increasing the energetic threshold required to fully 
assemble the RNP complexes and bind the correct target.  
Of note, the mismatches between the atypical spacers and their targets do not occur in a 
fashion that would allow for flexibility of target sequences (should they have mutated or drifted), 
but instead are positioned early in the crRNA spacer region, sometimes even in the seed-
sequence186. Tolerance of mismatches in the N+3 wobble-position of a codon is thought to be 
utilized by Tn7’s TnsD DNA-interacting residues so that Tn7 may still transpose downstream of 
homologous, but not identical, glmS sequences. While it appears that both Type I-F3 systems and 
Type V-K systems utilize distinct types of crRNAs for different target types, the Type I-B systems, 
(see Figure 12) appear to utilize either the TnsA/B/C + Cascade + TniQ pathway where integration 
occurs downstream of the Cascade-bound target, or proceed through a TnsA/B/C + TnsD pathway, 
where, like in Tn7, the target-site is specified by TnsD through protein-DNA interactions188.  The 
Type I-B systems appear to have encountered a similar problem as the I-F3 and V-K systems, but 
instead of providing sub-optimal crRNAs as a solution, the I-B systems retained, or incorporated, 
both TniQ and TnsD pathways for targeting MGEs and the host genome respectively. Interestingly, 
the TniQ and TnsD pathways appear to be in competition. When provided with targets for both 
TnsD and the crRNA around which Cascade is scaffolded, removal of either TniQ or TnsD 
increases transposition efficiency of the pathway that remains188. Of particular interest is that there 
appear to be two different mechanisms of host genome securitization that have evolved. One being 
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whether integration proceeds through the TniQ or TnsD pathway, and the other being the 
utilization of crRNAs with sub-optimal target-complementarity and altered structural elements that 
may partially inhibit Cascade assembly. 
As a testament to the speed at which the CRISPR field moves, two pre-prints were posted 
to BioRxiv describing solved Cryo-EM structures of TnsC homologs, shortly after initial drafting 
of this thesis. The first article describes the structure of the TnsC heptameric complex from E. coli 
Tn7, and the second describes the TnsC heptameric complex from the ShCAST Type V-K 
system187,190. Interestingly, the authors propose vastly different models for TnsC recruitment to 
their cognate DNA-targeting protein (TnsD for Tn7 and TniQ & Cas12k for ShCAST). Shen et al 
purify Tn7’s TnsC assembled on distorted dsDNA that contains a 7bp mismatch flanked by 20bp 
on both sides of complementary DNA, forming what they call the 20-7-20 substrate. The 7-bp of 
mismatched bases provides a bubble that mimics the DNA distortion imposed by TnsD under 
native conditions22. Using a gain-of-function mutation and truncated TnsC for improved protein 
stability, they solved the structure of a shortened TnsC mutant, TnsCA225Δ504-555, bound to the 20-
7-20 substrate. They found that TnsC forms a ring of seven TnsC protomers, and that this ring is 
stabilized by bound, non-hydrolyzed, ATP187. ATP hydrolysis prevents stabilization of the ring 
and, as TnsB induces hydrolysis of ATP in TnsC, is likely the mechanism through which target 
immunity is established40. Their proposed model has each TnsC protomer recruit a single copy of 
TnsA at the end of an extended “arm” of each TnsC protein. This TnsC/TnsA complex then builds 
a ring around the distorted DNA produced by TnsD, and the TnsC-bound TnsA proteins are then 
responsible for the recruitment of TnsB-decorated Tn7 Ends. The entire complex is then able to 
integrate the transposon at the proscribed site, immediately downstream of glmS187.  
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Park et al describe ShCAST TnsC, both as a filamentous species bound to DNA, and in 
complex with TniQ190. Unfortunately, the differences between ShCAST TniQ and V. cholerae 
TniQ (from Tn6677) prevent readers from drawing any conclusions, beyond the most obvious, 
about recruitment of their cognate TnsC proteins. Despite this, there is nothing in Halpin-Healy et 
al, nor their paper, that precludes their speculation of where a TnsC ring may contact the TniQ 
dimer at the PAM-distal end of a target-bound I-F3 Cascade185,190. The authors propose that unlike 
Tn7, TnsC searches for TniQ bound to DNA by forming filaments along dsDNA until it encounters 
a TniQ-Cas12k complex, and that this filament is then disassembled by TnsB (already bound to 
the ends of the transposon) until only the heptameric ring contacting TniQ directly remain. This 
TnsC “spring-washer” then accounts for the stretch of DNA between the target site and the 
insertion site. Furthermore, the disassembly of this filament may not be perfectly regular, and may 
account for the wide range of distances between the target site and insertion site that one can see 
in ShCAST190.  
Between the TnsC papers and the tendency of new CRISPR niches to explode in popularity, 
it is likely not long until there is an assembled structure of all components of CRISPR-associated 
transposons, and their mechanism is unraveled as the different structures and complexes are 
captured in various states of transposition. This is likely to happen concomitantly with the 
development of these systems as tools in heterologous systems. Of particular interest is the use of 
these tools in mammalian cells as they address near-all current shortcomings of modern DNA-
integration methods, such as cargo size limitations, unpredictable genomic scarring, and 
targetability191. 
It is likely that the coming years will see a further refinement of the classification of 
transposons, CRISPR-Cas systems, and their components, that will allow a greater understanding 
126 
of how these two systems intersected and established the observed mutualism. As more details are 
uncovered, those working in the field will incorporate the new data to better optimize these systems 
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Transposon-encoded CRISPR–Cas systems 
direct RNA-guided DNA integration
Sanne e. Klompe1, Phuc l. H. Vo2,3, tyler S. Halpin-Healy1,3 & Samuel H. Sternberg1*
Conventional CRISPR–Cas systems maintain genomic integrity by leveraging guide RNAs for the nuclease-dependent 
degradation of mobile genetic elements, including plasmids and viruses. Here we describe a notable inversion of 
this paradigm, in which bacterial Tn7-like transposons have co-opted nuclease-deficient CRISPR–Cas systems to 
catalyse RNA-guided integration of mobile genetic elements into the genome. Programmable transposition of Vibrio 
cholerae Tn6677 in Escherichia coli requires CRISPR- and transposon-associated molecular machineries, including a 
co-complex between the DNA-targeting complex Cascade and the transposition protein TniQ. Integration of donor 
DNA occurs in one of two possible orientations at a fixed distance downstream of target DNA sequences, and can 
accommodate variable length genetic payloads. Deep-sequencing experiments reveal highly specific, genome-wide 
DNA insertion across dozens of unique target sites. This discovery of a fully programmable, RNA-guided integrase lays 
the foundation for genomic manipulations that obviate the requirements for double-strand breaks and homology-directed 
repair.
Horizontal gene transfer, a process that allows genetic information to 
be transmitted between phylogenetically unrelated species, is a major 
driver of genome evolution across the three domains of life1–3. Mobile 
genetic elements that facilitate horizontal gene transfer are especially 
pervasive in bacteria and archaea, in which viruses, plasmids and trans-
posons constitute the vast prokaryotic mobilome4. In response to the 
ceaseless assault of genetic parasites, bacteria have evolved numerous 
innate and adaptive defence strategies for protection, including RNA-
guided immune systems encoded by clustered regularly interspaced 
short palindromic repeats (CRISPR) and CRISPR-associated (Cas) 
genes5–7. Remarkably, the evolution of CRISPR–Cas is intimately linked 
to the large reservoir of genes provided by mobile genetic elements, 
with core enzymatic machineries involved in both new spacer acquisi-
tion (Cas1) and RNA-guided DNA targeting (Cas9 and Cas12) derived 
from transposable elements8–13. These examples support a ‘guns- 
for-hire’ model, in which the rampant shuffling of genes between offen-
sive and defensive roles results from the perennial arms race between 
bacteria and mobile genetic elements.
We set out to uncover examples of functional associations between 
defence systems and mobile genetic elements. In this regard, we were 
inspired by a recent report that described a class of bacterial Tn7-like 
transposons encoding evolutionarily linked CRISPR–Cas systems 
and proposed a functional relationship between RNA-guided DNA 
targeting and transposition14. The well-studied E. coli Tn7 transposon 
is unique in that it mobilizes via two mutually exclusive pathways—one 
that involves non-sequence-specific integration into the lagging-strand 
template during replication, and a second that involves site-specific 
integration downstream of a conserved genomic sequence15. Notably, 
those Tn7-like transposons that specifically associate with CRISPR–Cas 
systems lack a key gene involved in DNA targeting, and the CRISPR–
Cas systems that they encode lack a key gene involved in DNA degrada-
tion. We therefore hypothesized that transposon-encoded CRISPR–Cas 
systems have been repurposed for a role other than adaptive immunity, 
in which RNA-guided DNA targeting is leveraged for a novel mode of 
transposon mobilization.
Here we demonstrate that a CRISPR–Cas effector complex from V. 
cholerae directs an accompanying transposase to integrate DNA down-
stream of a genomic target site complementary to a guide RNA, repre-
senting the discovery of a programmable integrase. Beyond revealing 
an elegant mechanism by which mobile genetic elements have hijacked 
RNA-guided DNA targeting for their evolutionary success, our work 
highlights an opportunity for facile, site-specific DNA insertion with-
out requiring homologous recombination.
Cascade directs site-specific DNA integration
We set out to develop assays for monitoring transposition from a plas-
mid-encoded donor into the genome, first using E. coli Tn7, a well-studied 
cut-and-paste DNA transposon16 (Extended Data Fig. 1a). The Tn7 
transposon contains characteristic left- and right-end sequences and 
encodes five tns genes, tnsA–tnsE, which collectively encode a heter-
omeric transposase: TnsA and TnsB are catalytic enzymes that excise 
the transposon donor via coordinated double-strand breaks; TnsB, a 
member of the retroviral integrase superfamily, catalyses DNA integra-
tion; TnsD and TnsE constitute mutually exclusive targeting factors that 
specify DNA insertion sites; and TnsC is an ATPase that communicates 
between TnsAB and TnsD or TnsE15. Previous studies have shown that 
E. coli TnsD (EcoTnsD) mediates site-specific Tn7 transposition into a 
conserved Tn7 attachment site (attTn7) downstream of the glmS gene 
in E. coli17,18, whereas EcoTnsE mediates random transposition into 
the lagging-strand template during replication19. We recapitulated 
TnsD-mediated transposition by transforming E. coli BL21(DE3) cells 
with pEcoTnsABCD and pEcoDonor, and detecting genomic transpo-
son insertion events by PCR and Sanger sequencing (Supplementary 
Table 1 and Extended Data Fig. 1).
To test the hypothesis that CRISPR-associated targeting complexes 
direct transposons to genomic sites complementary to a guide RNA 
(Fig. 1a), we selected a representative transposon from V. cholerae strain 
HE-45, Tn6677, which encodes a variant type I-F CRISPR–Cas sys-
tem20,21 (Extended Data Fig. 1f, Supplementary Note, Supplementary 
Table 2 and Supplementary Figs. 2–8). This transposon is bounded by 
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left- and right-end sequences, distinguishable by their TnsB-binding 
sites, and includes a terminal operon that comprises the tnsA, tnsB 
and tnsC genes. Notably, the tniQ gene, a homologue of E. coli tnsD, 
is encoded within the cas rather than the tns operon, whereas tnsE 
is absent entirely. Like other such transposon-encoded CRISPR–Cas 
systems14, the cas1 and cas2 genes responsible for spacer acquisition 
are conspicuously absent, as is the cas3 gene responsible for target 
DNA degradation. The putative DNA-targeting complex Cascade 
(also known as Csy complex6) is encoded by three genes: cas6, cas7 
and a natural cas8–cas5 fusion21 (hereafter referred to simply as cas8). 
The native CRISPR array, comprising four repeat and three spacer 
sequences, encodes mature CRISPR RNAs (crRNAs) that we also refer 
to as guide RNAs.
We transformed E. coli with plasmids that encode components of the 
V. cholerae transposon, including a mini-transposon donor (pDonor), 
the tnsA-tnsB-tnsC operon (pTnsABC), and the tniQ-cas8-cas7-cas6 
operon alongside a synthetic CRISPR array (pQCascade) (Fig. 1b). 
The CRISPR array was designed to produce a non-targeting crRNA or 
crRNA-1, which targets a genomic site downstream of glmS flanked by a 
5′-CC-3′ protospacer adjacent motif (PAM)22 (Supplementary Table 3). 
Notably, we observed PCR products from cellular lysate between a 
genome-specific primer and either of two transposon-specific primers 
in experiments containing pTnsABC, pDonor and pQCascade express-
ing crRNA-1, but not with a non-targeting crRNA or any empty vector 
controls (Fig. 1c, d).
Because parallel reactions with oppositely oriented transposon prim-
ers revealed integration events within the same biological sample, we 
hypothesized that, unlike E. coli Tn7, RNA-guided transposition might 
occur in either orientation. We tested this by performing additional 
PCRs, by adding a downstream genomic primer, and by targeting an 
additional site with crRNA-2 found in the same genomic locus but on 
the opposite strand. For both crRNA-1 and crRNA-2, transposition 
products in both orientations were present, although with distinct 
orientation preferences based on relative band intensities (Fig. 1e). 
Given the presence of discrete bands, it appeared that integration 
was occurring at a set distance from the target site, and Sanger and 
next-generation sequencing (NGS) analyses revealed that more than 
95% of integration events for crRNA-1 occurred 49 base pairs (bp) 
from the 3′ edge of the target site. The observed pattern with crRNA-2 
was more complex, with integration clearly favouring distances of 48 
and 50 bp over 49 bp. Both sequencing approaches also revealed the 
expected 5-bp target-site duplication that is a hallmark feature of Tn7 
transposition products15 (Fig. 1f, g).
The V. cholerae Tn6677 transposon is not naturally present down-
stream of glmS, and we saw no evidence of site-specific transposition 
within this locus when we omitted the crRNA (Fig. 1d). Nevertheless, 
we wanted to ensure that integration specificity was solely guided by the 
crRNA sequence, and not by any intrinsic preference for the glmS locus. 
We therefore cloned and tested crRNA-3 and crRNA-4, which target 
opposite strands within the lacZ coding sequence. We again observed 
bidirectional integration 48–50 bp downstream of both target sites, 
and were able to isolate clonally integrated, lacZ-knockout strains after 
performing blue–white colony screening on X-gal-containing LB-agar 
plates (Fig. 1h, i and Extended Data Fig. 2). Collectively, these exper-
iments demonstrate transposon integration downstream of genomic 
target sites complementary to guide RNAs.
Fig. 1 | RNA-guided DNA integration with a V. cholerae transposon. 
a, Hypothetical scenario for Tn6677 transposition into plasmid or 
genomic target sites complementary to a crRNA. b, Plasmid schematics 
for transposition experiments in which a mini-transposon on pDonor is 
mobilized in trans. The CRISPR array comprises two repeats (grey 
diamonds) and a single spacer (maroon rectangle). c, Genomic locus 
targeted by crRNA-1 and crRNA-2, two potential transposition products, 
and the PCR primer pairs to selectively amplify them. The PAMs and target 
sites are in yellow and maroon, respectively. d, PCR analysis of transposition 
with a non-targeting crRNA (crRNA-NT) and crRNA-1, resolved by agarose 
gel electrophoresis. e, PCR analysis of transposition with crRNA-NT, 
crRNA-1 and crRNA-2 using four distinct primer pairs, resolved by agarose 
gel electrophoresis. f, Sanger sequencing chromatograms for upstream 
and downstream junctions of genomically integrated transposons from 
experiments with crRNA-1 and crRNA-2. Overlapping peaks for crRNA-2 
suggest the presence of multiple integration sites. The distance between 
the 3′ end of the target site and the first base of the transposon sequence is 
designated ‘d’. TSD, target-site duplication. g, NGS analysis of the distance 
between the Cascade target site and transposon integration site, determined 
for crRNA-1 and crRNA-2 with four primer pairs. h, Genomic locus targeted 
by crRNA-3 and crRNA-4. i, PCR analysis of transposition with crRNA-NT, 
crRNA-3 and crRNA-4, resolved by agarose gel electrophoresis. For d, e and 
i, amplification of rssA serves as a loading control; gel source data may be 
found in Supplementary Fig. 1.
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Protein requirements of RNA-guided DNA integration
To confirm the involvement of transposon- and CRISPR-associated 
proteins in catalysing RNA-guided DNA integration, we cloned and 
tested a series of plasmids in which each individual tns and cas gene 
was deleted, or in which the active site of each individual enzyme was 
mutated. Removal of any protein component abrogated transposition 
activity, as did mutations in the active site of the TnsB transposase, 
which catalyses DNA integration23, the TnsC ATPase, which regulates 
target site selection24, and the Cas6 RNase, which catalyses pre-crRNA 
processing25 (Fig. 2a). A TnsA mutant that is catalytically impaired 
still facilitated RNA-guided DNA integration. On the basis of previous 
studies of E. coli Tn7, this variant system is expected to mobilize via 
replicative transposition as opposed to cut-and-paste transposition26.
In E. coli, site-specific transposition requires attTn7 binding by 
EcoTnsD, followed by interactions with the EcoTnsC regulator protein 
to directly recruit the EcoTnsA-TnsB-donor DNA27. Given the essen-
tial nature of tniQ (a tnsD homologue) in RNA-guided transposition, 
and its location within the cas8-cas7-cas6 operon, we envisioned that 
the Cascade complex might directly bind TniQ and thereby deliver it 
to genomic target sites. We tested this hypothesis by recombinantly 
expressing CRISPR RNA and the V. cholerae tniQ-cas8-cas7-cas6 
operon containing an N-terminal His10 tag on the TniQ subunit 
(Extended Data Fig. 3a). TniQ co-purified with Cas8, Cas7 and Cas6, 
as shown by SDS–PAGE and mass spectrometry analysis, and the rel-
ative band intensities for each Cas protein were similar to TniQ-free 
Cascade and consistent with the 1:6:1 Cas8:Cas7:Cas6 stoichiometry 
expected for a I-F variant Cascade complex28 (Fig. 2b and Extended 
Data Fig. 3b). The complex migrated through a gel filtration column 
with an apparent molecular mass of roughly 440 kDa, in good agree-
ment with its approximate expected mass, and both Cascade and 
TniQ–Cascade co-purified with a 60-nucleotide RNA species, which 
we confirmed was a mature crRNA by deep sequencing (Fig. 2c, d and 
Extended Data Fig. 3c, d). To validate the interaction between Cascade 
and TniQ further, we incubated separately purified samples in vitro and 
demonstrated complex formation by size-exclusion chromatography 
(Extended Data Fig. 3e). Together, these results reveal the existence of a 
novel TniQ–Cascade co-complex, highlighting a direct functional link 
between a CRISPR RNA-guided effector complex and a transposition 
protein.
To determine whether specific TniQ–Cascade interactions are 
required, or whether TniQ could direct transposition adjacent to 
generic R-loop structures or via artificial recruitment to DNA, we used 
Streptococcus pyogenes Cas9 (SpyCas9)29 and Pseudomonas aeruginosa 
Cascade (PaeCascade)28 as orthogonal RNA-guided DNA-targeting 
systems. After generating protein–RNA expression plasmids and pro-
gramming both effector complexes with crRNAs that target the same 
lacZ sites as our earlier transposition experiments, we first validated 
DNA targeting by demonstrating efficient cell killing in the presence of 
an active Cas9 nuclease or the PaeCascade-dependent Cas2-3 nuclease 
(Extended Data Fig. 4a, b). When we transformed strains containing 
pTnsABCQ and pDonor with a plasmid encoding either catalytically 
deactivated Cas9-sgRNA (dCas9-sgRNA) or PaeCascade and per-
formed PCR analysis of the resulting cell lysate, we found no evidence 
of site-specific transposition (Fig. 2e), indicating that a genomic R-loop 
is insufficient for site-specific integration. We also failed to detect trans-
position when TniQ was directly fused to either terminus of dCas9, 
or to the Cas8 or Cas6 subunit of PaeCascade (Fig. 2e), at least for the 
linker sequences tested. Notably, however, a similar fusion of TniQ to 
the Cas6 subunit of V. cholerae Cascade, but not to the Cas8 subunit, 
restored RNA-guided transposition activity (Fig. 2e and Extended Data 
Fig. 4c).
Together with our biochemical results, we conclude that TniQ forms 
essential interactions with Cascade, possibly via the Cas6 subunit, 
which could account for our finding that RNA-guided DNA inser-
tion occurs downstream of the PAM-distal end of the target site where 
Cas6 is bound30,31 (Fig. 2f). Because TniQ is required for transposi-
tion, we propose that it serves as an important connection between the 
CRISPR- and transposon-associated machineries during DNA target-
ing and integration, although further biochemical and structural studies 
will be required to define these mechanistic steps in greater detail.
Donor requirements of RNA-guided DNA integration
To determine the minimal donor requirements for RNA-guided DNA 
integration, as well as the effects of truncating the transposon ends and 
altering the cargo size, we first developed a quantitative PCR (qPCR) 
method for scoring transposition efficiency that could accurately and 
sensitively measure genomic integration events in both orientations 
(Extended Data Fig. 5). Analysis of cell lysates from transposition 
experiments using lacZ-targeting crRNA-3 and crRNA-4 yielded 
overall integration efficiencies of 62% and 42% without selection, 
respectively. The preference for integrating the ‘right’ versus the ‘left’ 
transposon end proximal to the genomic site targeted by Cascade was 
39-to-1 for crRNA-3 and 1-to-1 for crRNA-4, suggesting the existence 
of additional sequence determinants that regulate integration orienta-
tion (Fig. 3a, b).
With a quantitative assay in place, we were curious to investigate the 
effect of transposon size on RNA-guided integration efficiency and 
determine possible size constraints. When we progressively shortened 
or lengthened the DNA cargo in between the donor ends, beginning 
with our original mini-transposon donor plasmid (977 bp), we found 
that integration efficiency with our three-plasmid expression system 
was maximal with a 775-bp transposon and decayed with both the 
shorter and longer cargos tested (Fig. 3c). Interestingly, naturally occur-
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Fig. 2 | TniQ forms a complex with Cascade and is necessary for RNA-
guided DNA integration. a, PCR analysis of transposition with crRNA-4 
and a panel of gene deletions or point mutations, resolved by agarose 
gel electrophoresis. b, SDS–PAGE analysis of purified TniQ, Cascade 
and a TniQ–Cascade (Q–Cascade) co-complex. Asterisk denotes an 
HtpG contaminant. c, Denaturing urea–PAGE analysis of co-purifying 
nucleic acids. nt, nucleotides. d, Top, RNA sequencing analysis of RNA 
co-purifying with Cascade. Bottom, reads mapping to the CRISPR array 
reveal the mature crRNA sequence. e, PCR analysis of transposition 
experiments testing whether generic R-loop formation or artificial TniQ 
tethering can direct targeted integration. The V. cholerae transposon and 
TnsA-TnsB-TnsC were combined with DNA-targeting components that 
comprise V. cholerae (Vch) Cascade, P. aeruginosa (Pae) Cascade, or  
S. pyogenes dCas9-RNA (dCas9). TniQ was expressed either on its own from 
pTnsABCQ or as a fusion to the targeting complex (pCas-Q) at the Cas6 C 
terminus (6), Cas8 N terminus (8), or dCas9 N or C terminus. f, Schematic 
of the R-loop formed upon target DNA binding by Cascade, with the 
approximate position of each protein subunit denoted. The putative TniQ-
binding site and the distance to the primary integration site are indicated. 
NT, non-target strand; T, target strand. For a and e, amplification of rssA 
serves as a loading control; gel source data are in Supplementary Fig. 1.
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20 to more than 100 kb in size14, although their capacity for active 
mobility is unknown.
We next separately truncated both ends of the transposon. We found 
that around 105 bp of the left end and 47 bp of the right end were 
absolutely crucial for efficient RNA-guided DNA integration, corre-
sponding to three and two intact putative TnsB-binding sites, respec-
tively (Extended Data Fig. 6). Shorter transposons containing right-end 
truncations were integrated more efficiently, accompanied by a notable 
change in the orientation bias.
These experiments reveal crucial parameters for the development 
of programmable DNA integration technology. Future efforts will be 
required to explore how transposition is affected by vector design, 
to what extent transposon end mutations are tolerated, and whether 
rational engineering allows for integration of larger cargos and/or 
greater control over integration orientation.
Guide RNA and target DNA requirements
The Tn6677-encoded CRISPR–Cas system is most closely related to the 
I-F subtype, in which DNA target recognition by Cascade requires a 
consensus 5′-CC-3′ PAM22, a high degree of sequence complementarity 
within a PAM-proximal seed sequence28, and additional base-pairing 
across the entire 32-bp protospacer32. To determine sequence deter-
minants of RNA-guided DNA integration, we first tested 12 dinucleo-
tide PAMs by sliding the guide sequence in 1-bp increments along the 
lacZ gene relative to crRNA-4 (Fig. 3d). In total, 8 distinct dinucleotide 
PAMs supported transposition at levels that were more than 25% of 
the 5′-CC-3′ PAM, and transposition occurred at over 1% total effi-
ciency across the entire set of PAMs tested (Fig. 3d). Additional deep 
sequencing revealed that the distance between the Cascade target site 
and primary transposon insertion site remained fixed at approximately 
47–51 bp across the panel of crRNAs tested, although interesting pat-
terns emerged, suggesting an additional layer of insertion site prefer-
ence that requires further investigation (Fig. 3e and Extended Data 
Fig. 7a). Nevertheless, these experiments highlight how PAM recog-
nition plasticity can be harnessed to direct a high degree of insertion 
flexibility and specificity at base-pair resolution.
To probe the sensitivity of transposition to RNA–DNA mismatches, 
we tested consecutive blocks of 4-nucleotide mismatches along the 
guide portion of crRNA-4 (Fig. 3f). As expected from previous studies 
with Cascade homologues33–35, mismatches within the 8-nucleotide 
seed sequence severely reduced transposition, probably owing to the 
inability to form a stable R-loop. Unexpectedly, however, our results 
highlighted a second region of mismatches at positions 25–28 that 
abrogated DNA integration, despite previous studies demonstrating 
that the stability of DNA binding is largely insensitive to mismatches in 
this region33–35. For the terminal mismatch block, which retained 17% 
integration activity, the distribution of observed insertion sites was 
markedly skewed to shorter distances from the target site relative to 
crRNA-4 (Extended Data Fig. 7b), which we hypothesize is the result 
of R-loop conformational heterogeneity.
Our emerging model for RNA-guided DNA integration involves 
Cascade-mediated recruitment of TniQ to target DNA. In the absence 
of any structural data, we realized that we could investigate whether 
TniQ may be positioned near the PAM-distal end of the R-loop by 
testing engineered crRNAs that contain spacers of variable lengths. 
Previous work with E. coli Cascade has demonstrated that crRNAs 
with extended spacers form complexes that contain additional Cas7 
subunits36, which would increase the distance between the PAM-
bound Cas8 and the Cas6 at the other end of the R-loop. We therefore 
cloned and tested modified crRNAs containing spacers that were either 
shortened or lengthened in 6-nucleotide increments from the 3′ end. 
crRNAs with truncated spacers showed little or no activity, whereas 
extended spacers facilitated targeted integration, albeit at reduced levels 
with increasing length (Extended Data Fig. 7c, d). The +12-nucleotide 
crRNA directed transposition to two distinct regions: one approxi-
mately 49 bp from the 3′ end of the wild-type 32-nucleotide spacer, 
and an additional region shifted 11–13 bp away, in agreement with 
the expected increase in the length of the R-loop measured from the 
PAM (Fig. 3g). Although more experiments are required to deduce 
the underlying mechanisms that explain this bimodal distribution, 
as well as the insertion site distribution observed for other extended 
crRNAs, these data, together with the mismatch panel, provide further 
evidence that TniQ is tethered to the PAM-distal end of the R-loop 
structure.
Programmability and genome-wide specificity
We lastly sought to examine both the programmability and the genome-
wide specificity of our RNA-guided DNA integration system. First, 
we cloned and tested a series of crRNAs targeting additional genomic 
sites flanked by 5′-CC-3′ PAMs within the lac operon. Using the same 
primer pair for each resulting cellular lysate, we showed by PCR anal-

































































































































































































































































Fig. 3 | Influence of cargo size, PAM sequence, and crRNA mismatches 
on RNA-guided DNA integration. a, Schematic of alternative integration 
orientations and the primer pairs to selectively detect them by qPCR.  
b, qPCR-based quantification of transposition efficiency in both 
orientations with crRNA-NT, crRNA-3 and crRNA-4. T-LR and T-RL 
denote transposition products in which the transposon left end and 
right end are proximal to the target site, respectively. c, Total integration 
efficiency with crRNA-4 as a function of transposon size. The arrow 
denotes the wild-type (WT) pDonor used in most assays throughout this 
study. d, crRNAs were tiled along the lacZ gene in 1-bp increments relative 
to crRNA-4 (4.0) (top), and the resulting integration efficiencies were 
determined by qPCR (bottom). Data are normalized to crRNA-4.0, and 
the 2-nucleotide PAM for each crRNA is shown. e, Heat map showing the 
integration site distribution (x axis) for each of the tiled crRNAs (y axis) in 
d, determined by NGS. The 49-bp distance for each crRNA is denoted by 
a black box. f, crRNAs were mutated in 4-nucleotide blocks to introduce 
crRNA-target DNA mismatches (black, top), and the resulting integration 
efficiencies were determined by qPCR (bottom). Data are normalized 
to crRNA-4. g, The crRNA-4 spacer length was shortened or lengthened 
by 12 nucleotides (top), and the resulting integration efficiencies were 
determined by qPCR (bottom). Data are normalized to crRNA-4 (WT). 
The inset shows a comparison of integration site distributions for crRNA-4 
and crRNA-4.+12, determined by NGS. Data in b–d, f and g are shown as 
mean ± s.d. for n = 3 biologically independent samples.
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Our experiments thus far specifically interrogated genomic loci con-
taining the anticipated integration products, and it therefore remained 
possible that non-specific integration was simultaneously occurring 
elsewhere, either at off-target genomic sites bound by Cascade, or 
independently of Cascade targeting. We thus adopted a transposon 
insertion sequencing (Tn-seq) pipeline previously developed for mar-
iner transposons37,38, in which all integration sites genome-wide are 
revealed by NGS (Fig. 4b, Extended Data Fig. 8a, b and Methods). We 
first applied Tn-seq to a plasmid-encoded mariner transposon and 
found that our pipeline successfully recapitulated the genome-wide 
integration landscape previously observed with the Himar1c9 trans-
posase37,39 (Fig. 4c, d and Extended Data Fig. 8c, d).
When we performed the same analysis for the RNA-guided V. chol-
erae transposon programmed with crRNA-4, we observed exquisite 
selectivity for lacZ-specific DNA integration (Fig. 4c). The observed 
integration site, which accounted for 99.0% of all Tn-seq reads that 
passed our filtering criteria (Methods and Supplementary Table 4), 
precisely matched the site observed by previous PCR amplicon NGS 
analysis (Fig. 4e), and we did not observe reproducible off-target inte-
gration events elsewhere in the genome across three biological repli-
cates (Extended Data Fig. 8e, f). Our Tn-seq data furthermore yielded 
diagnostic read pile-ups that highlighted the 5-bp target-site dupli-
cation and corroborated our previous measurements of transposon 
insertion orientation bias (Fig. 4f). Tn-seq libraries from E. coli strains 
expressing pQCascade programmed with the non-targeting crRNA, 
or from strains lacking Cascade altogether (but still containing pDo-
nor and pTnsABCQ), yielded far fewer genome-mapping reads, and 
no integration sites were consistently observed across several biolog-
ical replicates (Fig. 4c, Extended Data Fig. 8g, h and Supplementary 
Table 4).
In addition to performing Tn-seq with the crRNAs targeting glmS 
and lacZ genomic loci (Extended Data Fig. 9a), we cloned and tested an 
additional 16 crRNAs targeting the E. coli genome at 8 arbitrary loca-
tions spaced equidistantly around the circular chromosome. Beyond 
requiring that target sites were unique, were flanked by a 5′-CC-3′ 
PAM, and would direct DNA insertion to intergenic regions, we applied 
no further design rules or empirical selection criteria. Remarkably, 
when we analysed the resulting Tn-seq data, we found that 16 out 
of 16 crRNAs directed highly precise RNA-guided DNA integration 
46–55 bp downstream of the Cascade target, with around 95% of all fil-
tered Tn-seq reads mapping to the on-target insertion site (Fig. 4g and 
Extended Data Fig. 9b, c). These experiments highlight the high degree 
of intrinsic programmability and genome-wide integration specificity 
directed by transposon-encoded CRISPR–Cas systems.
Discussion
Transposases and integrases are generally thought to mobilize their 
specific genetic payloads either by integrating randomly, with a low 
degree of sequence specificity, or by targeting specialized genomic loci 
through inflexible, sequence-specific homing mechanisms40. We have 
discovered a fully programmable integrase, in which the DNA inser-
tion activity of a heteromeric transposase from V. cholerae is directed 
by an RNA-guided complex known as Cascade, the DNA-targeting 
specificity of which can be easily tuned. Beyond defining fundamental 
parameters that govern this activity, our work also reveals a complex 
between Cascade and TniQ that mechanistically connects the transpo-
son- and CRISPR-associated machineries. On the basis of our results, 
and of previous studies of Tn7 transposition15, we propose a model 
for the RNA-guided mobilization of Tn7-like transposons encoding 
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E. coli genome (Mb)
Fig. 4 | Genome-wide analysis of programmable RNA-guided DNA 
integration. a, Genomic locus targeted by crRNAs 4–8 (top), and PCR 
analysis of transposition resolved by agarose gel electrophoresis (bottom). 
Amplification of rssA serves as a loading control; gel source data may be 
found in Supplementary Fig. 1. b, Tn-seq workflow for deep sequencing 
of genome-wide transposition events. c, Mapped Tn-seq reads from 
transposition experiments with the mariner transposon, and with the  
V. cholerae transposon programmed with either crRNA-NT or crRNA-4. 
The crRNA-4 target site is denoted by a maroon triangle. d, Sequence logo 
of all mariner Tn-seq reads, highlighting the TA dinucleotide target-site 
preference. e, Comparison of integration site distributions for crRNA-4 
determined by PCR amplicon sequencing and Tn-seq, for the T-RL 
product; the distance between the Cascade target site and transposon 
integration site is plotted. f, Zoomed-in view of Tn-seq read coverage at 
the primary integration site for experiments with crRNA-4, highlighting 
the 5-bp target-site duplication (TSD); the distance from the Cascade 
target site is plotted. g, Genome-wide distribution of genome-mapping 
Tn-seq reads from transposition experiments with crRNAs 9–16 for the 
V. cholerae transposon. The location of each target site is denoted by a 
maroon triangle.
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Cascade-binding site, an important question for future investigation is 
whether the V. cholerae transposon exhibits a similar mode of target 
immunity as E. coli Tn741, in which repeated transposition into the 
same genomic locus is prevented.
Almost all type I-F CRISPR–Cas systems within the Vibrionaceae 
family are associated with mobile genetic elements, and those found 
within Tn7-like transposons frequently co-occur with restriction- 
modification and type three secretion systems14,20. It is therefore tempting 
to speculate that RNA-guided DNA integration may facilitate sharing 
of innate immune systems and virulence mechanisms via horizontal 
gene transfer, particularly within marine environments42. Interestingly, 
we and others43,44 recently observed a unique clade of type V CRISPR–
Cas systems that also reside within bacterial transposons, which bear 
many of the same features as V. cholerae Tn6677: the presence of the 
tniQ gene, the lack of predicted DNA cleavage activity by the RNA-
guided effector complex45, and cargo genes that frequently include other 
innate immune systems (Extended Data Fig. 10). Although future 
experiments will be necessary to determine whether these systems 
also possess RNA-guided DNA integration activity, the bioinformatic 
evidence points to a more pervasive functional coupling between 
CRISPR–Cas systems and transposable elements than previously 
appreciated.
Many biotechnology products require genomic integration of large 
genetic payloads, including gene therapies46, engineered crops47 and 
biopharmaceuticals48, and the advent of CRISPR-based genome edit-
ing has increased the need for effective knock-in methods. Yet current 
genome engineering solutions are limited by a lack of specificity, as 
with viral transduction49, randomly integrating transposases50 and 
non-homologous end joining51 approaches, or by a lack of efficiency 
and cell-type versatility, as with homology-directed repair52,53. The abil-
ity to INsert Transposable Elements by Guide RNA-Assisted TargEting 
(INTEGRATE) offers an opportunity for site-specific DNA integration 
that would obviate the need for double-strand breaks in the target DNA, 
homology arms in the donor DNA, and host DNA repair factors. By 
virtue of its facile programmability, this technology could furthermore 
be leveraged for multiplexing and large-scale screening using guide 
RNA libraries. Together with other recent studies54–57, our work high-
lights the far-reaching possibilities for genetic manipulation that con-
tinue to emerge from the diverse functions of CRISPR–Cas systems.
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Methods
Data reporting. No statistical methods were used to predetermine sample size. 
The experiments were not randomized, and investigators were not blinded to allo-
cation during experiments and outcome assessment.
Plasmid construction. All plasmids used in this study are described in 
Supplementary Table 1, and a subset is available from Addgene. In brief, genes 
encoding V. cholerae strain HE-45 TnsA-TnsB-TnsC and TniQ-Cas8-Cas7-Cas6 
(Supplementary Table 2 and Supplementary Figs. 2–8) were synthesized by 
GenScript and cloned into pCOLADuet-1 and pCDFDuet-1, respectively, yield-
ing pTnsABC and pQCascadeΔCRISPR. A pQCascade entry vector (pQCas-
cade_entry) was generated by inserting tandem BsaI restriction sites flanked by 
two CRISPR repeats downstream of the first T7 promoter, and specific spacers 
(Supplementary Table 3) were subsequently cloned by oligoduplex ligation, yield-
ing pQCascade. To generate pDonor, a gene fragment (GenScript) encoding both 
transposon ends was cloned into pUC19, and a chloramphenicol-resistance gene 
was subsequently inserted within the mini-transposon. Further derivatives of 
these plasmids were cloned using a combination of methods, including Gibson 
assembly, restriction digestion-ligation, ligation of hybridized oligonucleotides, and 
around-the-horn PCR. Plasmids were cloned and propagated in NEB Turbo cells 
(NEB), purified using Miniprep Kits (Qiagen), and verified by Sanger sequencing 
(GENEWIZ).
For transposition experiments involving the E. coli Tn7 transposon, 
pEcoDonor was generated similarly to pDonor, and pEcoTnsABCD was subcloned 
from pCW4 (a gift from N. Craig, Addgene plasmid 8484). For transposition and 
cell killing experiments involving the I-F system from P. aeruginosa, genes encod-
ing Cas8-Cas5-Cas7-Cas6 (also known as Csy1-Csy2-Csy3-Csy4) were subcloned 
from pBW64 (a gift from B. Wiedenheft), and the gene encoding the natural Cas2-3 
fusion protein was subcloned from pCas1_Cas2/3 (a gift from B. Wiedenheft, 
Addgene plasmid 89240). For transposition and cell killing experiments involving 
the II-A system from S. pyogenes, the gene encoding Cas9 was subcloned from a 
vector in-house. For control Tn-seq experiments using the mariner transposon 
and Himar1C9 transposase, the relevant portions were subcloned from pSAM_Ec 
(a gift from M. Mulvey, Addgene plasmid 102939).
Expression plasmids for protein purification were subcloned from pQCascade 
into p2CT-10 (a gift from the QB3 MacroLab, Addgene plasmid 55209), and the 
crRNA expression construct was cloned into pACYCDuet-1.
Multiple sequence alignments (Supplementary Figs. 2–8) were performed using 
Clustal Omega with default parameters and visualized with ESPript 3.058. Analysis 
of spacers from C2c5 CRISPR arrays (Extended Data Fig. 10) was performed using 
CRISPRTarget59.
Transposition experiments. All transposition experiments were performed in 
E. coli BL21(DE3) cells (NEB). For experiments including pDonor, pTnsABC 
and pQCascade (or variants thereof), chemically competent cells were first co- 
transformed with pDonor and pTnsABC, pDonor and pQCascade, or pTnsABC 
and pQCascade, and transformants were isolated by selective plating on double 
antibiotic LB-agar plates. Liquid cultures were then inoculated from single colonies, 
and the resulting strains were made chemically competent using standard methods, 
aliquoted and snap frozen. The third plasmid was introduced in a new transforma-
tion reaction by heat shock, and after recovering cells in fresh LB medium at 37 °C 
for 1 h, cells were plated on triple antibiotic LB-agar plates containing 100 µg ml−1 
carbenicillin, 50 µg ml−1 kanamycin, and 50 µg ml−1 spectinomycin. After over-
night growth at 37 °C for 16 h, hundreds of colonies were scraped from the plates, 
and a portion was resuspended in fresh LB medium before being re-plated on triple 
antibiotic LB-agar plates as before, this time supplemented with 0.1 mM IPTG to 
induce protein expression. Solid media culturing was chosen over liquid cultur-
ing in order to avoid growth competition and population bottlenecks. Cells were 
incubated an additional 24 h at 37 °C and typically grew as densely spaced colonies, 
before being scraped, resuspended in LB medium, and prepared for subsequent 
analysis. Control experiments lacking one or more molecular components were 
performed using empty vectors and the exact same protocol as above. Experiments 
investigating the effect of induction level on transposition efficiency contained 
variable IPTG concentrations in the media (Extended Data Fig. 5d). To isolate 
clonal, lacZ-integrated strains via blue-white colony screening, cells were re-plated 
on triple antibiotic LB-agar plates supplemented with 1 mM IPTG and 100 µg ml−1 
X-gal (GoldBio), and grown overnight at 37 °C before colony PCR analysis.
PCR and Sanger sequencing analysis of transposition products. Optical density 
measurements at 600 nm were taken of scraped colonies that had been resuspended 
in LB medium, and approximately 3.2 × 108 cells (the equivalent of 200 µl of 
OD600 = 2.0) were transferred to a 96-well plate. Cells were pelleted by centrifu-
gation at 4,000g for 5 min and resuspended in 80 µl of H2O, before being lysed by 
incubating at 95 °C for 10 min in a thermal cycler. The cell debris was pelleted by 
centrifugation at 4,000g for 5 min, and 10 µl of lysate supernatant was removed 
and serially diluted with 90 µl of H2O to generate 10- and 100-fold lysate dilutions 
for qPCR and PCR analysis, respectively.
PCR products were generated with Q5 Hot Start High-Fidelity DNA Polymerase 
(NEB) using 5 µl of 100-fold diluted lysate per 12.5 µl reaction volume serving 
as template. Reactions contained 200 µM dNTPs and 0.5 µM primers, and were 
generally subjected to 30 thermal cycles with an annealing temperature of 66 °C. 
Primer pairs contained one genome-specific primer and one transposon-specific 
primer, and were varied such that all possible integration orientations could be 
detected both upstream and downstream of the target site (see Supplementary 
Table 5 for selected oligonucleotides used in this study). Colony PCRs (Extended 
Data Fig. 2b) were performed by inoculating overnight cultures with individual 
colonies and performing PCR analysis as described above. PCR amplicons were 
resolved by 1–2% agarose gel electrophoresis and visualized by staining with SYBR 
Safe (Thermo Scientific). Negative control samples were always analysed in par-
allel with experimental samples to identify mispriming products, some of which 
presumably result from the analysis being performed on crude cell lysates that 
still contain the high-copy pDonor. PCRs were initially performed with different 
DNA polymerases, variable cycling conditions, and different sample preparation 
methods. We note that higher concentrations of the crude lysate appeared to inhibit 
successful amplification of the integrated transposition product.
To map integration sites by Sanger sequencing, bands were excised after sep-
aration by gel electrophoresis, DNA was isolated by Gel Extraction Kit (Qiagen), 
and samples were submitted to and analysed by GENEWIZ.
Integration site distribution analysis by NGS of PCR amplicons. PCR-1 prod-
ucts were generated as described above, except that primers contained universal 
Illumina adaptors as 5′ overhangs (Supplementary Table 5) and the cycle number 
was reduced to 20. These products were then diluted 20-fold into a fresh polymer-
ase chain reaction (PCR-2) containing indexed p5/p7 primers and subjected to 10 
additional thermal cycles using an annealing temperature of 65 °C. After verifying 
amplification by analytical gel electrophoresis, barcoded reactions were pooled and 
resolved by 2% agarose gel electrophoresis, DNA was isolated by Gel Extraction Kit 
(Qiagen), and NGS libraries were quantified by qPCR using the NEBNext Library 
Quant Kit (NEB). Illumina sequencing was performed using a NextSeq mid output 
kit with 150-cycle single-end reads and automated demultiplexing and adaptor 
trimming (Illumina). Individual bases with Phred quality scores under 20 (cor-
responding to a base miscalling rate of >1%) were changed to ‘N,’ and only reads 
with at least half the called bases above Q20 were retained for subsequent analysis.
To determine the integration site distribution for a given sample, the following 
steps were performed using custom Python scripts. First, reads were filtered based 
on the requirement that they contain 20 bp of perfectly matching transposon end 
sequence. Fifteen base pairs of sequence immediately flanking the transposon were 
then extracted and aligned to a 1-kb window of the E. coli BL21(DE3) genome 
(GenBank accession CP001509) surrounding the crRNA-matching genomic 
target site. The distance between the nearest transposon–genome junction and 
the PAM-distal edge of the 32-bp target site was determined. Histograms were 
plotted after compiling these distances across all the reads within a given library 
(see Supplementary Table 4 for NGS statistics).
Cell killing experiments. For experiments with Cas9, 40 µl chemically com-
petent BL21(DE3) cells were transformed with 100 ng Cas9-sgRNA expression 
plasmid encoding either sgRNA-3 or sgRNA-4, which target equivalent lacZ sites 
as V. cholerae crRNA-3 or crRNA-4 but on opposite strands, or a truncated/non- 
functional sgRNA derived from the BsaI-containing entry vector (Supplementary 
Table 3). After a one-hour recovery at 37 °C, variable dilutions of cells were plated 
on LB-agar plates containing 100 µg ml−1 carbenicillin and 0.1 mM IPTG and 
grown an additional 16 h at 37 °C. The number of resulting colonies was quantified 
across three biological replicates, and the data were plotted as colony-forming 
units per microgram of plasmid DNA. Additional control experiments used an 
expression plasmid encoding Cas9 nuclease-inactivating D10A and H840A muta-
tions (dCas9).
For experiments with Cascade and Cas2-3 from P. aeruginosa, BL21(DE3) cells 
were first transformed with a Cas2-3 expression vector, and the resulting strains 
were made chemically competent. Forty microlitres of these cells were then trans-
formed with 100 ng PaeCascade expression plasmid encoding either crRNA-Pae3 
or crRNA-Pae4, which target equivalent lacZ sites as V. cholerae crRNA-3 or 
crRNA-4, or a truncated/non-functional crRNA derived from the BsaI-containing 
entry vector (Supplementary Table 3). After a one-hour recovery at 37 °C, variable 
dilutions of cells were plated on LB-agar plates containing 100 µg ml−1 carbenicillin 
and 50 µg ml−1 kanamycin and grown an additional 16 h at 37 °C. The number of 
resulting colonies was quantified across three biological replicates, and the data 
were plotted as colony-forming units per microgram of plasmid DNA. We found 
that even low concentrations of IPTG led to crRNA-independent toxicity in these 
experiments, whereas crRNA-dependent cell killing was readily observed in the 
absence of induction, presumably from leaky expression by T7 RNAP. We therefore 
omitted IPTG from experiments using PaeCascade and Cas2-3.
qPCR analysis of transposition efficiency. For both crRNA-3 and crRNA-4, 
pairs of transposon- and genome-specific primers were designed to amplify an 
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approximately 140–240-bp fragment resulting from RNA-guided DNA integration 
at the expected lacZ locus in either orientation. A separate pair of genome-specific 
primers was designed to amplify an E. coli reference gene (rssA) for normaliza-
tion purposes (Supplementary Table 5). qPCR reactions (10 µl) contained 5 µl 
of SsoAdvanced Universal SYBR Green Supermix (BioRad), 1 µl H2O, 2 µl of 
2.5 µM primers, and 2 µl of tenfold diluted lysate prepared from scraped colonies, 
as described for the PCR analysis above. Reactions were prepared in 384-well clear/
white PCR plates (BioRad), and measurements were performed on a CFX384 Real-
Time PCR Detection System (BioRad) using the following thermal cycling param-
eters: polymerase activation and DNA denaturation (98 °C for 2.5 min), 40 cycles 
of amplification (98 °C for 10 s, 62 °C for 20 s), and terminal melt-curve analysis 
(65–95 °C in 0.5 °C per 5 s increments).
We first prepared lysates from a control BL21(DE3) strain containing pDonor 
and both empty expression vectors (pCOLADuet-1 and pCDFDuet-1), and from 
strains that underwent clonal integration into the lacZ locus downstream of both 
crRNA-3 and crRNA-4 target sites in both orientations. By testing our primer 
pairs with each of these samples diluted across five orders of magnitude, and then 
determining the resulting Cq values and PCR efficiencies, we verified that our 
experimental and reference amplicons were amplified with similar efficiencies, 
and that our primer pairs selectively amplified the intended transposition product 
(Extended Data Fig. 5a, b). We next simulated variable transposition efficiencies 
across five orders of magnitude (ranging from 0.002 to 100%) by mixing control 
lysates and clonally-integrated lysates in various ratios, and showed that we could 
accurately and reproducibly detect transposition products at both target sites, in 
either orientation, at levels >0.01% (Extended Data Fig. 5b). Finally, we simu-
lated variable integration orientation biases by mixing clonally-integrated lysates 
together in varying ratios together with control lysates, and showed that these could 
also be accurately measured (Extended Data Fig. 5c).
In our final qPCR analysis protocol, each biological sample is analysed in three 
parallel reactions: one reaction contains a primer pair for the E. coli reference 
gene, a second reaction contains a primer pair for one of the two possible integra-
tion orientations, and a third reaction contains a primer pair for the other possi-
ble integration orientation. Transposition efficiency for each orientation is then 
calculated as 2ΔCq, in which ΔCq is the Cq difference between the experimental 
reaction and the control reaction. Total transposition efficiency for a given exper-
iment is calculated as the sum of transposition efficiencies for both orientations. 
All measurements presented in the text and figures were determined from three 
independent biological replicates.
We note that experiments with pDonor variants were performed by delivering 
pDonor in the final transformation step, whereas most other experiments were 
performed by delivering pQCascade in the final transformation step. Integration 
efficiencies between samples from these two experiments appeared to differ slightly 
as a result (compare Fig. 3b with Fig. 3c). Additionally, because we did not want to 
bias our qPCR analysis of the donor end truncation samples by successively short-
ening the PCR amplicon, different primer pairs were used for these samples. Within 
the left and right end truncation panel (Extended Data Fig. 6b, c), the transposon 
end that was not being perturbed was selectively amplified during qPCR analysis.
Recombinant protein expression and purification. The protein components 
for Cascade, TniQ and TniQ–Cascade were expressed from a pET-derivative 
vector containing an N-terminal His10-MBP-TEVsite fusion on Cas8, TniQ 
and TniQ, respectively (see Extended Data Fig. 3a). The crRNAs for Cascade 
and TniQ–Cascade were expressed separately from a pACYC-derivative vector 
(Supplementary Table 1). E. coli BL21(DE3) cells containing one or both plas-
mids were grown in 2xYT medium with the appropriate antibiotic(s) at 37 °C 
to OD600 = 0.5–0.7, at which point IPTG was added to a final concentration of 
0.5 mM and growth was allowed to continue at 16 °C for an additional 12–16 h. 
Cells were harvested by centrifugation at 4,000g for 20 min at 4 °C.
Cascade and TniQ–Cascade were purified as follows. Cell pellets were resus-
pended in Cascade lysis buffer (50 mM Tris-Cl, pH 7.5, 100 mM NaCl, 0.5 mM 
PMSF, EDTA-free Protease Inhibitor Cocktail tablets (Roche), 1 mM dithiothreitol 
(DTT), 5% glycerol) and lysed by sonication with a sonic dismembrator (Fisher) set 
to 40% amplitude and 12 min total process time (cycles of 10 s on and 20 s off, for a 
total of 4 min on and 8 min off). Lysates were clarified by centrifugation at 15,000g 
for 30 min at 4 °C. Initial purification was performed by immobilized metal-ion 
affinity chromatography with NiNTA Agarose (Qiagen) using NiNTA wash buffer 
(50 mM Tris-Cl, pH 7.5, 100 mM NaCl, 10 mM imidazole, 1 mM DTT, 5% glyc-
erol) and NiNTA elution buffer (50 mM Tris-Cl pH 7.5, 100 mM NaCl, 300 mM 
imidazole, 1 mM DTT, 5% glycerol). The His10-MBP fusion was removed by incu-
bation with TEV protease overnight at 4 °C in NiNTA elution buffer, and complexes 
were further purified by anion exchange chromatography on an AKTApure system 
(GE Healthcare) using a 5 ml HiTrap Q HP Column (GE Healthcare) with a linear 
gradient from 100% buffer A (20 mM Tris-Cl, pH 7.5, 100 mM NaCl, 1 mM DTT, 
5% glycerol) to 100% buffer B (20 mM Tris-Cl, pH 7.5, 1 M NaCl, 1 mM DTT, 5% 
glycerol) over 20 column volumes. Pooled fractions were identified by SDS–PAGE 
analysis and concentrated, and the sample was further refined by size exclusion 
chromatography over one or two tandem Superose 6 Increase 10/300 columns 
(GE Healthcare) equilibrated with Cascade storage buffer (20 mM Tris-Cl, pH 7.5, 
200 mM NaCl, 1 mM DTT, 5% glycerol). Fractions were pooled, concentrated, snap 
frozen in liquid nitrogen, and stored at −80 °C.
TniQ was purified similarly, except the lysis, NiNTA wash, and NiNTA elu-
tion buffers contained 500 mM NaCl instead of 100 mM NaCl. Separation by 
ion exchange chromatography was performed on a 5 ml HiTrap SP HP Column 
(GE Healthcare) using the same buffer A and buffer B as above, and the final 
size-exclusion chromatography step was performed on a HiLoad Superdex 75 
16/600 column (GE Healthcare) in Cascade storage buffer. The TniQ protein 
used in TniQ–Cascade binding experiments (Extended Data Fig. 3e) contained 
an N-terminal StrepII tag (Supplementary Table 1).
Mass spectrometry analysis. Total protein (0.5–5 µg) was separated on 4–20% 
gradient SDS–PAGE and stained with Imperial Protein Stain (Thermo Scientific). 
In-gel digestion was performed essentially as described60, with minor modifica-
tions. Protein gel slices were excised, washed with 1:1 acetonitrile:100 mM ammo-
nium bicarbonate (v/v) for 30 min, dehydrated with 100% acetonitrile for 10 min, 
and dried in a speed-vac for 10 min without heat. Gel slices were reduced with 
5 mM DTT for 30 min at 56 °C and then alkylated with 11 mM iodoacetamide 
for 30 min at room temperature in the dark. Gel slices were washed with 100 mM 
ammonium bicarbonate and 100% acetonitrile for 10 min each, and excess ace-
tonitrile was removed by drying in a speed-vac for 10 min without heat. Gel slices 
were then rehydrated in a solution of 25 ng µl−1 trypsin in 50 mM ammonium 
bicarbonate for 30 min on ice, and trypsin digestions were performed overnight 
at 37 °C. Digested peptides were collected and further extracted from gel slices in 
mass spectrometry (MS) extraction buffer (1:2 5% formic acid:acetonitrile (v/v)) 
with high-speed shaking. Supernatants were dried down in a speed-vac, and pep-
tides were dissolved in a solution containing 3% acetonitrile and 0.1% formic acid.
Desalted peptides were injected onto an EASY-Spray PepMap RSLC C18 50 cm 
× 75 µm column (Thermo Scientific), which was coupled to the Orbitrap Fusion 
Tribrid mass spectrometer (Thermo Scientific). Peptides were eluted with a non-
linear 100-min gradient of 5–30% mass spectrometry buffer B (MS buffer A: 0.1% 
(v/v) formic acid in water; MS buffer B: 0.1% (v/v) formic acid in acetonitrile) at a 
flow rate of 250 nl min−1. Survey scans of peptide precursors were performed from 
400 to 1,575 m/z at 120K full width at half-maximum resolution (at 200 m/z) with a 
2 × 105 ion count target and a maximum injection time of 50 ms. The instrument 
was set to run in top speed mode with 3-s cycles for the survey and the tandem 
mass spectrometry (MS/MS) scans. After a survey scan, tandem mass spectrometry 
was performed on the most abundant precursors exhibiting a charge state from 2 
to 6 of greater than 5 × 103 intensity by isolating them in the quadrupole at 1.6 Th. 
CID fragmentation was applied with 35% collision energy, and resulting fragments 
were detected using the rapid scan rate in the ion trap. The AGC target for MS/MS 
was set to 1 × 104 and the maximum injection time limited to 35 ms. The dynamic 
exclusion was set to 45 s with a 10 ppm mass tolerance around the precursor and 
its isotopes. Monoisotopic precursor selection was enabled.
Raw mass spectrometric data were processed and searched using the Sequest 
HT search engine within the Proteome Discoverer 2.2 software (Thermo Scientific) 
with custom sequences and the reference E. coli BL21(DE3) strain database down-
loaded from Uniprot. The default search settings used for protein identification 
were as follows: two mis-cleavages for full trypsin, with fixed carbamidomethyl 
modification of cysteine and oxidation of methionine; deamidation of asparag-
ine and glutamine and acetylation on protein N termini were used as variable 
modifications. Identified peptides were filtered for a maximum 1% false discovery 
rate using the Percolator algorithm, and the PD2.2 output combined folder was 
uploaded in Scaffold (Proteome Software) for data visualization. Spectral counting 
was used for analysis to compare the samples.
crRNA analysis and RNA sequencing. To analyse the nucleic acid component 
co-purifying with Cascade and TniQ–Cascade, nucleic acids were isolated by phe-
nol-chloroform extraction, resolved by 10% denaturing urea–PAGE, and visualized 
by staining with SYBR Gold (Thermo Scientific). Analytical RNase and DNase 
digestions were performed in 10 µl reactions with approximately 4 pmol nucleic 
acid and either 10 µg RNase A (Thermo Scientific) or 2 U DNase I (NEB), and were 
analysed by 10% denaturing urea–PAGE and SYBR Gold staining.
RNA sequencing was performed generally as previously described61. In brief, 
RNA was isolated from Cascade and TniQ–Cascade complexes by phenol- 
chloroform extraction, ethanol precipitated, and 5′-phosphorylated/ 
3′-dephosphorylated using T4 polynucleotide kinase (NEB), followed by clean-up 
using the ssDNA/RNA Clean & Concentrator Kit (Zymo Research). A ssDNA 
universal Illumina adaptor containing 5′-adenylation and 3′-dideoxycytidine mod-
ifications (Supplementary Table 5) was ligated to the 3′ end with T4 RNA Ligase 
1 (NEB), followed by hybridization of a ssDNA reverse transcriptase primer and 
ligation of ssRNA universal Illumina adaptor to the 5′ end with T4 RNA Ligase 
1 (NEB). cDNA was synthesized using Maxima H Minus Reverse Transcriptase 
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(Thermo Scientific), followed by PCR amplification using indexed p5/p7 primers. 
Illumina sequencing was performed using a NextSeq mid output kit with 150-cycle 
single-end reads and automated demultiplexing and adaptor trimming (Illumina). 
Individual bases with Phred quality scores under 20 (corresponding to a base mis-
calling rate of >1%) were changed to ‘N,’ and only reads with at least half the called 
bases above Q20 were retained for subsequent analysis. Reads were aligned to 
the crRNA expression plasmid used for recombinant Cascade and TniQ–Cascade 
expression and purification.
TniQ–Cascade binding experiments. Binding reactions (120 µl) contained 1 µM 
Cascade and 5 µM StrepII-tagged TniQ, and were prepared in Cascade storage 
buffer and incubated at room temperature for 30 min, before being loaded into 
a 100 µl sample loop on an AKTApure system (GE Healthcare). Reactions were 
resolved by size exclusion chromatography over a Superose 6 Increase 10/300 col-
umn (GE Healthcare) in Cascade storage buffer, and proteins in each peak fraction 
were acetone precipitated and analysed by SDS–PAGE. Control reactions lacked 
either Cascade or TniQ.
Tn-seq experiments. Transposition experiments were performed as described 
above, except pDonor contained two point mutations in the transposon right end 
that introduced an MmeI restriction site (Supplementary Table 1 and Extended 
Data Fig. 8a, b). Colonies from triple antibiotic LB-agar plates containing IPTG 
(typically numbering in the range of 102–103) were resuspended in 4 ml fresh 
LB medium, and 0.5 ml (corresponding to around 2 × 109 cells) was used for 
genomic DNA (gDNA) extraction with the Wizard Genomic DNA Purification 
Kit (Promega). This procedure typically yielded 50 µl of 0.5–1.5 µg µl−1 gDNA, 
which is a mixture of the E. coli circular chromosome (4.6 Mb, copy number of 1), 
pDonor (3.6 kb, copy number 100+), pTnsABC (6.9 kb, copy number ~20–40), 
and pQCascade (8.4 kb, copy number ~20–40).
NGS libraries were prepared in parallel on 96-well plates, as follows. First, 1 µg 
of gDNA was digested with 4 U of MmeI (NEB) for 12 h at 37 °C in a 50 µl reaction 
containing 50 µM S-adenosyl methionine and 1× CutSmart Buffer, before heat 
inactivation at 65 °C for 20 min. MmeI cleaves the transposon 17–19 nucleotides 
outside of the terminal repeat, leaving 2-nucleotide 3′-overhangs. Reactions were 
cleaned up using 1.8× Mag-Bind TotalPure NGS magnetic beads (Omega) accord-
ing to the manufacturer’s instructions, and elutions were performed using 30 µl of 
10 mM Tris-Cl, pH 7.0. MmeI-digested gDNA was ligated to a double-stranded i5 
universal adaptor containing a 3′-terminal NN overhang (Supplementary Table 5) 
in a 20 µl ligation reaction containing 16.86 µl of MmeI-digested gDNA, 280 nM 
adaptor, 400 U T4 DNA ligase (NEB), and 1× T4 DNA ligase buffer. Reactions were 
incubated at room temperature for 30 min before being cleaned up with magnetic 
beads as before. To reduce the degree of pDonor contamination within our NGS 
libraries, since pDonor also contains the full-length transposon with an MmeI site, 
we took advantage of the presence of a unique HindIII restriction site just outside 
the transposon right end within pDonor. The entirety of the adaptor-ligated gDNA 
sample was thus digested with 20 Units of HindIII (NEB) in a 34.4 µl reaction for 
1 h at 37 °C, before a heat inactivation step at 65 °C for 20 min. Magnetic bead-
based DNA clean-up was performed as before.
Adaptor-ligated transposons were enriched in a PCR-1 step using a univer-
sal i5 adaptor primer and a transposon-specific primer containing a universal i7 
adaptor as 5′ overhang. Reactions were 25 µl in volume and contained 16.75 µl of 
HindIII-digested gDNA, 200 µM dNTPs, 0.5 µM primers, 1× Q5 reaction buffer, 
and 0.5 U Q5 Hot Start High-Fidelity DNA Polymerase (NEB). Amplification was 
allowed to proceed for 25 cycles, with an annealing temperature of 66 °C. Reaction 
products were then diluted 20-fold into a second 20 µl polymerase chain reaction 
(PCR-2) containing indexed p5/p7 primers, and this was subjected to 10 additional 
thermal cycles using an annealing temperature of 65 °C. After verifying amplifica-
tion for select libraries by analytical gel electrophoresis, barcoded reactions were 
pooled and resolved by 2% agarose gel electrophoresis, DNA was isolated by Gel 
Extraction Kit (Qiagen), and NGS libraries were quantified by qPCR using the 
NEBNext Library Quant Kit (NEB). Illumina sequencing was performed using a 
NextSeq mid output kit with 150-cycle single-end reads and automated demul-
tiplexing and adaptor trimming (Illumina). Individual bases with Phred quality 
scores under 20 (corresponding to a base miscalling rate of >1%) were changed 
to ‘N,’ and only reads with at least half the called bases above Q20 were retained 
for subsequent analysis.
Tn-seq libraries with the mariner transposon were prepared as for the 
V. cholerae transposon, but with the following changes. Transformation reactions 
contained BL21(DE3) cells and a single pDonor plasmid, which encodes a KanR-
containing mariner transposon with MmeI restriction sites on both ends, and 
a separate expression cassette for the Himar1C9 transposase controlled by a lac 
promoter. Transformed cells were recovered at 37 °C for 1 h before being plated 
on bioassay dishes containing 100 µg ml−1 carbenicillin, yielding on the order of 
5 × 104 colonies. Cells were resuspended in 20 ml fresh LB medium after a single 
16-h overnight growth, and the equivalent of 2 × 109 cells were used for genomic 
DNA (gDNA) extraction. NGS libraries were prepared as described above, except 
the restriction enzyme digestion reactions to deplete pDonor contained 20 U of 
BamHI and KpnI instead of HindIII.
Tn-seq data visualization and analysis. The software application Geneious Prime 
was used to further filter reads based on three criteria: that read lengths correspond to 
the expected products resulting from MmeI cleavage and adaptor ligation to genomi-
cally integrated transposons (112–113 bp for the V. cholerae transposon and 87–88 bp 
for mariner); that each read contain the expected transposon end sequence (allowing 
for one mismatch); and that the transposon-flanking sequence (trimmed to 17 bp 
for the V. cholerae transposon and 14 bp for mariner) map perfectly to the reference 
genome. Mapping to the E. coli BL21(DE3) genome (GenBank accession CP001509) 
was done using the function ‘Map to reference’ and the following settings: Mapper: 
Geneious; Fine tuning: None (fast / read mapping); Word length: 17; Maximum 
mismatches: 0%; Maximum Ambiguity: 1. The ‘Map multiple best matches’ setting 
was set to either ‘none,’ effectively excluding any reads except those that map uniquely 
to a single site (which we will refer to as ‘uniquely mapping reads’), or to ‘all,’ which 
allows reads to map to one or multiple sites on the E. coli genome (which we will refer 
to as ‘processed mapping reads’). Both sets of reads were exported as fastq files and 
used for downstream analysis using custom Python scripts. We note that many reads 
removed in this process perfectly mapped to the donor plasmid (Supplementary 
Table 4), revealing that HindIII or BamHI/KpnI cleavage was insufficient to com-
pletely remove contaminating pDonor-derived sequences. Coverage data for ‘pro-
cessed mapping reads’ were exported to generate Fig. 4f.
To visualize the genome-wide integration site distribution for a given sample, 
‘uniquely mapping reads’ were mapped to the same E. coli reference genome with 
custom Python scripts. We define the integration site for each read as the genomic 
coordinate (with respect to the reference genome) corresponding to the 3′ edge of 
the mapped read. For visualization purposes, integration events within 5-kb bins 
were computed and plotted as genome-wide histograms in Fig. 4c, g and Extended 
Data Fig. 9a, b. Plots were generated using the Matplotlib graphical library. 
The sequence logo in Fig. 4d was generated using WebLogo 3.
Plots comparing integration sites among biological replicates (Extended Data 
Fig. 8d–h) were generated by binning the genome-wide histograms based on gene 
annotations (mariner) using GenBank accession CP001509, or into 100-bp bins (V. 
cholerae transposon). For the V. cholerae transposon, the bins were shifted so that 
the 3′ end of the Cascade target site for each sample would correspond to the start of 
its corresponding 100-bp bin. Linear regression and bivariate analysis for the mari-
ner plot (Extended Data Fig. 8d) was performed using the SciPy statistical package.
To analyse the primary integration site for each sample, custom Python scripts 
were used to map ‘processed mapping reads’ to a 600-bp genomic window sur-
rounding the corresponding genomic target site. For reads mapping to the oppo-
site strand as the target (that is, for the T-LR orientation, in which integration 
places the ‘left’ transposon end closest to the Cascade-binding site), the integration 
site was shifted 5 bp from the 3′ edge of the target site in order to account for 
the 5-bp target-site duplication. We define the primary integration site within 
this 600-bp window by the largest number of mapped reads, while we arbitrarily 
designate 100 bp centred at the primary integration site as the ‘on-target’ window. 
The percentage of on-target integration for each sample is calculated as the number 
of reads resulting from transposition within the 100-bp window, divided by the 
total number of reads mapping to the genome. We also determined the ratio of 
integration in one orientation versus the other; this parameter only utilizes on-target 
reads, and is calculated as the number of reads resulting from integration of the 
transposon ‘right’ end closest to the Cascade-binding site (T-RL), divided by 
the number reads resulting from integration of the transposon left end closest to 
the Cascade target site (T-LR). The distribution of integration around the primary 
site was plotted for both orientations for each sample, and was used to generate 
Fig. 4e and Extended Data Fig. 9c.
We note that these analyses are susceptible to potential biases from differential 
efficiencies in the ligation of 3′-terminal NN overhang adaptors, which are not 
taken into account in our analyses.
Statistics and reproducibility. Analytical PCRs resolved by agarose gel electro-
phoresis gave similar results in three independent replicates (Figs. 1d, e, i, 2a, 4a) or 
were analysed by gel electrophoresis once (Fig. 2e and Extended Data Figs. 1d, 2b, d 
and f) but verified with qPCR for three independent replicates (Fig. 2e). Sanger 
sequencing and next-generation sequencing of PCR amplicons was performed 
once (Figs. 1f, g, 3e, g, 4e and Extended Data Figs. 1e, 2a, e, 7). SDS–PAGE experi-
ments were performed for two or more different preparations of the same protein 
complexes and yielded similar results (Fig. 2b and Extended Data Fig. 3b). Protein 
binding reactions were performed and analysed by SDS–PAGE once (Extended 
Data Fig. 3e). Nucleic acid extraction from purified protein preparations and 
urea–PAGE analysis of samples with and without RNase or DNase treatment was 
performed twice, with similar results (Fig. 2c and Extended Data Fig. 3d). RNA 
sequencing was performed once (Fig. 2d).
Reporting summary. Further information on research design is available in 
the Nature Research Reporting Summary linked to this paper.
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Data availability
Next-generation sequencing data are available in the National Center for 
Biotechnology Information Sequence Read Archive (BioProject Accession: 
PRJNA546035). Custom Python scripts used for the described data analyses are 
available online via GitHub (https://github.com/sternberglab/Klompe_etal_2019).
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Extended Data Fig. 1 | Transposition of the E. coli Tn7 transposon 
and genetic architecture of the Tn6677 transposon from V. cholerae. 
a, Genomic organization of the native E. coli Tn7 transposon adjacent to 
its known attachment site (attTn7) within the glmS gene. b, Expression 
plasmid and donor plasmid for Tn7 transposition experiments.  
c, Genomic locus containing the conserved TnsD-binding site (attTn7), 
including the expected and alternative orientation Tn7 transposition 
products and PCR primer pairs to selectively amplify them. d, PCR 
analysis of Tn7 transposition, resolved by agarose gel electrophoresis. 
Amplification of rssA serves as a loading control; gel source data may 
be found in Supplementary Fig. 1. e, Sanger sequencing chromatograms 
of both upstream and downstream junctions of genomically integrated 
Tn7. f, Genomic organization of the native V. cholerae strain HE-45 
Tn6677 transposon. Genes that are conserved between Tn6677 and the 
E. coli Tn7 transposon, and between Tn6677 and a canonical type I-F 
CRISPR–Cas system from P. aeruginosa28, are highlighted. The cas1 and 
cas2-3 genes, which mediate spacer acquisition and DNA degradation 
during the adaptation and interference stages of adaptive immunity, 
respectively, are missing from CRISPR–Cas systems encoded by Tn7-like 
transposons. Similarly, the tnsE gene, which facilitates non-sequence-
specific transposition, is absent. The V. cholerae HE-45 genome contains 
another Tn7-like transposon (located within GenBank accession 
ALED01000025.1), which lacks an encoded CRISPR–Cas system and 
exhibits low sequence similarity to the Tn6677 transposon investigated in 
this study.
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Extended Data Fig. 2 | Analysis of E. coli cultures and strain isolates 
containing lacZ-integrated transposons. a, Top, genomic locus targeted 
by crRNA-3 and crRNA-4, including both potential transposition products 
and the PCR primer pairs to selectively amplify them. Bottom, NGS 
analysis of the distance between the Cascade target site and transposon 
insertion site for crRNA-3 (left) and crRNA-4 (right), determined with  
two alternative primer pairs. b, Top, schematic of the lacZ locus with  
or without integrated transposon after transposition experiments  
with crRNA-4. T-LR and T-RL denote transposition products in which 
the transposon left end and right end are proximal to the target site, 
respectively. Primer pairs g and h (external–internal) selectively amplify 
the integrated locus, whereas primer pair i (external–external) amplifies 
both unintegrated and integrated loci. Bottom, PCR analysis of 10 colonies 
after 24-h growth on +IPTG plates (left) indicates that all colonies contain 
integration events in both orientations (primer pairs g and h), but with 
efficiencies sufficiently low that the unintegrated product predominates 
after amplification with primer pair i. After resuspending cells, allowing 
for an additional 18 h of clonal growth on −IPTG plates, and performing 
the same PCR analysis on 10 colonies (right), 3 out of 10 colonies now 
exhibit clonal integration in the T-LR orientation (compare primer pairs 
h and i). The remaining colonies show low-level integration in both 
orientations, which presumably occurred during the additional 18-h 
growth owing to leaky expression. These analyses indicate that colonies 
are genetically heterogeneous after growth on +IPTG plates, and that 
RNA-guided DNA integration only occurs in a proportion of cells within 
growing colonies. I, integrated product; U, unintegrated product. Asterisk 
denotes mispriming product also present in the negative (unintegrated) 
control. c, Photograph of LB-agar plate used for blue–white colony 
screening. Cells from IPTG-containing plates were replated on X-gal-
containing plates, and white colonies expected to contain lacZ-inactivating 
transposon insertions were selected for further characterization. d, PCR 
analysis of E. coli strains identified by blue–white colony screening that 
contain clonally integrated transposons, as in b. e, Schematic of Sanger 
sequencing coverage across the lacZ locus for strains shown in d. f, PCR 
analysis of transposition experiment with crRNA-4 after serially diluting 
lysate from a clonally integrated strain with lysate from a control strain 
to simulate variable integration efficiencies, as in b. These experiments 
demonstrate that transposition products can be reliably detected by PCR 
with an external–internal primer pair at efficiencies above 0.5%, but that 
PCR bias leads to preferential amplification of the unintegrated product 
using the external-external primer pair at any efficiency substantially 
below 100%. For gel source data, see Supplementary Fig. 1.
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Extended Data Fig. 3 | Analysis of V. cholerae Cascade and TniQ–
Cascade complexes. a, Expression vectors for recombinant protein or 
ribonucleoprotein complex purification. b, Left, SDS–PAGE analysis 
of purified TniQ, Cascade and TniQ–Cascade complexes, highlighting 
protein bands excised for in-gel trypsin digestion and mass spectrometry 
analysis. Right, table listing E. coli and recombinant proteins identified 
from these data, and spectral counts of their associated peptides. Note 
that Cascade and TniQ–Cascade samples used for this analysis are distinct 
from the samples presented in Fig. 2. c, Size-exclusion chromatogram of 
the TniQ–Cascade co-complex on a Superose 6 10/300 column (left),  
and a calibration curve generated using protein standards (right). The 
measured retention time of TniQ–Cascade (maroon) is consistent with a 
complex having a molecular mass of approximately 440 kDa. d, RNase A  
and DNase I sensitivity of nucleic acids that co-purified with Cascade and  
TniQ–Cascade, resolved by denaturing urea–PAGE. e, TniQ, Cascade 
and a Cascade + TniQ binding reaction were resolved by size-exclusion 
chromatography (left), and indicated fractions were analysed by  
SDS–PAGE (right). Asterisk denotes an HtpG contaminant. For gel source 
data, see Supplementary Fig. 1.
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Extended Data Fig. 4 | Control experiments demonstrating efficient 
DNA targeting with Cas9 and P. aeruginosa Cascade. a, Plasmid 
expression system for S. pyogenes (Spy) Cas9-sgRNA (type II-A, left) and 
P. aeruginosa Cascade (PaeCascade) and Cas2-3 (type I-F, right). The 
Cas2-3 expression plasmid was omitted from experiments described in 
Fig. 2e. b, Cell killing experiments using S. pyogenes Cas9-sgRNA (left) or 
PaeCascade and Cas2-3 (right), monitored by determining colony-forming 
units (CFU) after plasmid transformation. Complexes were programmed 
with guide RNAs that target the same genomic lacZ sites as with V. cholerae 
crRNA-3 and crRNA-4, such that efficient DNA targeting and degradation 
results in lethality and thus a drop in transformation efficiency. c, qPCR-
based quantification of transposition efficiency from experiments using 
the V. cholerae transposon donor and TnsA-TnsB-TnsC, together with 
DNA targeting components comprising V. cholerae Cascade (Vch),  
P. aeruginosa Cascade (Pae) or S. pyogenes dCas9–RNA (dCas9). TniQ was 
expressed either on its own from pTnsABCQ or as a fusion to the targeting 
complex (pCas-Q) at the Cas6 C terminus (6), Cas8 N terminus (8),  
or dCas9 N or C terminus. The same sample lysates as in Fig. 2e were 
used. Data in b and c are shown as mean ± s.d. for n = 3 biologically 
independent samples.
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Extended Data Fig. 5 | qPCR-based quantification of RNA-guided 
DNA integration efficiencies. a, Potential lacZ transposition products 
in either orientation for both crRNA-3 and crRNA-4, and qPCR primer 
pairs to selectively amplify them. b, Comparison of simulated integration 
efficiencies for T-LR and T-RL orientations, generated by mixing clonally 
integrated and unintegrated lysates in known ratios, versus experimentally 
determined integration efficiencies measured by qPCR. c, Comparison of 
simulated mixtures of bidirectional integration efficiencies for crRNA-4, 
generated by mixing clonally integrated and unintegrated lysates in known 
ratios, versus experimentally determined integration efficiencies measured 
by qPCR. d, RNA-guided DNA integration efficiency as a function of 
IPTG concentration for crRNA-3 and crRNA-4, measured by qPCR. Data 
in b and c are shown as mean ± s.d. for n = 3 biologically independent 
samples.
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Extended Data Fig. 6 | Influence of transposon end sequences on RNA-
guided DNA integration. a, Sequence (top) and schematic (bottom) of 
V. cholerae Tn6677 left- and right-end sequences. The putative TnsB-
binding sites (blue) were determined based on sequence similarity to 
the TnsBbinding sites previously described14. The 8-bp terminal ends 
are shown in yellow, and the empirically determined minimum end 
sequences required for transposition are denoted by red dashed boxes. 
b, Integration efficiency with crRNA-4 as a function of transposon end 
length, as determined by qPCR. c, The relative fraction of both integration 
orientations as a function of transposon end length, determined by qPCR. 
ND, not determined. Data in b and c are shown as mean ± s.d. for n = 3 
biologically independent samples.
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Extended Data Fig. 7 | Analysis of RNA-guided DNA integration  
for PAM-tiled crRNAs and extended spacer length crRNAs.  
a, Integration site distribution for all crRNAs described in Fig. 3d, e having 
a normalized transposition efficiency more than 20%, determined by 
NGS. b, Integration site distribution for a crRNA containing mismatches 
at positions 29–32, compared with the distribution with crRNA-4, 
determined by NGS. c, The crRNA-4 spacer length was shortened or 
lengthened by 6-nucleotide increments, and the resulting integration 
efficiencies were determined by qPCR. Data are normalized to crRNA-4 
and are shown as mean ± s.d. for n = 3 biologically independent samples. 
d, Integration site distribution for extended length crRNAs compared with 
the distribution with crRNA-4, determined by NGS.
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Extended Data Fig. 8 | Development and analysis of Tn-seq.  
a, Schematic of the V. cholerae transposon end sequences. The 8-bp 
terminal sequence of the transposon is boxed and highlighted in light 
yellow. Mutations generated to introduce MmeI recognition sites are 
shown in red letters, and the resulting recognition site is highlighted in 
red. Cleavage by MmeI occurs 17–19 bp away from the transposon end, 
generating a 2-bp overhang. b, Comparison of integration efficiencies for 
the wild-type and MmeI-containing transposon donors, determined by 
qPCR. Labels on the x axis denote which plasmid was transformed last; we 
reproducibly observed higher integration efficiencies when pQCascade 
was transformed last (crRNA-4) than when pDonor was transformed last. 
The transposon containing an MmeI site in the transposon ‘right’ end 
(R∗-L pDonor) was used for all Tn-seq experiments. Data are mean ± s.d. 
for n = 3 biologically independent samples. c, Plasmid expression system 
for Himar1C9 and the mariner transposon. d, Scatter plot showing 
correlation between two biological replicates of Tn-seq experiments with 
the mariner transposon. Reads were binned by E. coli gene annotations, 
and a linear regression fit and Pearson linear correlation coefficient (r) are 
shown. e, Schematic of 100-bp binning approach used for Tn-seq analysis 
of transposition experiments with the V. cholerae transposon, in which 
bin 1 is defined as the first 100 bp immediately downstream (PAM-distal) 
of the Cascade target site. f, Scatter plots showing correlation between 
biological replicates of Tn-seq experiments with the V. cholerae transposon 
programmed with crRNA-4. All highly sampled reads fall within bin 1, 
but we also observed low-level but reproducible, long-range integration 
into 100-bp bins just upstream and downstream of the primary integration 
site (bins −1, 2 and 3). g, Scatter plot showing correlation between 
biological replicates of Tn-seq experiments with the V. cholerae transposon 
programmed with a non-targeting crRNA (crRNA-NT). h, Scatter plot 
showing correlation between biological replicates of Tn-seq experiments 
with the V. cholerae transposon expressing TnsA-TnsB-TnsC-TniQ but not 
Cascade. For f–h, bins are only plotted when they contain at least one read 
in either dataset.
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Extended Data Fig. 9 | See next page for caption.
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Extended Data Fig. 9 | Tn-seq data for additional crRNAs tested.  
a, b, Genome-wide distribution of genome-mapping Tn-seq reads from 
transposition experiments with the V. cholerae transposon programmed 
with crRNAs 1–8 (a) and crRNAs 17–24 (b). The location of each target 
site is denoted by a maroon triangle. Dagger symbol indicates that the lacZ 
target site for crRNA-3 is duplicated within the λ DE3 prophage, as is the 
transposon integration site; Tn-seq reads for this dataset were mapped to 
both genomic loci for visualization purposes only, although we are unable 
to determine from which locus they derive. c, Analysis of integration 
site distributions for crRNAs 1–24 determined from the Tn-seq data; the 
distance between the Cascade target site and transposon insertion site 
is shown. Data for both integration orientations are superimposed, with 
filled blue bars representing the T-RL orientation and the dark outlines 
representing the T-LR orientation. Values in the top-right corner of each 
graph give the on-target specificity (%), calculated as the percentage of 
reads resulting from integration within 100 bp of the primary integration 
site, as compared with the total number of reads aligning to the genome; 
and the orientation bias (X:Y), calculated as the ratio of reads for the 
T-RL orientation to reads for the T-LR orientation. Most crRNAs favour 
integration in the T-RL orientation 49–50 bp downstream of the Cascade 
target site. crRNA-21 is greyed out because the expected primary 
integration site is present in a repetitive stretch of DNA that does not allow 
us to map the reads confidently. Asterisks denote samples for which more 
than 1% of the genome-mapping reads could not be uniquely mapped.
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Extended Data Fig. 10 | Bacterial transposons also contain type V-U5 
CRISPR–Cas systems encoding C2c5. Representative genomic loci 
from various bacterial species containing identifiable transposon left and 
right ends (blue boxes, L and R), genes with homology to tnsB-tnsC-tniQ 
(shades of yellow), CRISPR arrays (maroon), and the CRISPR-associated 
gene c2c5 (blue). The example from Hassallia byssoidea (top) highlights 
the target-site duplication and terminal repeats, as well as genes found 
within the cargo portion of the transposon. As with the type I CRISPR–
Cas system-containing Tn7-like transposons, type V CRISPR–Cas 
system-containing transposons appear to preferentially contain genes 
associated with innate immune system functions, such as restriction-
modification systems. c2c5 genes are frequently flanked by the predicted 
transcriptional regulator, merR (light blue), and the C2c5-containing 
transposons appear to usually fall just upstream of tRNA genes (green), a 
phenomenon that has also been observed for other prokaryotic integrative 
elements62,63. Analysis of 50 spacers from the 8 CRISPR arrays shown 
with CRISPRTarget59 revealed 6 spacers with imperfectly matching targets 
(average of 6 mismatches), none of which mapped to bacteriophages, 
plasmids, or to the same bacterial genome containing the transposon itself. 
Whether C2c5 also mediates RNA-guided DNA integration awaits future 
experimentation.
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Structural basis of DNA targeting by a 
transposon-encoded CRISPR–Cas system
Tyler S. Halpin-Healy1, Sanne E. Klompe1, Samuel H. Sternberg1* & Israel S. Fernández1*
Bacteria use adaptive immune systems encoded by CRISPR and Cas genes to maintain 
genomic integrity when challenged by pathogens and mobile genetic elements1–3. 
Type I CRISPR–Cas systems typically target foreign DNA for degradation via joint 
action of the ribonucleoprotein complex Cascade and the helicase–nuclease Cas34,5, 
but nuclease-deficient type I systems lacking Cas3 have been repurposed for RNA-
guided transposition by bacterial Tn7-like transposons6,7. How CRISPR- and 
transposon-associated machineries collaborate during DNA targeting and insertion 
remains unknown. Here we describe structures of a TniQ–Cascade complex encoded 
by the Vibrio cholerae Tn6677 transposon using cryo-electron microscopy, revealing 
the mechanistic basis of this functional coupling. The cryo-electron microscopy maps 
enabled de novo modelling and refinement of the transposition protein TniQ, which 
binds to the Cascade complex as a dimer in a head-to-tail configuration, at the 
interface formed by Cas6 and Cas7 near the 3′ end of the CRISPR RNA (crRNA). The 
natural Cas8–Cas5 fusion protein binds the 5′ crRNA handle and contacts the TniQ 
dimer via a flexible insertion domain. A target DNA-bound structure reveals critical 
interactions necessary for protospacer-adjacent motif recognition and R-loop 
formation. This work lays the foundation for a structural understanding of how DNA 
targeting by TniQ–Cascade leads to downstream recruitment of additional 
transposase proteins, and will guide protein engineering efforts to leverage this 
system for programmable DNA insertions in genome-engineering applications.
We previously demonstrated that a transposon derived from V. cholerae 
Tn6677 undergoes programmable transposition in Escherichia coli 
directed by a crRNA, and that this activity requires four transposon- and 
three CRISPR-associated genes in addition to a CRISPR array7 (Fig. 1a). 
Whereas TnsA, TnsB and TnsC exhibit functions that are consistent with 
their homologues from the related and well-studied cut-and-paste DNA 
transposon E. coli Tn7 8, we showed that TniQ, a homologue of E. coli 
TnsD, forms a co-complex with the Cascade ribonucleoprotein com-
plex encoded by the type I-F variant CRISPR–Cas system. This finding 
suggested an alternative role for TniQ, compared with the role of E. coli 
TnsD in identifying target sites during Tn7 transposition. We proposed 
that RNA-guided DNA targeting by Cascade could deliver TniQ to DNA 
in a manner compatible with downstream transpososome formation, 
and that TniQ might interact with Cascade near the 3′ end of the crRNA, 
consistent with RNA-guided DNA insertion occurring around 49 bp down-
stream of the protospacer-adjacent motif (PAM)-distal edge of the target 
site. To determine this unambiguously, we purified the V. cholerae TniQ–
Cascade complex loaded with a native crRNA and determined its struc-
ture by cryo-electron microscopy (cryo-EM) (Supplementary Table 1).
Cryo-EM structure of TniQ–Cascade complex
The overall complex adopts a helical architecture with protuberances 
at both ends (Fig. 1, Extended Data Figs. 1, 2). The global architecture is 
similar to previously determined structures of Cascade from I-E and I-F 
systems9–12 (Extended Data Fig. 3), with the exception of a large mass 
of additional density attributable to TniQ (see below). Maximum like-
lihood classification methods implemented in Relion313 enabled us 
to identify marked dynamics in the entire complex, which appears 
to ‘breathe’, widening and narrowing the distance between the two 
protuberances (Extended Data Fig. 1d, Supplementary Video 1). The 
large subunit encoded by a natural Cas8–Cas5 fusion protein (hereafter 
referred to simply as Cas8) forms one protuberance and recognizes the 
5′ end of the crRNA via base- and backbone-specific contacts (Extended 
Data Figs. 4, 5a–c, 6a), similar to the canonical roles of Cas8 and Cas5 
(Extended Data Fig. 3). Cas8 contains two primary subdomains formed 
mainly by α-helices and a third domain of approximately 100 residues 
(residues 277 to 385) that is predicted to form three α-helices but could 
not be built in our maps owing to its intrinsic flexibility (Fig. 1c). How-
ever, low-pass-filtered maps revealed that this flexible domain connects 
with the TniQ protuberance at the opposite end of the crescent-shaped 
complex (Extended Data Fig. 2e). Additionally, there seemed to be a 
loose coupling between the Cas8 flexible domain and overall breathing 
of the complex, as stronger density for that domain could be observed 
in the closed state (Extended Data Fig. 1d, Supplementary Video 1).
Six Cas7 subunits protect much of the crRNA by forming a helical 
filament along its length (Fig. 1b, d), similar to other type I Cascade 
complexes9–12 (Extended Data Fig. 3). A ‘finger’ motif in Cas7 clamps 
the crRNA at regular intervals, causing every sixth nucleotide (nt) of 
the 32-nt spacer to flip out while leaving the flanking nucleotides 
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available for DNA recognition (Extended Data Figs. 4f, 6). These bases 
are pre-ordered in short helical segments, with a conserved pheny-
lalanine stacking below the first base of every segment. Cas7.1, the 
monomer furthest away from Cas8, interacts with Cas6 (also known 
as Csy4), which is the RNase responsible for processing of the precur-
sor RNA transcript derived from the CRISPR locus. The Cas6–Cas7.1 
interaction is mediated by a β-sheet formed by the contribution of a 
β-strand from Cas6 and the two β-strands that form the finger of Cas7.1 
(Extended Data Fig. 5f). Cas6 also forms extensive interactions with 
the conserved stem-loop in the repeat-derived 3′ crRNA handle (Fig. 1, 
Extended Data Fig. 5d, e), with an arginine-rich α-helix (residues 110 to 
128) docked in the major groove, positioning multiple basic residues 
within interaction distance of the negatively charged RNA backbone.
The interaction established between Cas6 and Cas7.1 forms a continu-
ous surface on which TniQ is docked, forming the other protuberance 
of the crescent. The intrinsic flexibility of the complex resulted in lower 
local resolutions in this area of the maps, which we overcame using 
local alignments masking the area comprising TniQ, Cas6, Cas7.1 and 
the crRNA handle (Extended Data Fig. 7). The enhanced maps enabled 
de novo modelling and refinement of TniQ, for which no previous struc-
ture or homology model has been reported, to our knowledge (Fig. 2). 
Notably, TniQ binds to Cascade as a dimer with head-to-tail configura-
tion (Fig. 2), a surprising result given the expectation that E. coli TnsD 
functions as a monomer during Tn7 transposition14.
TniQ binds to Cascade as a dimer
TniQ is composed of two domains: an N-terminal domain of approxi-
mately 100 residues formed by three short α-helices and a second, larger 
domain of approximately 300 residues with a signature sequence for 
the TniQ family. A DALI search15 using the refined TniQ model as a probe 
yielded marked structural similarity of the N-terminal domain to pro-
teins containing helix–turn–helix (HTH) domains. This domain is often 
involved in nucleic acid recognition; however, there are examples where 
it has been re-purposed for protein–protein interactions16. The remaining 
C-terminal TniQ domain is formed by ten α-helices of variable length and 
is predicted to contain two tandem zinc finger motifs, although this region 
was poorly defined in the maps (Fig. 2). Overall, the double domain com-
position of TniQ results in an elongated structure, bent at the junction of 
the HTH and the TniQ domain (Fig. 2). The HTH domain of one monomer 
engages the TniQ domain of the other monomer via interactions between 
α-helix 3 (H3) and α-helix 12 (H12), respectively, in a tight protein–protein 
interaction (Fig. 2c). This reciprocal interaction is complemented by 
multiple interactions established between the TniQ domains from both 
monomers (up to 45 non-covalent interactions as reported by PISA17).
Tethering of the TniQ dimer to Cascade is accomplished by specific 
interactions established with both Cas6 and Cas7.1 (Fig. 3). One monomer 
of TniQ interacts with Cas6 via its C-terminal TniQ domain, whereas the 
other TniQ monomer contacts Cas7.1 through its N-terminal HTH domain 
(Figs. 2b, 3). The loop connecting α-helices H7 and H8 of the TniQ domain 
of the first TniQ monomer is inserted in a hydrophobic cavity formed 
at the interface of two α-helices of Cas6 (Fig. 3b, d). The TniQ histidine 
residue 265 is involved in rearranging the hydrophobic loop connecting 
H7 and H8 (Fig. 3d), which is inserted in the hydrophobic pocket of Cas6 
formed by residues L20, Y74, M78, Y83 and F84. The buried surface in the 
Cas6–TniQ.1 interaction interface has an area of 420 Å2. The HTH domain 
of the other TniQ monomer interacts with Cas7.1 through a network of 
interactions established mainly by α-helix H2 and the linker connecting H2 
and H3, burying a surface area of 595 Å2 (Fig. 3c, e). Thus, the HTH domain 
and the TniQ domain exert dual roles to drive TniQ dimerization and dock 
onto Cascade. The aggregate buried surface area for the TniQ–Cascade 
interaction is 1,015 Å2, significantly smaller than other Cascade–effector 
interactions such as with the nuclease Cas3, in which 2,433 Å2 is buried18. 
This difference is not surprising given the flexibility observed for the 
TniQ dimer in its association with Cascade (Supplementary Video 1).
Structure of the DNA-bound TniQ–Cascade complex
To investigate the structural determinants of DNA recognition by the 





























































Fig. 1 | Overall architecture of the V. cholerae TniQ–Cascade complex. 
 a, Genetic architecture of the Tn6677 transposon (top), and plasmid constructs 
used to express and purify the TniQ–Cascade complex. Right, selected cryo-EM 
reference-free two-dimensional class averages in multiple orientations.  
b, Orthogonal views of the cryo-EM map of the TniQ–Cascade complex, 
showing Cas8 (purple), six Cas7 monomers (green), Cas6 (salmon), crRNA (grey) 
and TniQ monomers (blue, yellow). The complex adopts a helical architecture 
with protuberances at both ends. c, A flexible domain in Cas8 comprising 
residues 277–385 (grey) could only be visualized in low-pass-filtered maps. The 
unsharpened map is shown as semi-transparent, grey map overlaid on the post-
processed map segmented and coloured as in a. d, Refined model for the TniQ–
Cascade complex derived from the cryo-EM maps shown in b.
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bound to a double-stranded DNA (dsDNA) substrate containing the 
32-bp target sequence, 5′-CC-3′ PAM, and 20 bp of flanking dsDNA on 
both ends (Fig. 4, Extended Data Fig. 8). Density for 28 nucleotides of 
the target strand and 8 nucleotides of the non-target strand could be 
confidently assigned in the reconstructed maps (Fig. 4c). As with previ-
ous I-F Cascade structures, Cas8 recognizes the double-stranded PAM 
within the minor groove11 (Extended Data Fig. 9), and an arginine residue 
(R246) establishes a stacking interaction with a guanine nucleotide on 
the target strand, which acts as a wedge to separate the double-stranded 
PAM from the neighbouring unwound DNA where base-pairing with 
the crRNA begins (Fig. 4c).
Twenty-two nucleotides of the target strand within the 32-bp target 
showed clear density, but surprisingly, the terminal nine nucleotides 
were not ordered. The target-strand base pairs with the spacer region of 
the crRNA in short, discontinuous helical segments, as observed previ-
ously for I-E and I-F DNA-bound Cascade complexes11,12, with every sixth 
base flipped out of the heteroduplex by the insertion of a Cas7 finger 
(Extended Data Fig. 6b). The observed 22-bp heteroduplex is stabilized 
by the four Cas7 monomers proximal to the PAM (Cas7.6–Cas7.3), but 
even after local masked refinements, no density could be observed for 
any target strand nucleotides that would base-pair with the 3′ end of the 
crRNA spacer bound by Cas7.2 and Cas7.1. These two Cas7 monomers are 
proximal to Cas6 and in the region previously described to exhibit dynam-
ics owing to the interaction of the Cas8 flexible domain with the inner 
face of the TniQ dimer. In addition, the disordered nucleotides also cor-






































































































Fig. 2 | TniQ binds Cascade in a dimeric, head-to-tail configuration. a, Left, 
overall view of the TniQ–Cascade cryo-EM unsharpened map (grey) overlaid on 
the post-processed map segmented and coloured as in Fig. 1. Right, cryo-EM 
map (top) and refined model (bottom) of the TniQ dimer. The two monomers 
interact with each other in a head-to-tail configuration and are anchored to 
Cascade by Cas6 and Cas7.1. b, Secondary structure diagram of the TniQ dimer: 
thirteen α-helices are organized into an N-terminal HTH domain and a 
C-terminal TniQ domain. Dimer interactions between H3 and H12 are indicated, 
as are interaction sites with Cas6 and Cas7.1. c, Cryo-EM density for the H3–H12 
interaction shows clear side-chain features (top), allowing accurate modelling 
of the interaction (bottom). d, Schematic of the dimer interaction, showing the 













































Fig. 3 | Cas6 and Cas7.1 form a binding platform for TniQ. a, Top, magnified 
area showing the interaction site of Cascade and the TniQ dimer. Cas6 and Cas7.1 
are displayed as molecular Van der Waals surfaces, the crRNA is shown as grey 
spheres and the TniQ monomers are shown as ribbons. b, The loop connecting 
TniQ.1 α-helices H7 and H8 (blue) binds within a hydrophobic cavity of Cas6.  
c, Cas7.1 interacts with the HTH domain of the TniQ.2 monomer (yellow), mainly 
through H2 and the loop connecting H2 and H3. d, e, Experimental cryo-EM 
densities observed for the TniQ–Cas6 (d) and TniQ–Cas7.1 (e) interactions.
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are detrimental for RNA-guided DNA integration7. Thus, we propose 
that the partial R-loop structure that we observed could represent an 
intermediate conformation refractory to integration, and that further 
structural rearrangements may be critical for further stabilization of an 
open conformation, possibly driven by recruitment of the TnsC ATPase.
Here we present cryo-EM structures of a CRISPR–Cas effector com-
plex bound to the transposition protein TniQ, with and without target 
DNA. These structures reveal the unexpected presence of TniQ as a 
dimer that forms bipartite interactions with Cas6 and Cas7.1 within 
the Cascade complex, forming a probable recruitment platform for 
downstream-acting transposition proteins19 (Fig. 4d). Our structures 
further reveal a possible fidelity checkpoint, whereby formation of a 
complete R-loop requires conformational rearrangements that may 
depend on extensive RNA–DNA complementarity and/or downstream 
factor recruitment; this proofreading step could account for the highly 
specific RNA-guided DNA integration that we previously reported for 
the V. cholerae transposon7. In light of recent work demonstrating exap-
tation of type V-K CRISPR–Cas systems by similar Tn7-like transposons 
that also encode TniQ20,21, it will be informative to determine whether 
tethering of TniQ to evolutionarily distinct crRNA effector complexes—
Cascade or Cas12k—is a general theme of RNA-guided transposition.
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Fig. 4 | DNA-bound structure of the TniQ–Cascade complex. a, Schematic of 
crRNA and the portion of the dsDNA substrate that was experimentally 
observed within the electron density map for DNA-bound TniQ–Cascade. The 
target strand, non-target strand, PAM and seed regions are indicated (left); 
protein components are shown on the right. b, Selected cryo-EM reference-
free two-dimensional class averages for DNA-bound TniQ–Cascade; density 
corresponding to dsDNA could be directly observed protruding from the Cas8 
component in the two-dimensional class averages (white arrows). c, Cryo-EM 
map for DNA-bound TniQ–Cascade. The crRNA is shown in dark grey and the 
DNA is shown in red. Right bottom, detailed views of the PAM and seed-
recognition regions of the map, with refined models represented as sticks 
within the electron density. Cas8 is shown in purple, Cas7 is shown in green, 
the crRNA is in grey and DNA is shown in red. NTS, non-target strand. d, The  
V. cholerae transposon encodes a TniQ–Cascade co-complex that uses the 
sequence content of the crRNA to bind complementary DNA target sites. We 
propose that the incomplete R-loop observed in our structure (middle) 
represents an intermediate state that may precede a downstream ‘locking’ step 
involving proofreading of the RNA–DNA complementarity. TniQ is positioned 
at the PAM-distal end of the DNA-bound Cascade complex, where it probably 
interacts with TnsC during downstream steps of RNA-guided DNA insertion.
Methods
No statistical methods were used to predetermine sample size. The 
experiments were not randomized. The investigators were not blinded 
to allocation during experiments and outcome assessment.
TniQ–Cascade purification
Protein components of TniQ–Cascade were expressed from a pET-
derivative vector containing the native V. cholerae tniQ-cas8-cas7-
cas6 operon with an N-terminal His10-MBP-TEV site fusion on TniQ. 
The crRNA was expressed separately from a pACYC-derivative vector 
containing a minimal repeat–spacer–repeat CRISPR array encoding 
a spacer from the endogenous V. cholerae CRISPR array. The TniQ–
Cascade complex was overexpressed and purified as described previ-
ously7, and was stored in Cascade storage buffer (20 mM Tris-Cl, pH 7.5, 
200 mM NaCl, 1 mM DTT, 5% glycerol).
Sample preparation for electron microscopy
For negative staining, 3 µl of purified TniQ–Cascade ranging from 
100 nM to 2 µM was incubated with plasma treated (H2/O2 gas mix, Gatan 
Solarus) CF400 carbon-coated grids (EMS) for 1 min. Excess solution 
was blotted and 3 µl of 0.75% uranyl formate was added for an additional 
minute. Excess stain was blotted away and grids were air-dried over-
night. Grid screening for both negative staining and cryo conditions was 
performed on a Tecnai-F20 microscope (FEI) operated at 200 KeV and 
equipped with a Gatan K2-Summit direct detector. Microscope opera-
tion and data collection were carried out using the Leginon/Appion 
software. Initial negative staining grid screening allowed determina-
tion of a suitable concentration range for cryo conditions. Several grid 
geometries were tested in the 1–4 µM concentration range for cryo 
conditions using a Vitrobot Mark-II operated at 4 °C, 100% humidity, 
blot force 3, drain time 0, waiting time 15 s, and blotting times ranging 
from 3–5 s. The best ice distribution and particle density was obtained 
with 0.6/1 UltrAuFoil grids (Quantifoil).
Electron microscopy
A preliminary dataset of 300 images in cryo was collected with the 
Tecnai-F20 microscope using a pixel size of 1.22 Å/pixel with illumina-
tion conditions adjusted to 8 e−/pixel/second with a frame window of 
200 ms. Preprocessing and image processing were integrally done 
in Relion313 with ctf estimation integrated via a wrapper to Gctf22. An 
initial model computed using the SGD algorithm23 implemented in 
Relion3 was used as initial reference for a refine three-dimensional job 
that generated a sub-nanometric reconstruction with approximately 
10,000 selected particles. Clear secondary structure features in the 
two-dimensional averages and the three-dimensional reconstruction 
could be identified.
For the DNA-bound TniQ–Cascade complex containing DNA, 




CGGTCCAATGGCTTGATGAA-3′) for 5 min at 95 °C in hybridization 
buffer (20 mM Tris-Cl, pH 7.5, 100 mM KCl, 5 mM MgCl2) to form dsDNA, 
which was subsequently aliquoted and flash-frozen. Complex forma-
tion was performed by incubating a 3× molar excess of dsDNA with 
TniQ–Cascade at 37 °C for 5 min before vitrification, which followed the 
conditions optimized for the apo complex (defined as TniQ–Cascade 
with crRNA but no DNA ligand).
High-resolution data for the apo complex were collected in a Tecnai-
Polara-F30 microscope operated at 300 KeV equipped with a K3 direct 
detector (Gatan). A 30-µm C2 aperture was used with a pixel size of 
0.95 Å/pixel and illumination conditions in microprobe mode adjusted 
to a fluence of 16 e−/pixel/second. Four-second images with a frame 
width of 100 ms (1.77 e−/Å2/frame) were collected in counting mode.
For the DNA-bound complex, high-resolution data were collected 
in a Titan Krios microscope (FEI) equipped with an energy filter 
(20 eV slit width) and a K2 direct detector (Gatan) operated at 300 
KeV. A 50-µm C2 aperture was used with a pixel size of 1.06 Å/pixel and 
illumination conditions adjusted in nanoprobe mode to a fluence of 
8 e−/pixel/second. Eight-second images with a frame width of 200 ms 
(1.42 e−/Å2/frame) were collected in counting mode.
Image processing
Motion correction was performed for every micrograph applying the 
algorithm described for Motioncor224 implemented in Relion3 with 5 by 
5 patches for the K2 data and 7 by 5 patches for the K3 data. Parameters 
of the contrast transfer function for each motion-corrected micrograph 
were obtained using Gctf22 integrated in Relion3. Initial particle pick-
ing of a subset of 200 images randomly chosen was performed with 
the Laplacian tool of the Auto-picking module of Relion3, using an 
estimated size for the complex of 200 Å. Then, 15,000 particles were 
extracted in a 300-pixel box size and binned 3 times for an initial two-
dimensional classification job. Selected two-dimensional averages from 
this job were used as templates for Auto-picking of the full dataset. The 
full dataset of binned particles was subjected to a two-dimensional 
classification job to identify particles able to generate averages with 
clear secondary structure features. The selected subgroup of binned 
particles after the two-dimensional classification selection was refined 
against a three-dimensional volume obtained by SGD with the F20 data. 
This consensus volume was inspected to localize areas of heterogeneity 
that were clearly identified at both ends of the crescent shape char-
acteristic of this complex. Both ends were then individually masked 
using soft masks of around 20 pixels that were subsequently used in 
classification jobs without alignments in Relion3. The T parameter 
used for this classification job was 6 and the total number of classes 
was 10. This strategy allowed us to identify two main population of 
particles which correspond to an open and closed state of the complex. 
Particles from both subgroups were separately re-extracted to obtain 
unbinned data sets for further refinement. New features implemented 
in Relion3, namely Bayesian polishing and ctf parameters refinement, 
allowed the extension of the resolution to 3.4, 3.5 and 2.9 Å for the two 
apo and the DNA-bound complexes, respectively. Post-processing was 
performed with a soft-mask of 5 pixels being the B-factor estimated 
automatically in Relion3 following standard practice. A final set of 
local refinements was performed with the masks used for classifica-
tion. The locally aligned maps exhibit very good quality for the ends of 
the C-shape. These maps were used for de novo modelling and initial 
model refinement.
Model building and refinement
For the Cas7 and Cas6 monomers, the E. coli homologues (PDB acces-
sion code 4TVX) were initially docked with Chimera25 and transformed 
to poly-alanine models. Substantial rearrangement of the finger region 
of Cas7 monomers, as well as other secondary structure elements of 
Cas6, were performed manually in COOT26 before amino acid sub-
stitution of the poly-alanine model. Well-defined bulky side chains 
of aromatic residues allowed a confident assignment of the register. 
The crRNA was also well defined in the maps and was traced de novo 
with COOT. For Cas8 and TniQ in particular, no structural similarity 
was found in the published structures that was able to explain our 
densities. Locally refined maps using soft masks at both ends of the 
crescent-shaped complex rendered well-defined maps below 3.5 Å 
resolution. These maps were used for manual de novo tracing of a 
poly-alanine model in COOT that was subsequently mutated to the 
V. cholerae sequences. Bulky side chains for aromatic residues showed 
excellent density and were used as landmarks to adjust the register of 
the sequence.
For refinement, an initial step of real-space refinement against the 
cryo-EM maps was performed with the phenix.real_space refinement 
Article
tool of the Phenix package27, with secondary structure restraints acti-
vated. A second step of reciprocal space refinement was performed in 
Refmac528, with secondary restraints calculated with Prosmart29 and 
LibG30. Weight of the geometry term versus the experimental term 
was adjusted to avoid overfitting of the model into cryo-EM map, as 
previously reported31. Model validation was performed in Molprobity32.
Reporting summary
Further information on research design is available in the Nature 
Research Reporting Summary linked to this paper.
Data availability
Maps and models have been deposited in the Electron Microscopy Data 
Bank with accession codes EMD-20349, EMD-20350 and EMD-20351 
and the Protein Data Bank with accession codes 6PIF, 6PIG and 6PIJ.
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Extended Data Fig. 1 | Cryo-EM sample optimization and image processing 
workflow. a, Representative negatively stained micrograph for 500 nM TniQ–
Cascade. b, Left, representative cryo-EM image for 2 µM TniQ–Cascade. A small 
dataset of 200 images was collected in a Tecnai-F20 microscope equipped with 
a Gatan K2 camera. Right, reference-free two-dimensional class averages for 
this initial cryo-EM dataset. c, Left, representative image from a large dataset 
collected in a Tecnai Polara microscope equipped with a Gatan K3 detector. 
Middle, detailed two-dimensional class averages were obtained that were used 
for initial model generation using the SGD algorithm23 implemented in 
Relion313 (right). d, Image processing workflow used to identify the two main 
classes of the TniQ–cascade complex in open and closed conformations. Local 
refinements with soft masks were used to improve the quality of the map within 
the terminal protuberances of the complex. These maps were instrumental for 
de novo modelling and initial model refinement.
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Extended Data Fig. 2 | Fourier shell correlation curves, local resolution, and 
unsharpened filter maps for the TniQ–Cascade complex in closed 
conformation. a, Gold-standard Fourier shell correlation (FSC) curve using 
half maps; the global resolution estimation is 3.4 Å by the FSC 0.143 criterion.  
b, Cross-validation model-versus-map FSC. Blue curve, FSC between the 
shacked model refined against half map 1; red curve, FSC against half map 2, not 
included in the refinement; black curve, FSC between final model against the 
final map. The overlap observed between the blue and red curves guarantees a 
non-overfitted model. c, Unsharpened map coloured according to local 
resolutions, as reported by RESMAP33. d, Final model coloured according to 
B-factors calculated by REFMAC28. e, A flexible Cas8 domain encompassing 
residues 277–385 contacts the TniQ dimer at the other side of the crescent 
shape. Applying a Gaussian filter of increasing width to the unsharpened map 
allows for a better visualization of this flexible region.
Extended Data Fig. 3 | Alignment of TniQ–Cascade with structurally similar 
Cascade complexes. The V. cholerae I-F variant TniQ–Cascade complex (left) 
was superposed with Pseudomonas aeruginosa I-F Cascade11 (also known as Csy 
complex; middle, PDB ID: 6B45) and E. coli I-E Cascade9 (right, PDB ID: 4TVX). 
Shown are alignments of the entire complex (top), the Cas8 and Cas5 subunits 
with the 5′ crRNA handle (second from top), the Cas7 subunit with a fragment of 
crRNA (second from bottom) and the Cas6 subunit with the 3′ crRNA handle 
(bottom).
Article
Extended Data Fig. 4 | Representative cryo-EM densities for all the 
components of the TniQ–Cascade complex in closed conformation. a, Final 
refined model of TniQ–Cascade, with Cas8 in purple, Cas7 monomers in green, 
Cas6 in salmon, the TniQ monomers in blue and yellow, and the crRNA in grey. 
b–h, Final refined model inserted in the final cryo-EM density for select regions 
of all the molecular components of the TniQ–Cascade complex. Residues are 
numbered.
Extended Data Fig. 5 | Cas8 and Cas6 interaction with the crRNA. a, Refined 
model for the TniQ–Cascade shown as ribbons inserted in the semi-transparent 
Van der Waals surface, coloured as in Fig. 1. b, c, Magnified view of Cas8, which 
interacts with the 5′ end of the crRNA. The inset shows electron density for the 
highlighted region, where the base of nucleotide C1 is stabilized by stacking 
interactions with arginine residues R584 and R424. d, Cas6 interacts with the  
3′ end of the crRNA ‘handle’ (nucleotides 45–60). e, An arginine-rich α-helix is 
deeply inserted within the major groove of the terminal stem–loop. This 
interaction is mediated by electrostatic interactions between basic residues of 
Cas6 and the negatively charged phosphate backbone of the crRNA. f, Cas6 
(salmon) also interacts with Cas7.1 (green), establishing a β-sheet formed by 
β-strands contributed from both proteins.
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Extended Data Fig. 6 | Schematic representation of crRNA and target DNA 
recognition by TniQ–Cascade. a, TniQ–Cascade residues that interact with 
the crRNA are indicated. Approximate location for all protein components of 
the complex are also shown, as well as the position of each Cas7 finger. b, TniQ–
Cascade residues that interact with crRNA and target DNA, shown as in a.
Extended Data Fig. 7 | FSC curves, local resolution, and local refined maps 
for the TniQ–Cascade complex in open conformation. a, Gold-standard FSC 
curve using half maps; the global resolution estimation is 3.5 Å by the FSC 0.143 
criterion. b, Cross-validation model-versus-map FSC. Blue curve, FSC between 
shacked model refined against half map 1; red curve, FSC against half map 2, not 
included in the refinement; black curve, FSC between final model against the 
final map. The overlapping between the blue and red curves guarantees a non-
overfitted model. c, Unsharpened map coloured according to local 
resolutions, as reported by RESMAP33. Right, slice through the map shown on 
the left. d, Local refinements with soft masks improved the maps in flexible 
regions. Shown is the region of the map corresponding to the TniQ dimer. 
Unsharpened maps coloured according to the local resolution estimations are 
shown before (left) and after (right) masked refinements. e, Final model for the 
TniQ dimer region, coloured according to the local B-factors calculated by 
REFMAC28.
Article
Extended Data Fig. 8 | FSC curves, local resolution, and unsharpened filter 
maps for the DNA-bound TniQ–Cascade complex complex. a, Gold-standard 
FSC curve using half maps; the global resolution estimation is 2.9 Å by the FSC 
0.143 criterion. b, Cross-validation model-versus-map FSC. Blue curve, FSC 
between the shacked model refined against half map 1; red curve, FSC against 
half map 2, not included in the refinement; black curve, FSC between final 
model against the final map. The overlap observed between the blue and red 
curves guarantees a non-overfitted model. c, Left, unsharpened map coloured 
according to local resolutions, as reported by RESMAP33. dsDNA is visible at the 
top right projecting outside of the complex. Right, final model coloured 
according to B-factors calculated by REFMAC28.
Extended Data Fig. 9 | Alignment of DNA-bound TniQ–Cascade with 
structurally similar Cascade complexes. The DNA-bound structure of V. 
cholerae I-F variant TniQ–Cascade complex (left) was superposed with DNA-
bound structures of P. aeruginosa I-F Cascade11 (also known as Csy complex; 
middle, PDB ID: 6B44) and E. coli I-E Cascade9 (right, PDB ID: 5H9F). Shown are 
alignments of the entire complex (top), the Cas8 and Cas5 subunits with the  
5′ crRNA handle and double-stranded PAM DNA (middle top), the Cas7 subunit 
with a fragment of crRNA (middle bottom), and the Cas6 subunit with the  
3′ crRNA handle (bottom).
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